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Abstract
Background: Obesity has become more prevalent in the last 20 years. Dietary 
fibre (DF) and calcium (Ca) as functional food-ingredients are linked through 
epidemiology to weight-management, but the impact of these as isolated 
ingredients in obesity is unknown.
Objective: To investigate the short-term effects of DF from resistant starch 
(RS), or fenugreek (Fen), and Ca, on appetite, satiety and postprandial 
metabolism in overweight/obese subjects.
Methods: In a series of appetite experiments, these functional ingredients were 
given to overweight/obese subjects as part of standardized meals with a 
concomitant measurement of subjective appetite ratings, acute energy intake 
(El), and postprandial metabolism. In each case, the treatment effect was 
compared to a matched control.
Results: RS reduced the El at the subsequent ad libitum meal (ALM) (p=0.02), 
but had no significant impact on satiety or hunger.
Following RS, hunger and prospective food consumption was lower in the 
obese group versus the lean group (p=<0.001; />=0.057 respectively). There 
were no significant differences in El at the ALM or over the 24h period. While 
obese subjects had higher insulin and C-peptide, their postprandial plasma GLP-
XXll
1 was lower (p=0.009).
Consumption of a fenugreek-enriched drink elevated the plasma glucose levels 
and remained above fasting levels for 4 hours postprandial (p=0.02). This 
finding was combined with a reduction in energy intake at an ATM (p=0.030). 
However, no significant differences over 24h were observed between treatment 
groups. Conversely, the Ca-enriched drink reduced El at the ALM (p=0.017), 
decreased rated prospective consumption (p=0.012), hunger (p=0.05) and GLP-
1 (p<0.001).
Conclusion: Acute consumption of DF and Ca reduced food intake, indicating 
an effect on short-term satiety. Our data suggest a weak relationship between 
satiety and GLP-1 secretion in obese individuals. Further studies are required to 
determine these mechanisms on appetite and to confirm whether the effect can 
be maintained in the longer-term.
X X lll
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1. Chapter 1 Literature Review 
Introduction
The increased prevalence of obesity has been widely reported over the past 20 
years. This massive increase in obesity may implicate environmental rather than 
genetic factors, or even, an interaction between the two (Foresight, 2007). 
Obesity is a complex disease, and changes in lifestyle and dietary habits are 
known to play critical roles in its onset and development. Therefore, it is crucial 
to identify the changes in food-choices, which will be most effective in reducing 
obesity.
It should be noted that any disruption in the energy balance of the body is key to 
obesity-development. Therefore, there is sufficient demand to identify strategies 
that can help decrease energy intake on one side of the energy balance equation. 
One of these targets involves the control of appetite, satiation and satiety and, 
through the subsequent reduction in food intake, control of one’s bodyweight. 
The development of food enhancement-satiety is one of these potential 
strategies (Benelam, 2009). Food products, may lead to the early termination of 
eating and so help in controlling the meal/portion sizes and therefore, reduce 
overall energy intake (Halford & Harrold, 2012).
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The following literature review will discuss obesity-development and the effects 
of satiety with regard to some macronutrients (dietary fibre) and bioactive 
components (dietary calcium). It will also review the impact of consumption of 
viscous and non-viscous fibres on satiety and appetite control along with the 
effect of calcium consumption on obesity development.
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Obesity
1.2.1 Definition of obesity
Obesity is an “abnormal or excessive accumulation of body fat that may have 
detrimental effects on health”, as per the World health Organisation (WHO, 
2013b). Body Mass Index (BMI) is widely used among adults in order to classify 
them as overweight or obese. This is calculated as one’s weight in kilograms 
divided by height in meters squared.
The WHO classification of BMI is:
• A BMI between 20- 25 (kg/m^) is a healthy weight
• A BMI greater than or equal to 25 (kg/m^) is overweight
• A BMI greater than or equal to 30 (kg/m^) is obese.
Obesity is associated with an increased risk of numerous health problems, 
including several of the major causes of death and disability in the developed 
world: cardiovascular disease, diabetes and some of the most common cancers 
(WHO, 2002).
1.2.2 Prevalence of Obesity
According to the WHO, obesity has doubled around the world since the 1980s 
(WHO, 2009). Most recently, in a 2010 analysis by the International Association 
for the Study of Obesity (lASO) and the International Obesity Taskforce (lOTF), it
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was estimated that one billion adults were overweight and the number of obese 
people was close to 475 million, globally (lASO/ lOTF, 2010). Further, the 
lASO/IOTF analysis also reported that there were approximately 200 million 
overweight or obese children worldwide (lASO/ lOTF, 2010). The WHO also 
states that by 2015, approximately 2.3 billion of the adults will be overweight and 
>700 million, obese (WHO, 2009).
A recent analysis of the obesity trends for the next 20 years in both, the United 
States and the United Kingdom, as obtained from the National Health and 
Nutrition Examination Survey (NHANES) in the US and the Health Survey for 
England (HSE) (Wang et al., 2011) maintains that the US will witness an increase 
in obesity prevalence from 32% in 2007 to about 50-51% in 2030 among men and 
from 35% to 45%-52% for women. In the UK too, the prevalence of obesity is 
expected to rise by from about 26% in 2000 to 41%-48% among men and from 
26% to 35%-43% among women by 2030.
Therefore, the author suggests that by 2030, the number of obese adults in the US 
will be around 65 million. By 2030, there will be 11 million more obese adults in 
the UK compared to figures recorded in 2010. As a result, the numbers for those 
diagnosed with diabetes will increase between 6 to 8.5 million, and those with 
heart disease and stroke will be between 5.7 and 7.3 million (Wang et al., 2011).
Overweight and obese adults are common sights in Saudi Arabia. Based on the
National Nutrition Survey of 2007, the prevalence of obesity in Saudi Arabia was
4
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estimated at 23.6% among women and 14% in men. In addition, it has been
estimated that prevalence of overweight was approximately 30.7% for men 
compared with 28.4% among the women (Al-Othaimeen et al., 2007). The 
Coronary Artery Disease in Saudis Study (CADISS) of 2005, has also determined 
the prevalence of obesity in Saudi Arabia to stand at 35.5% which means that one 
in every three adults in Saudi Arabia is obese (Al-Nozha et al., 2005).
1.2.3 Etiology of obesity
Obesity development is caused by energy imbalance, which occurs when the 
energy intake exceeds energy expenditure and results in weight gain (Wilding, 
2011; Hofbauer, 2002). There are a number of factors -  both genetic and 
environmental — which may affect the body’s energy balance and cause obesity.
Over the last decades, the obesity rate has increased as a result of environmental 
changes affecting eating behaviour and the reductions in the levels of physical 
activities (Hill et al., 2003). In the developing world, being obese and overweight 
is on the rise due to globalisation that affects the diet, physical activity levels and 
body-size of individuals thereby adopting pathways similar to those observed in 
the developed countries.
Despite the fact that the genetic factors may also increase one’s disposition to be 
obese, there is less chance of pathogenic factors being responsible because the rate
Najlaa Al-Mana Thesis
of obesity has doubled since the 1980s. Therefore, it has been suggested that the
‘obesogenic’ environmental factors may lead to obesity-development through the 
availability of high-energy, dense food and the tendency to lead a sedentary 
lifestyle (Wardle et al., 2007; Friedman, 2009).
Various behavioural factors play important roles in obesity-development. In the 
last four decades, high-energy diets especially the western diet, have been seen to 
affect eating patterns through an increase in the consumption of energy-dense 
foods including, soft drinks that are high in fat and/or sugar. Evidence shows that 
consumption of high-fat foods results in a reduction in the satiety responses 
compared to high-complex carbohydrate diets (Hancox et al., 2004). In addition, 
such types of foods are often more economical and so may indicate the role of the 
socioeconomic status as a prime player in both countries and individuals when it 
comes to gaining weight (Putnam & Allshouse., 1999). It has been repeatedly 
shown that people with low socioeconomic status are more likely to develop 
obesity (Drewnowski & Specter, 2004).
While environmental and behavioural factors are important, evidence shows that 
genetic factors may affect an individual’s susceptibility for obesity (Agras et al., 
2004; Agras & Mascola, 2005; Bell et al., 2005). Several genes associated with 
obesity have been discovered in animals, although only a few single genes have 
been identified in humans (Comuzzie & Allison, 1998). The most common single 
gene correlated with obesity is the melanocortin-4 receptor gene, which acts to
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suppress food intake and is present in approximately 4% of the obese population 
with its subsequent deficiency leading to severe obesity (Farooqi et ah, 2000). The 
fat mass and obesity-associated protein (FTO) gene has also been linked with an 
increase in the risk of common obesity (Frayling et al., 2007). Evidence has shown 
that FTO variations are associated with moderate increases in food intake, lower 
satiety, and reduction in lipolysis in adipocytes (Wardle et al., 2009; Walley et al., 
2009; Haupt et al., 2008). In addition, another important gene involved in body 
weight regulation, leptin, has been proved to play a role in reduction of body 
weight while its deficiency among children has often been responsible for severe 
obesity (Clement et al., 1998; Montague et al., 1997)
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1.3 The role of Satiation and Satiety on Appetite regulation
Appetite has been defined by Blundell as a concept that “covers the whole field 
of food intake, selection, motivation and preference” (Blundell et ah, 2010). 
Generally, appetite is affected by the consumption of foods and drinks through 
two phases, which include satiation (Intra- meal) and satiety (Inter-meal) 
(Blundell et al., 2010; Halford & Harrold, 2012).
The term hunger refers to the sensations that can promote food consumption 
combined with cognitive factors, which bring an end to a meal. Hunger can 
define the time, the quality and the quantity of the food consumed (Blundell et 
al., 2010; Mattes et al., 2005; Halford & Harrold, 2012).
Satiation (Intra- meal) is involved the process that leads to the termination of 
eating, which may be accompanied by a feeling of satisfaction (Benelam, 2009; 
Halford & Harrold, 2012). Interestingly, intra-meal satiation can define the 
duration and the size of a meal as well as the rate of consumption (Benelam, 
2009; Halford & Harrold, 2012).
Satiety (Inter-meal) refers to the feeling of fullness that persists after eating, 
potentially suppressing further energy intake until hunger returns (Blundell et 
al., 2010; Benelam, 2009; Halford & Harrold, 2012). Additionally, inter-meal 
satiety may regulate food consumption between eating occasions and delay the
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initiation of the next meal and so, control the number of eating episodes over 
the course of a day (Halford & Harrold, 2012).
Notably, while satiation plays a role in controlling the amount of energy 
consumed at each meal, satiety impacts the length of intervals between meals 
and the amount consumed at the next meal. Both satiation and satiety, 
significantly impact energy intake; therefore, total daily energy intake is a 
function of both, the number and the size of the meals. However, other 
processes are required to promote satiety despite the effectiveness of fullness as 
an inhibitor of food intake after the consumption of a meal. Therefore, the 
chemical and the physical properties of the food, which include the 
macronutrient composition, the bulk and the solidity, as well as the sensory 
process of eating may affect satiety. For example, palatability may impact via 
hunger stimulation and satiation postponement.
The satiety cascade (Figure 1.1) is a model that refers to a conceptual 
framework that evaluates the effect of food on satiation and satiety (Blundell et 
al., 1987). The cascade also highlights the factors that may affect satiation and 
satiety from the time the meal begins to late satiety. These factors include the 
sensory, cognitive, post-ingestive and post-absorptive stages (Blundell et al.,
1987) as shown in Figure 1.1.
A satiety cascade also demonstrates the role of the sensory and cognitive factors
that may affect satiation and satiety including the taste o f the food or the drink,
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its texture and smell. In the stomach, the post-ingestive factors commence their 
work. At first, to initiate satiation, the distension of the stomach sends afferent 
signals to the brain. In the small and large intestines, the GI tract releases 
hormones, which are detected within the arcuate nucleus of the hypothalamus 
and these ultimately promote satiation and satiety. In the post-absorptive stage, 
the brain provides some information about the nutrient status, which may affect 
satiety (Blundell et al., 1987).
Meal quality
Expectations
Reward/Pleasure
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Associations
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prior beliefs 
and associations
Meal Quantity
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Osmotic load 
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GLP-1 
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Ghrelin
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Figure 1.1 The Satiety Cascade from (Blundell at al., 2010)
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1.4 Physiological mechanisms of satiety
Satiety is affected by both the short-term signals that refer to the food intake 
response and by longer-term signals that include the levels of energy stored in 
the body. The signals act via different mechanisms on the brain’s hypothalamus, 
which results in the production of signals that influence energy expenditure and 
energy intake.
1.4.1 Short-term signals of satiety
The gut releases a number of hormones after the consumption of food, which 
impacts directly or indirectly on specific areas of the hypothalamus to regulate 
satiety. A summary of gut hormones and their actions is shown in Table 1.1. 
This thesis will focus on the role of the gut hormones GLP-1.
GLP-1 is secreted from the L-cells of the distal small intestine (ileum) and the
large intestine in proportion to carbohydrate and fat absorption (Vilsboll et al.,
2003; Holst, 2007; Hameed et al., 2009; Dailey & Moran, 2013). Two forms of
GLP-1 can be found in the circulatory system GLP-1 (7-36) amide and GLP-1
(7-37) amide with the major bioactive form in humans, GLP-1 (7-36). GLP-1 is
rapidly degraded by the enzyme dipeptidyl-peptidase IV (DPP-IV) and only 10-
15% reaches the systemic circulatory system, intact (Holst, 2007; Harrold et al.,
2012; Dailey & Moran, 2013). Following the meal, GLP-1 concentrations
increase within 10-15 minutes and peak by 40 minutes, and remain elevated for
11
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2-3 hours after the meal (Neary & Batterham, 2009; Rask et al., 2001; Duca & 
Covasa, 2012).
The mechanism of the effect of GLP-1 on appetite regulation has been 
suggested to be by through the release of insulin, which inhibits the release of 
glycogen from the liver (Holst, 2007; Murphy & Bloom, 2006; Harrold et al., 
2012). This stimulation of insulin release by GLP-1 may lower the glucose in 
the blood and inhibit gastric emptying, which may impact satiety (‘ileal brake’) 
(Holst, 2007; Wren & Bloom, 2007; Duca & Covasa, 2012).
In addition, GLP-I may slow gastric emptying and regulate the release of 
gastric acid, which results in the ‘ileal brake’ mechanism of the upper 
gastrointestinal tract, which in turn may enhance satiety and inhibit food intake 
(Dailey & Moran, 2013; Hameed et al., 2009; Verdich, Toubro, et al., 2001; 
Naslund et al., 1999).
The actions of GLP-1 are mediated by the direct impact on GLP-1 receptor 
(GLP-1 R) (Yamamoto et al., 2003; Vilsboll et al., 2012). GLP-1 R is a G 
protein-coupled receptor expressed in the gut, brainstem, hypothalamus and 
vagal afferent nerves (Vahl et al., 2007; Dailey & Moran, 2013; Murphy & 
Bloom, 2006). It has been suggested that GLP-I may reach the central nervous 
system (CNS) directly via the area postrema, which lacks a blood-brain barrier, 
however; this pathway is still not completely clear (Hameed et al., 2009).
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Administration of GLP-1 in normal-weight (Degen et al., 2007; Gutzwiller et 
al., 2004), diabetic (J.-P. Gutzwiller et al., 1999) and obese subjects (Naslund et 
al., 2004) results in decreased energy intake, reduction in hunger ratings and 
increased feelings of fullness. Evidence has shown that the released GLP-1 is 
reduced in obese subjects (Holst et al., 1983; Ranganath et al., 1996; Naslund et 
al., 1999) while GLP-1 levels are normalised after weight loss (Verdich, 
Toubro, et al., 2001).
Table 1.1 The summary of the role of gut hormones on appetite regulation and other actions.
Gut
hormones
Feeding Receptor Major secretion site Other action
PYY Y2 L cells in gut Delays gastric emptying, 
pancreatic exocrine secretion 
and gastric acid secretion
PP Y4, Y5 PP cells in pancreas Delays gastric emptying, 
attenuates pancreatic exocrine 
secretion
GLP-1 GLP-1 L cells in gut Incretin, decrease blood 
glucose, delays gastric 
emptying
OXM i GLP-1 L cells in gut Inhibit gastric acid secretion and gastric emptying
Glucagon GCGR Pancreatic a cells Enhancing physiological 
response to stress
CCK CCK1,2 I cells o f small intestine Gall bladder contraction and 
pancreatic enzyme secretion
Ghrelin t GHS Stomach Growth hormone secretion, promote gastric motility
Amylin 1 AMYl-3 Pancreatic p cells Adiposity signals
PYY: peptide YY, PP: pancreatic polypeptide, GLP-1: glucagon-like peptide-1, OXM: oxyntomodulin, CCK: 
cholecystokinin, GCGR: glucagon receptor. Adapted from (Suzuki et al., 2012).
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1.4.1.1 The glucostatic’ theory for short-term appetite régulation
Mayer (1953) identified the ‘glucostatic’ theory that glucose availability to 
specific glucose-sensing neurons is an important factor regulating eating 
behaviour and, eventually, body weight (Mayer, 1953). As the main metabolic 
fuel for the brain is glucose, any reduction in blood glucose or any obstruction 
of neuronal glucose utilisation can stimulate food intake. According to this 
theory, the central nervous system (CNS) contains the ‘feeding center’ located 
in the lateral hypothalamic area (LHA), reduction in blood glucose stimulates 
the LHA and increases food intake. Subsequently, post-prandial hyperglycemia 
can also activate the “ satiety center”  in the ventromedial hypothalamus 
(VMH), which inhibits the ‘feeding center’ and terminates eating (Levin et al., 
2006; Chaput & Tremblay, 2009a).
The glucose-sensing neurons may interact with other appetite-regulating 
neuronal systems known to impact (directly or indirectly) the hypothalamus. 
Thus any food ingredient, which changes blood glucose levels and therefore 
interaction with the glucose sensors, may affect eating behaviour.
14
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1.4.2 Long-term satiety signals
Long-term satiety signals indicate the levels of fat storage in the body to the 
brain to ensure balance between energy intake and expenditure, which may help 
in weight management. In this respect, these signals may differ from short-term 
signals, which act during a long period of time rather than as an immediate 
action at each meal (Harrold et al., 2012; Drapeau and Gallant, 2013; Chambers 
et al., 2013).
The peptide hormone insulin is produced from the beta cells of Islet of 
Langerhans in the pancreas. The secreting amount of this hormone is 
comparable with the c-peptide or connecting peptide as both are the part of 
same original proinsulin molecule (Dimitriadis et al., 2011; Polonsky et al.,
1988). However, C-peptide and insulin follow different pathways for metabolic 
clearance. Insulin is extracted by the liver and c-peptide is lost through renal 
filtration (Rossell et al., 1983; Marques et al., 2004). As such, each has a 
different half-life, 30 minutes for c-peptide and only 5 minutes for insulin. For 
this reason, circulating concentrations of c-peptide is almost five fold higher 
than the corresponding concentration of insulin. In addition, almost 50% of 
secreted insulin is removed by the liver through the portal system at the time of 
pass transit (Polonsky & Rubenstein, 1984). Hence, the use of c-peptide as
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the surrogate marker of the insulin secretion (Hills & Brunskill, 2009; Cobelli et 
al., 2007; Toffolo et al., 1995). The measurements of the concentration of both 
the insulin and c-peptide demonstrate the information about the hepatic 
clearance as well as insulin secretion (Campioni et al., 2009; Cobelli et al., 
2007; Faber et al., 1981). The calculation of Hepatic insulin clearance is 
considered as the proportion of c-peptide to insulin AUC, and this ratio should 
be inferred as the caution due to other related factors (Polonsky & Rubenstein, 
1984).
Insulin has an anorexigenic action in the brain (see next section) that reduces 
food intake and body weight. Administration of insulin in animals leads to a 
reduction in food intake and a decrease in body weight (Ikeda et al., 1986), 
while an increase in energy intake and body weight has been observed after the 
inhibition of insulin (McGowan et al., 1992), which indicates that it may have 
contributed to the feeling of satiety (Suzuki et al., 2012).
However, insulin resistance when associated with obesity, may be associated by 
other conditions, such as dyslipidaemia, central fat deposition and high blood 
pressure (Frayn & Stanner, 2005). The obese individual may also be less 
sensitive to the satiating effects of insulin. In a study investigating passive over­
consumption of high-fat foods in lean and obese males, it has been shown that 
hyperinsulinaemia was correlated with a deficit in appetite control (Speechly &
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Buffenstein, 2000). This finding could indicate that insulin resistance played a 
part in reducing the effect of insulin on these areas (Anthony et al., 2006).
Leptin is a peptide hormone produced from the ob gene that is expressed by the 
adipose tissue. The leptin circulating levels are proportionate to fat mass and 
BMI, thus weight-loss may be expected to lead to a reduction in leptin levels 
(Maffei et al., 1995; Suzuki et al., 2012).
Leptin may affect energy intake and expenditure, which may explain the impact 
on body weight. In this regard, chronic leptin administration to rodents has been 
known to increase energy expenditure, reduce food intake and result in the loss 
of bodyweight and fat mass (Halaas et al., 1995).
A mutation of the ob gene, resulting in a deficit of circulating leptin results in 
severe obesity among humans (Montague et al., 1997), which can be normalised 
by administering leptin in children (Farooqi et al., 1999) and adults (Licinio et 
al., 2004). While leptin deficiency can result in greater obesity and a higher 
percentage body fat compared with control (Farooqi et al., 2001), most obese 
individuals have high levels of leptin (Maffei et al., 1995), which explained its 
modest impact on body weight when administered (Fogteloo et al., 2003). Thus, 
it is concurred that leptin resistance may be correlated with obesity rather than 
its deficiency (Kastin & Pan, 2000; Münzberg, 2009) and this may be mediated 
by its inability to reach target sites in the brain (Banks & Farrell, 2003) and/or
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impaired cellular responses within selected neurons in defined brain regions 
(Enriori et al., 2007; Scarpace & Zhang, 2009).
Although, it has been suggested that leptin is a biomarker for satiety (de Graaf 
et al., 2004), its increased levels may not accurately predict increased satiety. 
Therefore, while leptin can be useful as a biomarker of satiety in the longer- 
term only, it may not be effective with chronically high leptin levels in obese 
individuals. For example, high circulation of leptin levels do not appear to 
reduce body fat, in what has been termed leptin resistance (Benelam, 2009; 
Suzuki et al., 2012).
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1.5 Satiety signals integration in the brain
Long and short signals of satiety may have direct action via receptors in the 
brain or indirect action through the nervous system on the areas of the brain that 
impact appetite regulation. The brain neurones express neuropeptides, which 
influence energy homeostasis (Benelam, 2009; Chambers et al., 2013; Harrold 
et al., 2012).
In animal studies, stimulation or damage to various parts of the brain has proved 
that the hypothalamus is the centre of appetite regulation (Morgane & Jacobs, 
1969), thus originating pathways inside the hypothalamus arcuate nucleus area 
(ARC regulate food intake and satiety (Wynne et al., 2005; Benelam, 2009).
Accordingly, these pathways can be divided into anorexigenic, which inhibit 
food intake and orexigenic, stimulating food intake. Further, signals from the 
gut, pancreas and adipose tissue may impact each pathway either by stimulating 
them or inhibiting them. Therefore, the levels of energy storage in the body and 
the availability of nutrients may determine the overall impact in which, 
increased food intake and reduced energy expenditure or vice versa may occur 
(Perry & Wang, 2012; Lopaschuk et al., 2010).
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1.5.1 Anorexigenic pathways in the hypothalamus
Neurones in the ARC that express the neuropeptides proopiomelanocortin 
(POMC) and cocaine-and-amphetamine-related transcript (CART) are 
stimulated by leptin and have an anorexigenic impact (Perry & Wang, 2012; 
Lopaschuk et al., 2010). The POMC is a generator for the neuropeptide, a- 
melanocyte-stimulating hormone (aMSH), which activates melanocortin 3 
(MC3) and melanocortin 4 (MC4) receptors (Ellacott & Cone, 2004). The 
central administration of aMSH inhibits food intake in rats (Rossi et al., 1998) 
and leads to increased energy expenditure (Pierroz et al., 2002). Mutation in the 
POMC or the MC4 gene also leads to hyperphagia-induced obesity in both, 
human and animal models (Yang & Harmon, 2003). Administration of CART 
to rats under normal conditions and during food-deprivation inhibits food 
intake, whereas experimental reductions in the CART resulted in increase the 
food intake (Kristensen et al., 1998).
1.5.2 Orexigenic pathways in the hypothalamus
Neurones that secrete NPY and agouti-related peptide (AgRP) are orexigenic
and activated by ghrelin while peptide YY (PYY), GLP-1, oxyntomodulin
(OXM), PP, pancreatic polypeptide (PP), insulin and leptin have an inhibitory
effect. The NPY administration in animals results in hyperphagia and obesity
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(Stanley et al., 1986) and a concomitant reduction in energy expenditure 
(Billington et al., 1991). The reduction in energy expenditure and the increase 
in food intake are both attributed to the activation of the Y1 and Y5 receptors in 
the hypothalamus by the NPY (Gehlert,1999). Further, the inhibitory impact of 
the NPY may lead to the production of the POMC (Roseberry et al., 2004), 
therefore, creating a dual effect of stimulating food intake while inhibiting 
pathways that reduce it. The AgRP is an antagonist of the MC3 and MC4 
receptors, which suppresses the inhibitory impact of aMSH on appetite, thus, 
the AgRP administration increases feeding behaviour in rats (Rossi et al., 1998) 
(Figure 1.2).
i * Y  V
Figure 1.2 (Murphy & Bloom, 2006) ARC, arcuate nucleus; NPY/AgRP, neuropeptide Y and agouti
related peptide; POMC, pro-opiomelanocortin; PVN, paraventricular nucleus; GLP-1, glucagon-like 
peptide-1; PP, pancreatic polypeptide; PYY, peptide YY; OXM, oxyntomodulin. (Murphy & Bloom, 
2006).
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1.6 Satiation and Satiety Measurements approaches
Satiation may be influenced by a number of factors, which include the 
food varieties, dietary restraints and palatability. Therefore, measurement 
of satiation is conducted in a laboratory setting to control the environment 
in order to eliminate confounding effects (Mattes et al., 2005; Benelam,
2009; Blundell et al., 2010).
Measurement of food intake is considered a reliable approach to assess appetite. 
However, eating behaviour can be influenced by number of factors; thus, 
appetite studies should be conducted under environmentally controlled 
laboratory settings (Mattes et al., 2005; Benelam, 2009) . Although, laboratory 
situations may result in an artificial environment and may led to lack of external 
validity that may affect the subject’s normal eating patterns (Blundell et al., 
2010).
Free-living conditions are another approach to measure food intake. This 
approach theoretically, has high external validity; however, using it can cause a 
number of problems. Free-living studies involve self-reporting for dietary 
intake, which are subject to bias. For example, under-reporting of energy intake, 
mis-reporting of macronutrients, difficulties in controlling the study 
environment and other confounding factors may affect the results (Livingstone 
et al., 2000; Blundell et al., 2010; Benelam, 2009). Therefore, overlapping
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protocols are highly recommended to minimize the problems in both 
approaches. (Livingstone et al., 2000; Blundell et al., 2010)
1.6.1 Experimental techniques in short-term laboratory setting appetite 
study
One of the most effective designs to investigate the impact of the treatment on 
appetite regulation in the short-term, is "the preload-test meal" (Blundell et al.,
2010). Subjects are provided with standardised "preload-test meal", which is 
prepared by matching taste, texture and appearance with variations in energy 
density or/and macronutrients’ composition. This "preload meal" may include 
the treatment under investigation or placebo treatment (PL) (Rolls & Hammer, 
1995; Blundell et al., 2010).
The impact of the preload on appetite can be quantitatively assessed by the ad  
libitum test meal to allow the investigator to measure energy intake (Bellisle et 
al., 2012), while the 24h food intake is self-reported by the subject using a Food 
Diary (Blundell et al., 2010). The timing and energy content of this meal 
should be justified to maximise the impact of the preload on the appetite 
(Halford & Harrold, 2012). However, the interval between the preload and the 
subsequent test meal should range from 30 min to several hours depending on 
the treatment under investigation (Blundell et al., 2010). The importance of the
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length of the interval may be attributed to a number of physiological 
mechanisms, which affect satiety during the sensory, cognitive, post-ingestive, 
pre-absorptive and post-absorptive phases at the satiety cascade (Benelam, 
2009; Blundell et al., 2010).
In the preload study, we usually employ within-subject repeated measure 
designs with preferably a crossover double-blind design (Halford & Harrold, 
2012) particularly when measuring physiological effects to reduce the inter­
individuals variations influences (Benelam, 2009). However, a between- 
subjects design may be required to avoid any confounding demand 
characteristics in which subjects’ knowledge of the study’s purpose may affect 
the food behaviour. Therefore, pilot testing is always recommended (Halford & 
Harrold, 2012).
1.6.2 Self-reported measures of Satiety
Appetite can be measured subjectively using self-reported Visual Analogue 
Scales (VAS) usually prior to the test meal and at certain time intervals. VAS 
consists of a line are often 100 mm with words anchored by an extreme at each 
end. For example, a question in the scale, such as ‘How hungry are you?’, ‘Not 
at all hungry’ . ‘As hungry as I have ever felt’ may necessitate participants to 
make a mark on the line describing their feelings, which can be quantified by
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measuring the distance from the left end of the line to the mark. Administration 
of VAS is often starting by the beginning of the study day, prior and after 
fixed/pre-load meal and ad libitum meals at intervals during the study day (Flint 
et al., 2000; Stubbs et al., 2000).
Completion of the VAS may result in inter-individual differences, therefore, a 
‘within subject’ study design may usually be used wherein the subjects act as 
their own controls rather than as separate groups of control and test subjects 
(Flint et al., 2000; de Graaf et al., 2004).
VAS originally used the traditional paper form, which later developed to 
include the electronic collection of the VAS through the use of portable 
electronic notepads. Electronic VAS has some advantages compared with the 
paper forms, such as the ability to log on automatically. This also gives 
participants reminders to complete the VAS (Stratton et al., 1998). However, 
participants may not record their feelings on the extremes of the scale when 
using the electronic form because the scale here may be smaller compared with 
the paper form.
VAS is simple and quick to use and enables comparison with various types of
experimental manipulations. In addition, it has been shown that VAS may
reflect a valid method that assesses satiety and appetite in the short-term (Flint
et al., 2000). However, there are some issues such as, the correlation of VAS to
the actual food intake may be moderate, which may impact the results if  the
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VAS is the only method to assess appetite (Mattes et ah, 2005). VAS 
interpretation is another concern. Participants may not realise that the mark of 
40 mm on the satiety scale can result in half the sensation experienced at the 80 
mm mark. Also, participants may be hesitate to make full use of the scale by 
any of the extremes (Livingstone et ah, 2000). However, although VAS has 
some problems, it is still the most common method used in satiety studies along 
with food intake
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1.7 The effect of palatability on appetite
Palatability indicates a pleasant experience during food consumption. Its 
definition is debated since it is not an innate characteristic of the food itself and 
depends on the self-evaluation, which will be affected by the previous 
experiences of the individual and the eating conditions (Yeomans, 1998; 
Benelam, 2009; Stubbs & Whybrow, 2004). The sensory properties of the diet, 
it is suggested, play an important role in palatability and may include taste, 
texture, temperature and visual appearance (R. J. Hyde & Witherly, 1993). In 
this respect, a definition for palatability, according to these sensory factors, as 
created by Yeomans, defined the palatability as “the hedonic evaluation of oro- 
sensory food cues under standardised conditions” (Yeomans, 1998).
Palatability has been measured using different scales and the most common 
rating methods are the Fixed-Point Scales (FPS) and the continuous. Visual 
Analogue Scales (VAS)(Guy-Grand et al., 1994). However, VAS is often used 
in appetite and satiety studies, which consist of questions such as 'how pleasant 
have you found the food?',, 'how palatable is this food?', or 'how much did you 
like the food? (Guy-Grand et al., 1994; Hill et al., 1984; Rogers et al., 1988; 
Warwick et al., 1993; Yeomans & Symes, 1999; Yeomans, 1996; De Graaf et 
al., 1999). Therefore, palatability is classified according to how pleasant or
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well-liked the food is: the more pleasant or liked, the higher the palatability 
(Sorensen et ah, 2003).
A number of factors affecting palatability and food intake, include fat, protein 
and alcohol. Also, mealtimes exercise significant impact on feelings of hunger 
and the palatability ratings (de Castro et ah, 2000). Laboratory studies have 
shown that palatable foods may be correlated to the subjective appetite and 
energy intake (Hill et ah, 1984; Yeomans, 1996; Yeomans et ah, 1997; 
Yeomans, 1998).
It should be noted that adding some ingredients, such as fat can increase the 
palatability of the food and so, indirectly increase the meal size, increase 
appetite, eating rate and meal duration (Yeomans, 1998). Therefore, it is 
important to control food composition because the most palatable food tends to 
be the least satiating, while the least palatable foods are the most satiating 
(Yeomans, 1998).
The effect of the reduced palatability on satiety and satiation has been 
investigated when large quantities of citric acid have been added to a soup (De 
Graaf et ah, 1999). Palatability has been shown to be inversely related to the 
amount of citric acid in the soup. In this study, subjects consume the soup ad  
libitum to measure satiation by giving a fixed amount and then measuring 
appetite. This study found that the amounts eaten were inversely related to the
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palatability, while no effect on appetite ratings was observed, which indicate 
that palatability may affect satiation but not satiety (De Graaf et ah, 1999).
Palatability has been correlated to energy density, in which, the lower-energy 
dense foods tend to be the least palatable and vice versa, which may be 
mediated to the inherent choices regarding the rich-energy foods (Benelam, 
2009; Berthoud, 2007; Drewnowski, 1998). However, the relationship between 
palatability and energy density is not straightforward and may be affected by 
manipulation of the taste and the texture of the food without changing energy 
density (Benelam, 2009; Stubbs & Whybrow, 2004; Drewnowski, 2003).
The effect of palatability may have a role in triggering appetite and food intake. 
Evidence shows that highly palatable food may stimulate the brain rewards 
system (Berthoud & Morrison, 2008). Therefore, increasing the palatability of 
the diet may affect body weight and ultimately, the development of obesity 
(Van Kleef et al., 2012).
1.7.1 Sensory-specific satiety
Sensory-specific satiety (SSS) refers to the decline in the pleasantness of a food 
or drink following consumption compared with the decline in the pleasantness 
of food or drink that were tasted, but not consumed to satiety. For instance, 
following sausage consumption, the liking of the sausages will decrease while
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the liking of other savoury foods reduced less, and the liking of sweet products 
increased (Rolls et ah, 1981). Evidence have shown that sensory ratings may be 
reduced but without any increase in satiety, with the greatest reduction in the 
pleasantness of the foods over the first 20 minutes from the meal initiation 
(Rolls et ah, 1988; Hetherington et ah, 1989; Johnson & Vickers, 1993). 
Therefore, SSS is often correlated with the sensory stimulation accompanying 
ingestion rather than the post-absorptive effects of consuming these foods. It 
has also found that sensory-specific satiety may impact meal termination 
(Hetherington, 1996). Some food properties are involved in SSS, such as 
sensations of saltiness, sweetness, flavour of the food, visual appeal and food 
texture.
SSS may be affected by a number of different macronutrients, however, the 
results are inconsistent (Rolls et ah, 1988; Johnson & Vickers, 1993; Rolls et 
ah, 1989; Miller et ah, 2000). Some studies have shown a trend where high- 
protein foods increase SSS compared to low-protein foods (Johnson & Vickers, 
1993). In addition, it has been suggested that dietary fibre may also play a role 
in SSS. However, in a study comparing the effect of muffins or soup matched 
on sensory characteristics, no effect of a high-fibre treatment a low-fibre 
treatment was observed (Manthey & Vickers, 1996).
SSS induced by a test meal may be affected by the participant’s age. SSS is 
inversely correlated with the age (Rolls & McDermott, 1991). Therefore, this
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issue should be taken into account when using the buffet style test meal to avoid 
overconsumption.
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1.8 The confounding factors in satiety studies
Confounding variables in satiety studies may need to be controlled to avoid any 
interruption that can affect food consumption and satiety measurements. These 
factors can be divided into the physiological and behavioural factors.
1.8.1 Physiological confounders
Body weight may influence the satiety responsiveness via a variation in energy 
intake. The energy requirements are different among the obese and lean 
individuals which may explain their different responses to the tests. 
Additionally, it has been demonstrated that obese and lean individuals may have 
differences in terms of physiological appetite regulation, which may influence 
satiety research findings (Benelam, 2009; Gregersen et al., 2011).
The subject’s gender may influence appetite and energy intake. It is usually 
observed that male participants will have higher energy requirements compared 
to females of a similar body size due to differences in lean body mass. The 
menstrual cycle in women also appears to influence the energy intake due to the 
hormonal fluctuations during the cycle. For example, during the follicular 
phase, energy intake is low when estrogen is relatively high, while during the 
luteal phase, the energy intake increases with an increase in the progesterone 
levels (Bryant et al., 2007; Brennan et al., 2009). In fact, it has been estimated
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that a baseline intake of 364 kJ or 87 kcal/day can account for the differences in 
energy intake between the two phases, which may confound the results (Lissner 
et ah, 1988). This phenomenon may affect food intake and appetite studies, thus 
cycle phase should be considered in research that involves female participants 
(Tarage et al., 2008; Bryant et al., 2007).
1.8.2 Behavioural confounders
Dietary restraint may be assigned to the tendency to voluntarily restrict food 
consumption to maintain or reduce body weight, which is usually associated 
with dieting behaviour. Dietary restraint may be linked with ‘disinhibition’ in 
which, binge eating is present as a result of loss of control over eating (Johnson 
et al., 2012). Indeed, this phenomenon may have an impact on satiety, thus, the 
use of questionnaires such as the Dutch eating behaviour questionnaire (van 
Strien et al., 1986) or the three-factor eating questionnaire (Stunkard & 
Messick, 1985) is widespread in estimating the participants likelihood to 
exhibit dietary restraint behaviour. Participants who have scored above a 
threshold level are usually excluded from participating in satiety studies 
(Benelam, 2009; Mela, 1996; Johnson et al., 2012).
Eating behaviour can be affected by a number of factors, such as dietary habits, 
consumption of alcohol and physical activity levels. Therefore, investigators
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should remind the participant to refrain from any physical activity, alcohol 
consumption and the food intake should be undertaken on the day prior to the 
study day (Benelam, 2009; Blundell et ah, 2010; Livingstone et ah, 2000). The 
effect of prior knowledge and beliefs about the test meal investigated may play 
a role in the investigation of satiety. Although, the content of the test meal 
should be manipulated to avoid this, participants may still have the ability to 
distinguish the test meal from the control. Nevertheless, participants may 
become familiar with the study conditions when multiple visits to the laboratory 
are needed and this may also influence their response (Livingstone et ah, 2000).
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1.9 The effect of food composition on satiety
Food composition has been identified as affecting body weight, reduce appetite, 
food intake and increase 24-h energy expenditure (Astrup et ah, 2010; Phillips, 
2013; Soares & She-Ping-Delfos, 2010). A number of studies investigated 
different approach to reduce energy intake, such as manipulating the amount or 
the type of carbohydrate, protein, fibre and bioactive food ingredients. These 
ingredients included macronutrients, such as dietary fibre and bioactive 
components, such as calcium. The effects of these ingredients on satiety have 
been described below.
1.9.1 The effect of Dietary Fihre on satiety
Over the last few decades, the definition of Dietary Fibre (DF) has been widely 
debated. Therefore, many definitions used by different organisations are mainly 
based either on analytical criteria (solubility), or the physicochemical properties 
of DF (viscosity and fermentability) (Institute of Medicine, 2001). It has been 
agreed based on scientific evidence that the definition of DF should be based on 
the physiological properties of food ingredients and not focused solely on the 
physiochemical characteristics. Therefore, this classification affects the Codex 
Alimentarius Commission (Codex) (Codex Alimentarius Commission, 2009) 
and a number of other definitions including the French definition (Agence 
Française de Sécurité Sanitaire des Aliments, 2001), The German definition
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(Deutsche Gesellschaft fur Erahrugn, 2002) and those of the Health Council of 
The Netherlands, the United States Institute of Medicine, the American 
Association of Cereal Chemists(AACC) and Food Standards Australia New 
Zealand. Generally, these definitions are based on the physiological properties 
and vary in the type and the importance of these effects.
In an attempt to attain a global definition of DF, the Codex Committee on 
Nutrition and Foods for Special Dietary Uses (CCNFSDU) and the F AO 
experts met in 2008 and issued recommendations to accept different definitions 
for Dietary Fibre. In 2009, Codex introduced the final definition for DF:
“Dietary fibre means carbohydrate polymers with ten or more monomeric units 
which are not hydrolysed by the endogenous enzymes in the small intestine of 
humans and belong to the following categories:
• Edible carbohydrate polymers naturally occurring in the food as 
consumed
• carbohydrate polymers, which have been obtained from food raw 
material by physiological, enzymic or chemical means and which have been 
shown to have a physiological effect of benefit to health as demonstrated by 
generally accepted scientific evidence to competent authorities
• synthetic carbohydrate polymers which have been shown to have a 
physiological effect of benefit to health as demonstrated by generally accepted
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scientific evidence to competent authorities” (Codex Alimentarius 
commission, 2009; Phillips, 2013; Phillips & Cui, 2011)
The definition also annotated that the decision to include carbohydrates with 
three to nine monomeric units that cannot be digested nor absorbed by the small 
intestine should be left to the national authorities (Codex Alimentarius 
commission, 2009; Phillips & Cui, 2011). In addition, another issue central to 
this definition was the absence of scientific evidence about the beneficial health 
effects and the appropriate fibre analytical methodology (Codex Alimentarius 
commission, 2009; Phillips & Cui, 2011).
This debate between the definition of dietary fibre and the best analytical 
methods have rendered the classification of dietary fibre for public health and 
food industry purposes, less defined (Buttriss & Stokes, 2008). This conflict 
resulted in driving the dietary fibre classification away from the initial 
assumptions surrounding the health benefits of consumption of DF (Brownlee,
2011). However, a number of factors seem to impact the physiological effects 
of dietary fibres, such as:
1. The dietary fibre rheological/biophysical properties in the gut that simulate 
the conditions of gastrointestinal pointed out as “ viscosity”  (Dikeman & 
Fahey, 2006; Jenkins et al., 2000)
2. The dietary fibre food matrix functionality (Englyst & Englyst, 2005; 
McDougall et al., 1996)
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3. The effects of different types of dietary fibres and their biochemical 
characteristics (Brownlee, 2011).
4. The influence of dietary fibres on fermentation in the large intestine and the 
production of short-chain fatty acid (Brownlee, 2011).
1.9.1.1 Dietary Fibre Recommendations
The recommendations of dietary fibre vary widely depending on the definition 
and the analytical methods used. The Association of Official Analytical 
Chemists (AOAC) method is commonly used by the food industry for labelling 
purpose. The recommendations for dietary fibre intake in the European 
countries based on the Association of official analytical chemists (AOAC) are 
in the range of 25-35 g per day. The European Food Safety Authority (EFSA) 
panel recommends a daily intake of 25g for adults (EFSA Panel on Dietetic 
Products, 2010), while the recommendations for adults in USA is 25-38 g/day. 
However, currently the average intake of Americans adults is (16.5-17.9 g/day) 
for men, and (12.1-13.8 g/day) for women (Marshall, 2011). Also the average 
intake of adults in the UK is currently below the recommendations at 
approximately 13 g/day (Buttriss & Stokes, 2008). Thus, the DRV has been set 
as 18 g of non-starch polysaccharides per day, with a range of 12-24 g per day 
for individuals (Buttriss & Stokes, 2008).
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In the Middle East, there is little evidence on population energy and macro- 
nutrient intake, although there are a number of interventions which have been 
undertaken to determine the effect of dietary habits on nutritional status (Al- 
Sendi et ah, 2003; Musaiger & Al-Mannai, 2000; Musaiger, 1998). For 
example, Saudi Arabia’s economic development during the last decade 
significantly impacted the nutritional and lifestyle habits of its people (A1 
Qauhiz, 2010). As a result, the adoption of Western lifestyle witnessed an 
increase in non-communicable diseases such as type 2 diabetes (Reddy, 2002). 
Low consumption of dietary fibre has also been reported in Saudi Arabia and 
attributed to insufficient intake of pulses, vegetables and fruit. (Al-Shagrawi R, 
Al-Badr N, 1995; Al-Shagrawi, 1998; Alissa et ah, 2005; Alissa & AlKadi, 
2011)
1.9.1.2 Classification and Physicochemical Properties of Dietary Fibre
Dietary fibre has been classified as soluble or insoluble according to analytical 
methods approved by the Association of Official Analytical Chemists (AOAC) 
(Institute of Medicine, 2001). However, this classification is a controversial 
subject given solubility is arguably not the sole property of the dietary fibre. 
Viscosity and fermentability are alternative physicochemical properties of 
dietary fibres that have been agreed to be more relevant to the classification in
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terms of predicting the physiological effects of consum ption (Institute of 
Medicine, 2001).
Although soluble dietary fibres may include viscous and fermentable fibres, 
which have been attributed cholesterol-lowering properties, not all soluble 
fibres are viscous, such as partially hydrolyzed guar gum and inulin. Therefore, 
soluble fibres per se may not reduce cholesterol levels (Slavin, 2013). Similarly, 
insoluble fibres are known to have faecal bulking properties as well as 
resistance to microbial fermentation. However, some types of insoluble fibres, 
such as resistant starch are readily fermentable in the colon. Thus, it appears 
that the classification of DF according to solubility does not reflect 
physiological benefits (Slavin, 2013). In this regard, it has been suggested that 
viscosity and fermentability of the dietary fibre may be a better classification 
when based on physiological functions (Slavin, 2013, 2005; Anderson et al., 
2009).
Viscosity indicates a thickening or gel forming properties of a fibre when mixed 
with liquids, which includes a number of polysaccharides, such a guar gum, p- 
glucan and pectin (Dikeman & Fahey, 2006). Viscosity may be affected by a 
number of factors, such as concentrations, structures, chemical compositions 
and molecular weight, thus evaluating viscosity in the intestinal tract is not 
simple. In addition, food processing, pH, and gut motility also affect viscosity 
(Dikeman & Fahey, 2006; Kristensen & Jensen, 2010). However, viscous fibre
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ingestion per se has been correlated with reductions in postprandial glucose and 
insulin responses, lower cholesterol levels, reduced hunger sensations, weight 
management and improved insulin resistance (Anderson et ah, 2009; Everson et 
ah, 1992; Ziai et ah, 2005; Lyly et ah, 2009; Georg et ah, 2012).
Fermentability indicates the process by which, dietary fibre is metabolized by 
colonic bacteria in the large intestine, producing by-products, such as the short 
chain fatty acids (SCFA) with significant, beneficial health effects. Some types 
of dietary fibre are more likely to be completely fermented than others, such as 
pectin while cellulose is only partially fermented (Barry et ah, 1995). 
However, methods to measure fermentation have many limitations. Both the in 
vivo and the in vitro methods may not give a complete view of the fermentation 
process by specific type of fibre in individuals. In this regard, the in vitro 
methods tend to determine the fermentability of different types of dietary fibre 
in the human faecal samples, which may not illustrate the changes, dynamics, 
and metabolites of the human colon. The in vivo methods are unable to predict 
the fermentation of the dietary fibre due to the inherent differences in the 
individual’s composition of colonic bacteria (Rose et al., 2007).
Overall, the classification of the dietary fibre is not straightforward owing to the 
differences in the physical, chemical and physiological properties of the various 
types of dietary fibres. Therefore, there is no gold standard for measuring the 
physicochemical characteristics of different types of dietary fibres. The
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variations in these characteristics may depend on the type of fibre and the 
product under investigation. Also, it should be noted that these properties 
(viscosity and fermentability) might vary between individuals on the basis of 
post-ingestive GI factors.
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1.10 Resistant starch
Resistant Starch (RS) has recently gained attention as a functional food 
ingredient due to its potential health benefits (Sajilata et ah, 2006). RS is a type 
of dietary starch that is not digested in the small intestine of healthy individuals 
and thus, reaches the colon intact (Englyst et ah, 1992). It is defined as the 
'total amount of starch and the products of starch degradation that resists 
digestion in the small intestine of healthy people' (Asp,1992).
RS has been divided into four categories based on the physical and chemical 
characteristics in addition to botanical sources (Nugent, 2005). RSI is 
physically inaccessible to digestive enzymes and it is stable to heat which 
include seeds, legumes and whole grains. RS2 consist of ungelatinized starch 
which is resistant to enzyme digestion and can be formed naturally in uncooked 
potato, bananas and high-amylose com. RS3 is composed of retrograded 
amylase which can be formed in breads, com flakes or cooked and cooled 
potatoes. RS3 is of particular interest, because of its thermal stability which 
enables to use it in a wide range of conventional foods (Haralampu, 2000). 
Food processing such as heat and moisture can affect RSI and RS2 but may 
form RS3 (Faraj et al., 2004). Furthermore, RS3 has shown a higher water- 
holding capacity than granular starch (Sanz et al., 2008). On the contrary, RS4 
are chemically modified starches to obtain resistance to enzymatic digestion
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which include some starch ethers, starch esters, and cross-linked starches 
(Englyst et ah, 1992; Fuentes-Zaragoza et ah, 2010).
Some studies have shown that only 30-70% of RS in the colon can be 
fermented to short-chain fatty acids through bacterial amylases, whereas the 
reminder of the RS is excreted via faeces (Sharma et ah, 2008). For example, 
of the total RS3 in com and wheat, bacteria in the colon ferment accounts for 
only 84% and 65%, respectively. Likewise, about 96% of RS2 from green 
bananas and 89% RS2 from raw potato may be fermented by bacteria (Behall & 
Howe, 1996). In addition, the digestibility of RS has been shown to differ 
between individuals due to inherent differences in enzymic activities and 
intestinal transit time (Sharma et ah, 2008).
In addition, human-intrinsic factors may affect a-amylase activity and starch 
breakdowns, which include amylose-lipid complex formation, the availability of 
native a-amylase inhibitors and non-starch polysaccharides (Englyst et ah, 
1992). There are a number of physiological factors that may influence the 
amount of RS. These factors include increased chewing that may reduce the 
particle size (reducing RS), as well as the inter-individual transit time 
differences and biological factors (e.g. menstmal cycle) which may play a role 
in the digestibility of starch due to effects on gut transit time (Nugent, 2005).
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With regard to the energy value of RS, about 8 kJ/g (2 kcal/g) has been 
estimated experimentally, as being lower compared to the energy value for fully 
digestible starch 15 kJ/g (4.2 kcal/g) (Liversey, 1994).
1.10.1 RS Intake
RS intake varies worldwide from 30 to 40 g/d in the developing countries 
(Baghurst et al., 2001) and 10 and 18 g/day in India and China (Platel & 
Shurpalekar, 1994; Muir et al., 1998). RS intakes in Europe have been 
estimated to range between 3 and 6 g/day, which can be considered as low 
(Dyssler & Hoffmann, 1994). Although, RS intake in the UK is estimated at 
2.76 g/day (Tomlin & Read, 1990) that in Australia has been estimated to range 
from 5 to 7 g/day (Baghurst et al., 2001). Australia’s Commonwealth Scientific 
and Industrial Research Organization (CSIRO) has recommended that the total 
intake of RS should be around 20 g a day based on a study by (Baghurst et al., 
2001).
1.10.2 Physiological effects of resistant starch
RS has been in the spotlight for the potential health effects as well as functional
properties (Sajilata et al., 2006). Various physiological effects have been
attributed to the consumption of the RS (Sajilata et al., 2006). RS is one of the
dietary sources of non-digestible carbohydrates that may be important in
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promoting health, improving large bowel function and preventing bowel 
inflammatory diseases (IBD) and colorectal cancer (CRC) (Topping et ah, 
2003).
RS is fermented by the bacteria in the large intestine resulting in the production 
of the short chain fatty acids (SCFA). These SCFA include butyrate, acetate 
and propionate, which have been attributed to the impact of the RS (Nugent, 
2005; Sajilata et al. 2006; Fuentes-Zaragoza et al. 2010; Topping et al. 2003). 
Evidence from animal studies have shown that RS ingestion leads to an increase 
in the faecal and caecal total SCFA and the levels of propionate, butyrate and 
acetate (Ferguson et al., 2000; Henningsson et al., 2003). In humans, most 
studies have shown that RS consumption has resulted in increased faecal 
excretion and/or faecal concentrations of SCFA (Phillips et al., 1995; Silvester 
et al., 1995; Cummings et al., 1996; Birkett et al., 2000; Muir et al., 2004), 
however, these studies have mixed findings (Hylla et al., 1998). It is possible 
that these differences in the effects are mediated by either the experimental 
method used, the source, the type and amount of RS, changes in length of transit 
time between individuals, and the duration of consumption. For example, while 
RS2 (from raw potato starch) has been suggested to increase the concentration 
of butyrate in humans and rats (Cummings et al., 1996; Ferguson et al., 2000; 
Martin et al., 2000; Henningsson et al., 2003), RS3 (retrograded starch) has
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been shown to increase the concentration of acetate in pigs (Martin et ah, 2000), 
but not in humans (Cummings et ah, 1996).
1.10.3 Mechanism of action of RS on appetite and satiety
The potential mechanism behind the impact of RS on appetite may be mediated 
by fermentation and the increase in the production of short chain fatty acids 
(SCFA).
The increased SCFA production increases GLP-1 and PYY release, which may 
stimulate the neurones in the hypothalamus. In addition, SCFA has been shown 
to stimulate the binding of the G-protein-coupled receptors GPR41 and GPR43 
in the colonic L cell that modulates the release of the hormones GLP-1 and 
PYY, which improve insulin secretion (Sina et al., 2009; Maslowski et al., 
2009). Evidence has shown also that GPR41 and GPR43 trigger leptin release 
from adipocytes (Covington et al., 2006).
A number of studies have found a correlation between the consumption of RS, 
fermentation and an increase in the production of SCFAs that lead to and 
invariably changes the satiety hormones in both, rodents and humans.
Keenan and colleagues (2006) investigated the effect of RS inclusion in the diet
compared to non-fermentable cellulose energy-controlled diet in rats. They
found that RS consumption increased caecal SCFA concentrations, which
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resulted in an increase in peptide YY (PYY) and glucagon-like peptide-1 (GLP- 
1) levels compared with the control (Keenan et ah, 2006). Similarly, Zhou and 
others (2006) found that RS-fed animals also had significantly higher levels of 
PYY and (GLP-1) (Zhou et ah, 2006).
Further work by Zhou and others (2008) has been investigated to understand the 
effect of consumption of RS among rats. An increase in GLP-1 and PYY 
expression and secretion was noted, compared to the control. This result 
indicates that RS consumption can lead to an increase in the concentration of 
SCFA, which affects the stimulation of gene expression (Zhou et ah, 2008).
Some of the studies, although investigating the potential mechanisms of the 
effect of RS on appetite, have also shown an impact on food intake and body 
weight albeit with mixed findings. Aziz and others (2009) have shown that the 
consumption of high amylose diets, such as ad libitum lead to a reduction in 
energy intake, weight gain and lower fat-pad mass in rats afflicted with diet- 
induced obesity (Aziz et ah, 2009). Likewise, another study demonstrates a 
reduction in energy intakes in RS-fed rodents in addition to lower total, 
subcutaneous, visceral and liver fat depots and smaller adipocytes. (So et ah, 
2007)
In summary, studies in animals indicate that RS results in an increase in both
GLP-1 and PYY, which is mediated by an increase in the production of SCFA
as a direct result of RS fermentation. Although some studies have shown a
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reduction in body weight and fat mass following RS, the impact on energy 
intake is less clear. It should be noted that the effect of RS provided in many of 
these animal studies would not be tolerated in humans Also, the duration and 
the length of time in these animals’ studies that range from days to weeks may 
be difficult to apply to the time span in humans.
In human, however, very few studies have investigated the effects of RS on 
GLP-1 and PYY and these have reported mixing findings (summarised in Table 
1.2) (Raben et al., 1994; Robertson et al., 2003; Bodinham et al., 2013). In the 
earliest study by Raben (1994), a reduction in plasma GLP-1 concentrations 
after RS consumption was observed. However, these meals had not been 
matched for glycaemic carbohydrate and so this would be expected. Robertson 
and colleagues (2003) reported no effect of RS on GLP-1 concentrations 
(Robertson et al., 2003).
The number of studies that investigated the effects of RS on energy intake and 
satiety are limited and have shown conflicting results. In one study, the 
consumption of 50 g of RS (Hi-Maize) incorporated into tomato soup resulted 
in a significant reduction in energy intake at an ad libitum test meal (Anderson 
et al., 2010).
One study compared the effect of four types of high fibre (HP) muffins of
different fibre content varying from 8.0 to 9.6 g (RS2, barley P-glucan and oat
fibre, com bran, polydextrose) with that of low fibre (LF) muffins (1.6g), which
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were matched for macronutrient content on postprandial satiety in 20 subjects 
(Willis et ah, 2009). They found that the RS muffins were the most satiating in 
terms of satisfaction and fullness for up to 3 hours post-prandially. Whilst com 
bran muffins had similar effects for fullness only, lower prospective 
consumption was observed in only the com bran muffins. It could be concluded 
from these results that subjective satiety is affected by the fibre type and is 
highly variable between subjects.
Bodinham and colleagues (2010) showed that consumption of 80g of RS (60 %) 
divided between breakfast and lunch meals partaken by 20 young adults 
resulted in a reduction in energy intake at an ad-libitum dinner meal and over 
the 24-hour period. However; no effect was reported on subjective appetite 
ratings (Bodinham et ah, 2010).
Another study compared the consumption of 50g raw potato starch (21 g RS2) 
with 50g pre-gelatinized potato starch (Og RS) mixed into non-nutritive symps 
in 10 male subjects. They found that the RS supplements resulted in lower 
subjective scores for satiety and fullness and created a reduction in postprandial 
glucose, insulin and GLP-1 responses compared to the fully digestible starch 
(Raben et ah, 1994).
On the contrary, Kendall and others (2010) found that ingestion of 25g dose of a
RS3 cereal bar could lead to an increase in subjective appetite ratings measured
at 15, 30, and 45 minutes post-prandially. There was a trend toward reduced
50
Najlaa Al-Mana Thesis
average satiety over the 2-hours post-meal time periods compared to the 
control. Despite the effect on subjective appetite, no difference in food intake 
after 2 hours at ad-libitum test meal was observed between the supplements 
(Kendall, Esfahani, Sanders, et ah, 2010). It is possible that the RS required 
longer time for the effect on food intake to become evident.
It is possible that a variability in the satiation effects is caused by the 
differences in the forms of the supplements since the RS was in liquid form and 
the control was in the gel form. It has been suggested that liquids may have less 
satiating effects post-prandially when compared with solids (Mourao et ah, 
2007).
It should be noted that some of these studies have shown that RS supplements 
were less palatable compared with the control, which could influence the 
outcome of these studies with regard to the effect of RS on food intake (Willis 
et ah, 2009; Kendall, Esfahani, Sanders, et ah, 2010).
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1.11 Fenugreek
Dietary fibre is one of the functional food ingredients that have been shown 
to play a role in promoting health (Kendall, Esfahani & Jenkins, 2010; 
Buttriss & Stokes, 2008; Phillips, 2013). Fenugreek as a source of dietary 
fibre may be considered one of the functional food ingredients identified as a 
rich source of both soluble and insoluble fibre. Galactomannan is the soluble 
fibre derived from fenugreek seeds. It is similar to other galactomannans, 
such as guar gum and locust bean gum (Youssef et al., 2009).
The structure of fenugreek galactomannans is composed of a linear 
backbone of P-d (1 ^ 4 )  d-mannose units with a-d (1—^ 6) d-galactose single 
units attached as side chains (Evans et al., 1992). In comparison, while the 
mannose: galactose ratio in fenugreek is approximately 1.1:1, the mannose: 
galactose ratio in guar gum galactomannans and locust bean gum is 1.6:1 
and 3.4:1, respectively (Garti, 1999). This uniform ratio of fenugreek can 
provide the maximum solubility, and it may explain why its viscosity is 
lower than other galactomannans of similar molecular weight and 
concentration (Cui, 2001). These properties can facilitate the use of 
fenugreek fibre as a functional ingredient in different food applications 
(Brummer et al., 2003).
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The fenugreek seeds are mainly composed of (20-25%) proteins, (55-65%) 
dietary fibre, (20-25%) mucilaginous soluble fibre, (6-8%) fatty acids, 
essential oils and (2-5%) steroidal saponins. In addition, some other minor 
components present in the fenugreek seed, such as alkaloids and free amino 
acids (4-hydroxyisoleucine), act as facilitators of insulin secretion (Trivedi 
et ah, 2007).
Fenugreek {trigonella foenum-graecum L., leguminosae), which belongs to 
the fabaceae (or leguminosae) plant family, has been used traditionally in 
the Middle East, Asia and in some regions of Europe, China and North 
America as a herbal medicine to treat digestive disorders and to increase 
milk production in lactating women (Raju & Rao, 2011; Shirani & 
Ganesharanee, 2009).
Fenugreek’s health-promoting properties have been widely reported, 
particularly as they pertain to metabolic disorders, such as hyperglycaemia, 
type 2 diabetes and hypercholesterolemia. Recently, fenugreek extraction 
has been developed as an appetite suppressant. This was accomplished by 
removing the saponins group that is responsible for the bitter taste and 
strong aroma (Im & Maliakel, 2008; Meghwal & Goswami, 2012), as the 
saponins group has been shown to stimulate hunger (Petit et al., 1995; 
Muralidhara et al., 1999).
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1.11.1 Fenugreek and Glycaemic Response
There are significant numbers of investigations on the effect of the fenugreek 
dietary fibre on the control of blood glucose and insulin secretion. The effect of 
fenugreek fibre on insulin secretion has been proposed to be due to 4- 
hydroxyisoleucine content (Broca et al., 2004).
One study found that the consumption of 15 g infused fenugreek seeds in water 
resulted in a significant reduction in post-prandial glucose concentrations in 21 
non-insulin dependent, diabetic subjects (Madar et al., 1988).
Another randomized, controlled crossover study by Sharma and colleagues have 
shown that the daily consumption of 100 g of fenugreek seed powder for 10 
days resulted in a significant reduction in fasting blood sugar and substantial 
improvement in the glucose tolerance tests of 15 diabetic patients (Sharma & 
Raghuram, 1990).
Also a randomized, controlled crossover demonstrated that the addition of 25g 
of fenugreek daily for 15 days could lead to a significant decrease in the area 
under the curve for glucose with an improvement in glucose tolerance among 
10 diabetic subjects (Raghuram et al., 1994).
A daily diet with 5 g of fenugreek was given to 40 coronary artery disease and
diabetes subjects compared with 30 healthy subjects for 3 months. They found
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that a significant reduction in fasting blood glucose and post-prandial glucose 
levels was observed in 20 mild hyperglycemia subjects, while no significant 
effects were reported among the severe hyperglycemia and healthy subjects 
(Bordia et ah, 1997).
Four studies were conducted with diabetic individuals. A double blind and 
controlled study by Gupta and others was carried out on 25 newly diagnosed 
diabetics in 2001. The subjects were divided into 2 groups (12 subjects in the 
treatment group consumed 1 g hydro alcoholic extract of fenugreek seeds, 13 
subjects in the control group consumed placebo capsules daily) for 2 months. 
This study found no significant differences in fasting blood glucose or oral 
glucose tolerance between the groups. However, the area under curve of blood 
glucose and insulin sensitivity were significantly different for both (Gupta et al., 
2001).
Another study investigated the effects of the ingestion of 100 g fenugreek 
powder containing (50% DF) for 10 days in type 2 diabetes afflicted patients. 
This data has shown a reduction in the fasting blood glucose level by 25 %, 
which was mediated by the soluble fibre fraction in fenugreek (Sharma et al., 
1990).
Animal studies have shown that oral administration of fenugreek fibre twice
daily in doses of 0.5 g/ kg for 28 days in diabetic rats resulted in a reduction in
the serum fructosamine levels, while no significant effect on the insulin level
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was observed compared with the placebo. This study also indicated that 
fenugreek fibre could exercise a beneficial impact on dyslipidemia (Hannan et 
al., 2003). Another study with 18 diabetic subjects, who were divided into two 
groups, had 11 subjects consuming lOg/d of fenugreek seed powder in hot water 
compared with 7 subjects consuming the same amount of fenugreek seeds 
mixed in yoghurt for 8 weeks. This study found that consumption of lOg/d of 
fenugreek seed powder mixed with hot water resulted in a significant reduction 
in fasting blood glucose, while no significant effect was reported by the yogurt 
group due to interfere action of active ingredients of fenugreek (Kassaian et al., 
2009).
The hypoglycaemic effect of fenugreek was also investigated in other studies 
that included healthy and obese individuals. One study was conducted to 
investigate the effects of consuming 40mg/kg of aqueous extract of fenugreek 
seeds on 20 healthy men. A reduction in blood glucose levels was reported 4 
hours following the consumption (Abdel-Barry et al., 2000).
A single blind, randomized, crossover study carried out on 18 healthy yet obese 
subjects investigated the effects of the addition of 4g or 8g of isolated fenugreek 
fibre compared with the effects on the control group. This study found no 
significant differences in the post-prandial blood glucose levels and insulin 
sensitivity within 3.5 hours following the consumption (Mathem et al., 2009).
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More recently, in another double-blind, randomized, and placebo-controlled 
study involving 38 healthy overweight men subjects, 18 subjects consumed 
1176 mg/d hydro-alcohol extract of fenugreek seed compared with the control 
placebo group for 6 weeks (Chevassus et ah, 2010). No significant changes in 
fasting blood glucose or insulin were observed between the groups.
1.11.2 Fenugreek and Cholesterol Management:
The effects of dietary fibre, in particular the soluble fibre, such as 
galactomannans on hypercholesterolemia, have been widely investigated. These 
investigations have demonstrated that galactomannans derived from fenugreek 
lower the plasma cholesterol level more effectively due to the uniform structure 
of galactose to mannose in a 1:1 ratio (Brummer et al., 2003). In addition, 
soluble fibre fractions have been found to reduce only the low-density 
lipoproteins and triglycerides; without affecting the beneficial high-density 
cholestérols (Boban et al., 2007).
A study of 60 diabetic subjects with high cholesterol and triglycerides levels 
reported a significant reduction in blood glucose; LDL cholesterol and 
triglycerides levels after consumption of 25 g of fenugreek fibre. The 
hypolipidaemic effect of the soluble fibre may be mediated by the ability to 
bind bile acids, which are then, lost in faeces excreted and not recycled back to
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the liver (Levrat et al., 1994). Further, the fermentation of soluble fibre in the 
colon by bacteria and the production of SCFAs, are thought to perhaps cause a 
reduction in hepatic cholesterol synthesis.
1.11.3 Fenugreek and obesity
Various observational studies have reported a correlation between the 
consumption of dietary fibre and body weight. In this respect, high-fibre, low- 
fat and high-protein diets may all have a beneficial impact on body weight 
(Abete et al., 2008). It has been suggested that diets rich in dietary fibre and 
protein may increase secretion of the anorexigenic and insulinotropic hormones, 
GLP-1, which leads to improved glucose tolerance and decreased weight gain 
(Reimer & Russell, 2008). Therefore, as isolated dietary fibre derived from 
fenugreek contains (55-65%) dietary fibre (30-40% soluble fibre) and (20-25%) 
protein, it may be considered as a functional food ingredient.
A few studies have explored the effect of fenugreek on satiety, however, 
fenugreek galactomannan which is similar to guar gum that has been shown to 
affect food intake and satiety (Chow et al., 2007). This study investigated the 
effect of consumption of a novel viscous fibre-containing nutrition bar at lunch 
compared with control bars in 99 overweight and obese adult subjects with type 
2 diabetes. The viscous fibre increased fullness by 27.1%, decreased 
prospective consumption by 15.8%, and decreased hunger by 14.2% in the 120-
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240 min post-lunch areas under the curve (AUC) compared to the control 
(Chow et ah, 2007).
Mathem and others (2009) investigated the effect of isolated fenugreek fibre on 
satiety and food intake for 18 obese subjects. This single-blind, randomized, 
crossover study consisted of three test breakfasts, containing either 0 g 
(placebo), 4 g or 8 g of isolated fenugreek fibre powder, which was mixed with 
a low-calorie beverage. This study found that while the palatability reduced 
with increasing doses of fenugreek fibre {P < 0.05), (8g) of fenugreek fibre 
resulted in a significant increase in satiety and reduction in energy intake at 
lunch. This study concluded that Fenugreek fibre may have short-term 
beneficial effects on food intake among the obese subjects (Mathem et al., 
2009).
A more recent study by Chevassus and others (2010) investigated the effects of 
repeated administration of 1176mg(3 times/d) of dry hydro-alcoholic fenugreek 
seed extract as oral coated tablets on food intake for 6 weeks among 39 
overweight subjects. This study demonstrated that repeated administration of a 
fenugreek seed extract resulted in a significant reduction in dietary fat intake in 
healthy overweight subjects. Fenugreek fibre however, had no significant 
effects on body weight, appetite/satiety scores or oxidative parameters 
(Chevassus et al., 2010).
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1.12 The effect of bioactive components on satiety
1.12.1 Dietary Calcium
Accumulating evidence shows that diet may play a significant role in body 
weight management. The role of diets enriched with protein, fat, and 
carbohydrate on body fat mass, body composition and obesity has been widely 
recognised (Mela, 1996; Gilbert et al., 2011; Alissa et al., 2005; Aziz et al., 
2009). In addition, the potential role of the level of dietary calcium (Ca) on 
body weight regulation and fat mass has been the focus of attention (Zemel, 
2003; Zemel et al., 2000; Shi et al., 2001; Lin et al., 2000; Davies et al., 2000).
It should be noted that inconsistency in the data concerning the effects of 
dietary calcium on body weight regulation is mediated by the differences in the 
Ca source (dairy versus non-dairy), differences in the formulations of the Ca 
supplement and differences in the dosage (Soares & She-Ping-Delfos, 2010). It
has been suggested that -600-800 mg/day of Ca intake is needed for a
favourable influence on body weight regulation (Dougkas et al., 2011). Further, 
it is not clear whether the impact of Ca supplementation per se or in 
combination with increased dairy food intake would be effective in weight 
regulation (Jones et al., 2013). For example, increasing the calcium intake 
through consumption of dairy products may lead to an overlapping of the
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effects of calcium with other components in dairy, such as bioactives, protein, 
probiotics, and potentially vitamin D (Soares, Chan She Ping-Delfos, & 
Ghanbari, 2011).
The absorption of calcium is not straightforward and is highly variable between 
individuals. There are different factors that may confound the absorption of the 
calcium (Allen, 1982). It has been suggested that two factors may affect the 
calcium absorption, which includes calcium bioavailability and the individual’s 
vitamin D status.
1.12.2 The effect of calcium and energy balance regulation
A number of investigators have observed an inverse relationship between 
dietary calcium intake and BMI (Brooks et al., 2006; Davies et al., 2000; 
Beydoun et al., 2008). In 2000, Davies and colleagues were the first to observe 
this correlation, which found that changes in calcium intake could be 
responsible for about 3% of the differences in body weight when data from 
observational studies among women was re-analysed (Davies et al., 2000). 
While the calcium intake may be obtained from dairy sources, it is possible that 
this relationship between calcium intake and BMI may be confounded by other 
dairy components (protein, bioactive peptides), or explained by a healthier 
lifestyle in individuals habitually having a higher dairy intake, or conversely, an
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unhealthy lifestyle in subjects with low-dairy intakes(Zemel, 2003; Astrup et 
al., 2010). Therefore, it appears that it is important to conduct randomised, 
controlled trials, and examine the potential mechanisms to clarify the impact of 
calcium on energy balance.
Numerous studies have investigated the impact of consumption of dairy calcium 
on the BMI and body fat mass in humans and have shown that dairy calcium 
may aid in an energy-restricted diet by promoting body fat loss and/or by the 
prevention of weight gain (Zemel et al., 2004; M B Zemel et al., 2005; Michael 
B Zemel et al., 2005; Eagan et al., 2006; Thompson et al., 2005; Shi et al., 
2000). Comparative studies in humans and animals have shown that the impact 
of dairy calcium on body fat mass could be more manifest compared with that 
initiated by supplementary calcium (Zemel et al., 2004; M B Zemel et al., 2005; 
Shi et al., 2000). Therefore, it is possible that other bioactive ingredients in 
dairy sources such as protein, probiotics and/or vitamin D may have an impact 
on the changes in body fat mass either separately or in combination with 
calcium (Astrup et al., 2010).
Although many studies on calcium supplementation were initially designed to 
determine the impact of calcium supplementation on bone markers rather than 
on body fat mass and BMI, these studies indicate that calcium supplements had 
no significant effect on body fat mass or BMI (Winzenberg et al., 2007; 
Trowman et al., 2007). Additionally, it is also possible that these studies were
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just too small to detect small changes either in body fat mass or BMI. Evidence 
from the very large Women’s Health Initiative study on calcium 
supplementation (1000 mg elemental calcium plus 400 lU of cholecalciferol 
(vitamin D)) compared with the placebo in post-menopausal women, indicates 
that calcium supplementation enabled a consistent change in body weight by 
0.13 kg (P = 0.001) (Caan et al., 2007). This study found that women who 
consumed less than 1200 mg of calcium daily at baseline for three years were 
11% less likely to slow down the process of weight gain (1-3 kg). They were 
also 11% less likely to gain weight in moderation (<3 kg).
1.12.3 Mechanisms of the effect of calcium on body weight
It has been suggested that increased calcium intake may increase faecal energy 
loss, increase energy expenditure and/or decrease energy intake, which may 
lead to a reduction in body weight (Astrup, 2008). Three different mechanisms 
for these effects of calcium on body weight have been proposed, which include 
(i) increased excretion of faecal fat, (ii) the effects on fat metabolism in 
adipocytes and (iii) changes to appetite regulation (Astrup et al., 2010) as 
illustrated in Figure 1.3.
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Figure 1.3 The potential mechanisms of the effect of dietary calcium on body weight. GI, gastrointestinal; 
Ca^ ,^ calcium; PTH, parathyroid honnonc; SNS, sympathetic nervous system; [Ca^ ]^ I, intracellular calcium; 
FAS, Fatty acid synthase; UCP, uncoupling protein; DIT, diet-induced thermogcnesis. Adapted from (Soares et 
ah, 2010).
1.12.4 Increased excretion of faecal fat
Evidence has shown that increased dairy calcium intake contributes to increased 
faecal fat and energy excretion (Bendsen et al., 2008; Jacobsen et al., 2005). 
Accordingly, data from meta-analyses indicates that an increase in a daily dairy 
calcium intake by approximately 1200 mg leads to increased faecal fat excretion 
by 5.2 g/day. Therefore, increased faecal fat excretion by 2 to 5.2 g/d 
corresponds to a change in body weight of 1 to 2.2 kg/y (Christensen et al., 
2009). In agreement, many studies have shown that calcium supplementation 
may lead to an increase in fat excretion (Christensen et al., 2009). Likewise, 
animal studies have found similar effects (Yuangklang et al., 2004; Pilvi et al..
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2007; Papakonstantinou et al., 2003). It is possible that the binding of bile acids 
and/or the formation of insoluble calcium-fatty acid soaps may mediate the 
increased excretion of faecal fat (Govers et al., 1994).
1.12.5 Effect on fat metabolism in adipocytes
Evidence from in vitro and animal studies have suggested that increased dietary 
calcium intake may suppress lipogenesis and induce lipolysis, which may lead 
to increased energy expenditure and fatty acid oxidation. Zemel and colleagues 
have shown that lower calcium intake may lead to a rise in the levels of 1,25- 
dihydroxyvitamin D (1,25(OH) 2 D), which may result in a stimulation of 
calcium uptake into adipocytes by membrane vitamin D receptors (Zemel et al., 
2000). The increase in intracellular calcium levels ([Ca^^]i) elevates the 
lipogenesis and reduces the lipolysis by increasing fatty acid synthase activity 
and expression thus, inhibiting hormone-sensitive lipase. Conversely, an 
increase the calcium intake would result in a reduction in the levels of 1,25(OH) 
2 D, which would consequently lead to a decrease in lipogenesis and an 
increase in lipolysis (Zemel, 2003; Zemel & Sun, 2008). Current evidence from 
human investigations is, however, insufficient to confirm or reject this 
hypothesis. More importantly, the role of lipogenesis appears to be minor in 
humans (Hellerstein, 2001). Although, currently there is no evidence to show 
the effect of calcium on energy expenditure in humans, the evidence for lipid
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oxidation changes, whilst available and is inconsistent (Boon et ah, 2007; Niels 
Boon et al., 2005; Bortolotti et al., 2008; Jacobsen et al., 2005; Melanson et al., 
n.d.; Melanson et al., 2005; Teegarden et al., 2008).
1.12.6 Appetite regulation
It has been proposed that some macronutrients, such as calcium, may have a 
role in appetite regulation and food intake. Tordoff and colleagues have 
hypothesised that low-calcium intake may lead to an increase in the desire to eat 
calcium-containing products and other calcium-rich foods, such as dairy 
products (Tordoff, 2001).
Recently, it has been suggested that the calcium-specific appetite associated 
with energy intake facilitates fat loss (Major et al. 2009). Few studies have 
investigated the role of calcium in appetite regulation and this hypothesis is yet 
to be fully tested (Gonzalez et al. 2013; Lorenzen et al. 2007; Ping-Delfos & 
Soares, 2011). Although some investigations have reported that a high-calcium 
meal results in a reduction in energy intake over 24-h (Ping-Delfos & Soares,
2011), others have indicated no significant changes in energy intake, appetite 
sensation ratings or post-prandial gut hormones concentration including, 
insulin and glucagon- like peptide-1 (GLP-1) (Lorenzen et al., 2007).
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The mechanism that dietary calcium may affect food intake and appetite 
regulation is still unknown. However, calcium may influence hormonal 
responses, which may impact the physiological functions. Thus, it might be 
important to measure the response of some biomarkers o f appetite and food 
intake, to calcium intake, such as ghrelin, cholecystokinin (CCK), peptide YY 
(PYY), and glucagon-like peptide-1 (GLP-1). Indeed, appetite regulation is a 
complex interaction in which, not only are the hormonal controls involved, but 
so are the other environmental and behavioural factors that may affect the 
control of food intake (Teegarden et al., 2008).
After the ingestion of food, some of the gastrointestinal peptides are released 
via the K-cells and L-cells of the intestine, such as glucose-dependent 
insulinotropic peptide 1-42 (GIPI-42) and glucagon-like peptide-17-36 (GLP- 
17-36) (Holst, 2007). These peptides stimulate the release of insulin through a 
direct impact on b-cells (Vilsboll et al., 2003; Salehi et al., 2012), however; the 
action of GLP-I7-36 occurs through the nervous system when the anorectic 
component is produced (Holst, 2007; Babic et al. 2012; Verdich et al. 2001).
Macronutrients including fat and carbohydrates potentiate the secretion of GIP 
and GLP-I through direct action with endocrine K- and L-cells (Deacon, 2005). 
Recent evidence has shown that calcium may play an important role. In rodents, 
the total GIP and GLP-I secretion is stimulated in a segment of the isolated 
intestine with increasing luminal concentrations of calcium at levels relevant to
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those found post-prandially in humans (Fordtran & Locklear, 1966; Mace et al.,
2012). The stimulation of GIP and GLP-I by calcium is increased with the 
amino acid L-phenylalanine. However, the increase in the GIP and GLP-I 
levels after consumption of calcium remains to be confirmed among the 
humans.
A recent study has demonstrated that high calcium consumption may stimulate 
post-prandial plasma GIP and GLP-1 and lead to an increase in the post­
prandial insulinaemia and satiety in humans (Gonzalez & Stevenson, 2013). 
However, no effect of calcium on substrate metabolism was observed (lipid and 
carbohydrate oxidation). In this study, an increase in the calcium content of a 
meal from 250 to 1,240 mg increases the post-prandial responses of GIP and 
total GLP-I over 2 h (Gonzalez & Stevenson, 2013).
A limited number of studies have examined the effect of calcium consumption 
on appetite and food intake. Major and colleagues (2009) investigated the effect 
of consumption of calcium + vitamin D supplements in individuals with a very 
low daily calcium intake (<600 mg/d) compared with the placebo for 15 weeks 
(Major et al., 2009). They found that the daily consumption of calcium 
supplementation led to a reduction in the ad libitum fat intake. The hypothesis 
of this study was that calcium-deficient individuals were more likely to select 
and consume a high-fat foods containing calcium, such as dairy products. 
However, the mechanism that could explain the increase in hunger and energy
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intake as a result of the lack of calcium was not unearthed by this small study. 
Another study by Jacobsen and colleagues (2005) found that consumption of 
meals containing calcium (medium and high) led to an increase in faecal fat loss 
and reduced the area under the curve (AUC) for serum chylomicron, which was 
correlated to triglycerides compared to the calcium (low) meal.
Acute consumption of calcium has not been shown to affect either appetite 
sensations, appetite regulating hormone levels, or energy intake at an ad libitum 
meal (Lorenzen et al., 2007). This study investigates a different level of dairy 
product supplementation in overweight male subjects. There were three test 
meals comprising of dairy products as the source of Calcium: low calcium 
(68 mg), medium calcium (350 mg) and high calcium (793 mg), compared with 
a calcium supplement incorporated into a meal containing whey, casein and 
lactose. However; dairy protein was equivalent in all the test meals. Notably, 
the high-calcium meal was more palatable than the low-calcium one but no 
significant difference was noted in the energy intake from the ad libitum meal 
following the consumption of the test meals. It should be noted that an increase 
in the palatability theoretically, could result in an increase in energy intake, 
which could contribute to a reduction in the individual’s compensation. 
Likewise, another study has shown that an increase in the food intake by 209 
kcal/d after consumption of high-dairy components compared with low-dairy 
components may not display significant differences in subjective appetite
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ratings (Hollis & Mattes, 2007). On the contrary, studies in rodents indicated 
that there were no differences in energy intake between low and high calcium 
intake (Zhang & Tordoff, 2004; Siddiqui et al., 2007).
A recent study by Gilbert and colleagues (2011) investigates the effect of milk 
supplementation on appetite markers during weight loss. It shows that 
consumption of milk supplementation (I200mg/d) resulted in a reduction in 
subjective feelings of hunger and the desire to eat in overweight women. This 
effect was accompanied by the trend favouring lower fat and energy intake. 
Therefore, these effects could be mediated by both, a Ca supplement and high- 
diary protein intake (Gilbert et al., 2011). Another study has shown that 
calcium intake results in a suppression of hunger during short-term weight loss 
(Kabmova-Hlavata et al., 2008). Evidence has indicated that calcium with 
vitamin D decreased energy intake at buffet meals and prolonged the inter-meal 
interval between the buffet meal and the dinner with a reduction in energy 
intake during 24 hours. Thus, the reported effect in this study may be due to the 
combination of the calcium and vitamin D (Ping-Delfos & Soares, 2011). More 
recently, a study by Gonzalez and colleagues (2013) has shown that increasing 
the dairy calcium content of a meal can result in an increase in the feelings of 
fullness and insulin concentrations, but there will be no impact on the substrate 
oxidation or energy expenditure prior, during or following exercise as has been 
observed in physically active males (Gonzalez, Rumbold, & Stevenson, 2013).
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1.13 Outline of the thesis
The studies described in the thesis investigated food ingredients that may affect 
appetite, energy intake and the maintenance of body weight. Thereby, they may 
act as potential anti-obesity agents.
Generally, dietary fibre increase satiety and reduce food intake (Lyly et al., 
2009; Slavin, 2013; Willis et al., 2009). Evidence has shown sustained satiety 
and a decrease in food intake after the consumption of dietary fibre from 
resistant starch in lean subjects (Bodinham et al., 2010). Therefore, the present 
thesis aimed to investigate whether consumption of the non-viscous fibre RS at 
breakfast and lunch would be effective in prolonging satiety and reducing 
energy intake in overweight/obese subjects, as these subjects could benefit from 
dietary manipulation (Chapter 3). In chapter three we also investigated whether 
the satiating effect of RS was related to the glycaemic response or the release of 
the gut hormone GLP-1. It has been suggested that differences between lean and 
obese subjects exist in appetite regulation and, therefore, in the response to 
specific ingredients. Consequently, the outcomes observed in lean subjects may 
not be replicated in the obese, who may also exhibit insulin resistance, as a 
confounder. Thus, we investigated satiety, appetite response and the glycaemic
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and GLP-1 response in lean and obese groups following the ingestion of RS 
(Chapter 4).
Dietary calcium has been linked to obesity (Zemel et al., 2000; Shi et al., 2000; 
Teegarden et al., 2008; Davies et al., 2000). It has been reported that obesity 
was associated with a lower intake of both dietary fibre (Alissa et al., 2005; 
Alissa & AIKadi, 2011) and dietary calcium in females in the Middle East (Al- 
Assaf & Al-Numair, 2007; Washi & Ageib, 2010). One of the suggested 
mechanisms of the effect of calcium on body weight is its effect on appetite 
(Tordoff, 2001). Therefore, a logical step was to investigate the effect of 
consumption of dietary fibre and the effect of dietary calcium on appetite and 
food intake in overweight/obese females, both in combination and in isolation. 
Fenugreek was chosen, as it is a common form of fibre eaten in the Middle East, 
and it would make the data highly translatable. We hypothesised that a 
combination of both ingredients (fenugreek and calcium) may have an additive 
effect on appetite and satiety. We investigated whether the effect of these 
ingredients on food intake would be due to the glycaemic response and/or the 
gut hormone GLP-I response (Chapter 5).
We further examined whether daily intake of dietary calcium was associated 
with body mass index and body composition in both pre-menopausal and post-
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menopausal South Asian UK women (Chapter 6). In the absence of data from 
the Middle East being the most readily available cohort in the UK.
Finally, the results of the above described studies are discussed to conclude the 
potential role of these food ingredients on appetite regulation and weight 
management (Chapter 7).
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1.14 General Aims of the thesis
The aim of the studies presented within this thesis is to demonstrate the role of 
dietary fibre and dietary calcium in appetite regulation and the metabolic 
response in overweight/obese subjects. The impact of the test meal palatability 
will be taken into account in the investigations within this thesis.
1.14.1 Objectives of the thesis
To assess the postprandial subjective measures of appetite using VAS, 
actual food intake at a subsequent ad libitum meal, 24 hour intake, 
postprandial metabolic concentrations and gut peptide involved in satiety 
GLP-1, when RS supplementation incorporated into breakfast and lunch 
compared with placebo.
To investigate the differences in the postprandial subjective measures of 
appetite using VAS, actual food intake at a subsequent ad libitum meal, 
24 hour intake, postprandial metabolic concentrations and gut peptide 
GLP-1 between obese and lean subjects when RS supplementation 
incorporated into breakfast and lunch compared with placebo
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• To assess the postprandial subjective measures of appetite using VAS, 
actual food intake at a subsequent ad libitum meal, 24 hour intake, 
postprandial metabolic concentrations and gut peptide involved in satiety 
GLP-1 when breakfast was incorporated with either:
a) 6g of fenugreek fibre
b) 500mg of calcium
c) A combination of both fenugreek fibre and calcium
compared with placebo (drink with no added fenugreek or calcium)
To identify any association between daily calcium intake and body 
weight, body mass index and waist to hip circumferences in both 
premenopausal and postmenopausal UK South Asian women
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Chapter 2 Materials and Methods
This chapter describes the general methods relating to the clinical studies reported 
in Chapters 3-5. Any deviations to these methods are described in the individual 
experimental chapters.
2.1 Requirements and Screening
Participants were recruited from the student population at the University of Surrey 
and from the local community by poster advertisement, e-mail advertisements, and 
verbal announcements. Written information about the study was given to people 
who showed an interest in it.
Prior to starting each study participants were invited to attend a screening session 
at the Clinical Research Centre (CRC) at the University of Surrey to explain the 
study design and assess their suitability for inclusion in the study. The screening 
required completion of self-certified medical questionnaires; the Dutch Eating 
Behaviour Questionnaire (DEBQ) and the Food Preferences Questionnaire (FPQ). 
Anthropometric measurements (age, height, body weight, and BMI) were 
calculated. An initial blood sample was collected by finger prick to test for blood 
haemoglobin levels using the HemoCue Hb 201+ and blood glucose levels using 
the HemoCue 201+. The participants were asked to sign a consent form if  they met
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the inclusion criteria of the study and were asked about their food preferences prior 
to starting the study.
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2.1.1 Self-Certified Medical and Lifestyle Questionnaire
All participants were asked to complete the self-certified medical 
questionnaire in the screening session. Generally, this questionnaire 
consisted of questions aiming to obtain details of the medical history of the 
participants, any type of medications they normally used, and information 
regarding their lifestyle related to exercise, smoking habits, and alcohol 
intake (Appendix B).
The general exclusion criteria for participating in the studies conducted as 
part of this thesis included the diagnosis of anaemia, those following 
weight reducing diets, and those not weight-stable for at least the preceding 
3 months. In addition, any individuals with current or previous medical 
conditions were excluded. Medical conditions for exclusion included 
cardiovascular diseases such as stroke and angina, liver disease, diabetes, 
endocrine disease, clinical depression, any psychological disorders, and 
gastrointestinal disease, which included Crohn’s disease, coeliac disease 
and irritable bowel syndrome. Participants were also excluded if they had 
participated in another study in the last 3 months or had any history of drug 
or alcohol abuse in the last 2 years, and were taking certain prescription 
medications or supplements. Female participants were excluded if  they 
were pregnant or lactating. Any additional specific exclusion or inclusion 
criteria are provided at the beginning of each chapter.
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2.1.2 Dutch Eating Behaviour Questionnaire
During the screening session all participants completed a DEBQ questionnaire 
to understand their eating behavior and to ensure they were not highly 
restrained, emotional or extemal-eaters (Appendix C). This tool was presented 
by van Strien and colleagues to improve assessment of the eating behavior 
process in obese individuals (Van Strien et ah, 1986). The DEBQ was 
developed in the 1980s and the questions are based around the psychosomatic 
(emotional eating) theory, externality theory, and the theory of restrained eating 
(van Strien et al., 1986). The psychosomatic theory focuses on emotional 
eating, which is described as excessive eating in response to states of arousal 
(such as stress or fear) when normally these emotions would result in loss of 
appetite (van Strien et al., 1986). The externality theory is portrayed by 
excessive eating in response to food cues irrespective of feelings of 
hunger/fullness (van Strien et al., 1986). The theory of restrained eating 
suggests that an individual’s “natural weight" is set higher than others and 
therefore there is constant pressure to reduce weight, even in the presence of 
hunger, resulting in continuous control by dieting; once this control is lost, 
excessive eating results (Van Strien et al., 1986).
The DEBQ questionnaire requires a response of never, seldom, sometimes, 
often, very often, and not relevant. These comprise of 33 questions that 
constitute a score of 1-5, with not relevant scoring 0. The DEBQ questionnaire
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separated into those relating to emotional, restrained, and external eating (as 
indicated by the colours on the questionnaire, which are green for external, blue 
for emotional and red for restrained). The values for each category are averaged 
to provide a score. If a participant responds “not relevant” to a question, the 
division for that category is reduced by one for each not relevant response. A 
high cut-off of 4.5 for all studies was used in order to exclude only those who 
were highly responsive in any category.
2.1.3 Food Preferences Questionnaire
During the screening session, all participants were requested to complete a food 
preferences questionnaire. This questionnaire was designed to assess the dietary 
and eating behaviours of the individual and included questions regarding the 
participant’s eating habits, and any food allergies or dietary requirements that 
they may have (Appendix F).
2.2 Anthropometry and Blood Pressure (BP)
2.2.1 Height
Height was measured at the screening session using a Harpenden stadiometer 
(Seca 213, Seca, Birmingham, UK) without shoes. Participants were asked to 
stand erect, facing forward in a horizontal plane with their heels, buttocks,
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shoulder blades and back of the head touching the wall, ankles together, knees 
straight and arms by their side. The measuring bar was gently lowered to touch 
the top of the participant’s head and height was recorded to the nearest 0.1 cm.
2.2.2 Body weight (BW), Body Mass Index (BMI) and % Body Fat
Body weight was measured to the nearest 0.1kg in the fasted state using digital 
scales (TANITA TBF-300, Tanita B.V, Hoofddorp, The Netherlands). The 
Tanita measured body composition by bioimpedance analysis (BIA) via the 
lower body. Body weight was assessed by Tanita and body fat % was then 
calculated based on the measurement of body weight, bioelectrical impedance, 
age, gender, body type and height. Participants were measured and weighed 
with bare feet wearing light clothing; a correction of 0.5kg was entered before 
weighing to allow for the weight of clothing.
2.2.3 Waist and hip circumference
Waist and hip circumference were measured over light clothing using a flexible 
tape measure. Participants were asked to stand with their feet together and arms 
relaxed at their side. Waist measurements were taken at the mid-way between 
the lowest rib and the iliac crest. Hip measurements were taken to the nearest 
cm at the maximum circumference around the buttocks, below the iliac crest.
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2.2.4 Blood Pressure (BP)
Blood pressure measurements were taken on each study visit using an automatic 
blood pressure cuff (Omron MX3 Plus, Omron Health care Europe, United 
Kingdom). Participants were instructed to sit and relax for five minutes prior to 
the measurement. Three readings were taken on the relaxed non-dominant arm, 
whilst the participant remained silent.
2.3 Capillary Blood Glucose and Haemoglobin
Capillary blood samples were collected by fingerpick test at the screening 
sessions. Fasting blood samples were immediately analysed for blood glucose 
levels using the HemoCue® 201+ (HemoCue, Sweden) and blood Haemoglobin 
(Hb) concentrations were measured using the HemoCue®Hb 201+ (HemoCue, 
Sweden). Participants who had concentrations above normal ranges (glucose >6 
mmol/1; haemoglobin <13g/dl for males and <12g/dl for females) were 
excluded from participating in the study.
The HemoCue method is a portable photometric method using a modified 
azide-methemoglobin for haemoglobin and glucose dehydrogenase for glucose. 
Instant and highly accurate results can be obtained by this method with a small 
amount of blood (Stork et al., 2005).
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2.4 Subjective and Quantitative Assessment of Appetite
2.4.1 Visual Analogue Scales for Appetite and Palatability
Subjective ratings of appetite and satiety were assessed in this thesis using 
Visual Analogue Scales (VAS) (Appendix D). VAS have been validated by 
Flint and colleagues (2000) and used previously in many investigations to 
assess subjective appetite sensations (Stubbs et al., 2000). A number of internal 
and external factors may affect subjective feelings of hunger or desire to eat on 
the test day. Internal factors consist of physiological variables, while external 
factors include the physical activity, temperature, and weather (de Graaf et al., 
2004; Blundell et al., 2010).
How much do you think you can eat?
Nothing at all A  lot
Extremely full
How full do you feel?
Not at all full
Figure 2.1 Example VAS to assess sensations regarding appetite
VAS consist of a line, 100mm in length with extreme expressions at each end 
(“I have never been more hungy’V I am not hungry at all”) (Figure 2.1.). 
Subjects were requested to mark the line at the point that most appropriately
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reflected their feelings. VAS scores were determined by measuring the distance 
between the left end of the line and the mark. In this investigation, participants 
were asked to complete two fasting VAS assessments (-15, 0 hours) and then 
every 30 minutes during the postprandial period. For each time point, every 
participant was given a new booklet and each question was introduced on 
separate page to avoid repeated response. A ‘within subject’ study design was 
used to avoid the inter-individual differences that may occur when different 
subjects complete the VAS. In this study, subjects acted as their own controls.
Participants were also asked to assess the pleasantness and palatability of the 
test supplement during the test breakfast and lunch meals by completing 
100mm VAS regarding taste, texture, and aftertaste (Appendix) (Krai & Rolls, 
2004; Yeomans, 1998).
2.4.2 Ad libitum Pasta Meal
The assessment of appetite in this thesis was measured using the quantitative 
method of an ad libitum meal. Participants were seated in isolation and provided 
with a large, pre-weighed ad libitum pasta meal. The meal was made by 
cooking 400g Tesco Fusili pasta for 12-15 minutes then adding the contents of a 
500g jar of Ragu original pasta sauce and stirring in 30g Tesco vegetable oil 
and lOOg Tesco mild cheddar cheese. If eaten fully, the meal provided (9665 kJ 
energy; 83.5g protein; 335.6g carbohydrate; 68.Ig fat; and 15.9g fibre). This
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meal had a mean weight of 1502.2 [SD 5.8, SEM 4.1] g and the energy density 
of this meal was 6.2 [SD 0.4, SEM 0.3] kJ/g.
The ad libitum pasta meals were served in large plain bowls and were weighed 
before serving. Participants were instructed to eat until they felt comfortably 
full. To discourage participants from over-consumption, they were informed 
they could take any leftovers home after the study. After the participant finished 
eating, the meal was re-weighed to determine the amount consumed. The 
energy and macronutrient intake was then calculated based on energy density.
2.4.3 24-Hour Intake
Overall 24-h intake was estimated by asking participants to complete food 
diaries on the day prior to each study visit and on each experimental visit 
including the remainder of the study day. Prior to the actual study day, all 
participants were instructed on how to fill in the food diary. Participants 
returned the completed diaries at the subsequent visit and these were checked 
with the investigator. Food diaries were analysed for energy intake (El), 
macronutrient, and fibre intake using Dietplan6 (Forestfield Software Ltd, 
Horsham, UK). The Food Standard Agency (FSA) Food Portion Sizes book was 
used to attribute a medium portion size when these were not provided by the 
participant (Food Standard & Agency, 2002). However, when the participant 
provided the actual brands, the nutritional values for these products were used.
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2.5 Blood Sampling and Analysis
2.5.1 Venous Blood Sample Collection
Venous blood samples were collected from an indwelling cannula at regular 
intervals during clinical investigation days. Blood sample timings are given in 
details in individual study protocols during the study days in each chapter.
Blood was collected into fluoride sodium oxalate tubes for glucose analysis; 
potassium EDTA-coated tubes for insulin and triglyceride (TG) analysis; and 
potassium EDTA-coated tubes with added aprotinin (200 klU/ml whole blood) 
(Sigma-Aldrich company Ltd, Gillingham, Dorset, UK) for gut peptide (GLP-1) 
analysis in order to inhibit enzymatic degradation.
All collected blood samples were preserved at 4°C to reduce degradation until 
centrifugation. All blood samples were centrifuged at 3000 rpm for 10 minutes 
using a Heraeus centrifuge (Thermo electron corporation, Waltham, MA). 
Plasma samples were then aliquoted into microtubes and stored at -20°C until 
batch analysis at the end of each study to prevent inter-assay variability. On the 
day of analysis, all plasma samples were defrosted at 4°C and centrifuged at 
1750 g (3000 rpm) for 10 minutes in order to separate the plasma from any 
fibrin. Following centrifugation, all samples were re-aliquoted into new 
microtubes prior to analysis.
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2.6 Analysis of Plasma Samples
2.6.1 ILAB 650
2.6.1.1 Plasma Glucose
Plasma glucose samples were collected for the investigations in chapters 3, 4, 
and 5. These samples were analysed by enzymatic colorimetric method using a 
commercially available kit utilizing the enzyme glucose oxidase 
(Instrumentation Laboratory Co., Lexington, USA) for the ILAB 650 
(Instrumentation Laboratory, Milan, Italy). The oxidations of glucose were 
catalysed by glucose oxidase to generate gluconic acid and hydrogen peroxide 
(H2O2) as shown below.
_  _  Glucose oxidase
D-Glucose + O 2  + H 2 O ----------------------- ► Gluconic A cid + H 2 O 2
The hydrogen peroxide produced then interacts with phenol and 4- 
aminoantipyrene, which is catalysed by peroxidase and results in the generation 
of quinoneimine dye and water.
Peroxidase
2 H2 O2  + phenol + 4-aminoantipyrine--------------------- ► Red quinoneimine + 4 H2 O
The concentration of quinoneimine dye produced is estimated by measuring the 
absorbance at 510 nm. The level of quinoneimine generated is directly 
correlated directly with the quantity of glucose in the sample.
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Quality control (QC) samples of glucose at concentrations of 5.9 mmol/1 and
15.3 mmol/1 were included at the start and end of each assay to check for 
accuracy. Across all the investigations in chapter 3, 4 and 5, the inter-assay 
coefficient of variation (CV) was <3 % and the intra- assay CV was <2 %.
2.6.1.2 Plasma TG
Plasma TG samples were collected for the investigations in chapter 5 and were 
analysed by enzymatic colorimetric method (Instrumentation Laboratory Co., 
Lexington, USA) on the ILAB 650 (Instrumentation Laboratory, Milan, Italy). 
This method is based on the generation of H2O2 from TG, which occurs in three 
phases as outlined below.
Firstly, glycerol is produced from the lipoprotein lipase catalysed hydrolysis of 
TG. Then the glycerol is phosphorylated with adenosine triphosphate (ATP), 
which is catalysed by glycerol kinase to produce glycerol-3-phosphate and 
adenosine diphosphate (ADP). The oxidations of glycerol-3-phosphate are then 
catalysed by glycerol-3-phosphate oxidase to generate dihydroxyacetone 
phosphate and H2O2 .
. _  Lipoprotein Lipase 
T A G - ^   -----► Glycerol+ FFA
, Glycerol kinase
Glycerol + ATP--------------------- ► Glycerol-3-P + ADP
 ^ ^  Glycerol-3-P oxidase ,
Glycerol-3-P + O2 --------------------- ► Dihydroxyacetone phospate + H2 O2
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Finally, 4-chlorophenol and 4-aminophenazone are oxidised in the presence of 
the generated H2O2 and the peroxidase catalyst to produce a complex of 
quinoneimine red dye.
H2 O2  + 4-chlorophenol + 4-aminophenazone ^ quinoneimine + H2 O
The concentration of quinoneimine dye complex produced is estimated by 
measuring the absorbance at 510 nm. The level of quinoneimine generated is 
directly correlated with the TG concentration of the sample.
QCs of concentration 1.14 mmol/1 and 3.18mmol/l were measured (at the start 
and end of each assay. The inter-assay CV in the study in chapter 5 was <1 % 
and the intra- assay CV was <0.80 %.
2.6.3 Analysis of Plasma Insulin
2.6.3.1 Radioimmunoassay (RIA)
Plasma insulin samples were collected and analysed by radioimmunoassay 
(RIA) using a human insulin-specific kit in chapters 3 and 4 (EMD Millipore, 
Missouri, USA). In this method, all plasma insulin concentrations were 
measured in duplicate by using the double antibody/PEG procedure. A fixed 
concentration of labelled antigen was used in this assay that competes with 
insulin to bind the antibody in the blood sample. This assay determines the true 
level of insulin as there is no cross-reactivity with human proinsulin (<0.2).
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The human Insulin assay has the limit of insulin sensitivity of 2.71 pU/mL and 
the level of linearity of 200 |xU/mL. QCs of this assay were determined at the 
first and the last stage of each run. The expected range of these QCs were 
between 10-22 pU/mL for QCl and 25-53 pU/mL for QC2. Across all the 
investigations in chapter 3 and 4, the inter-assay CV was <32 % and the intra­
assay CV was <13 %.
2.6.3.2 Human Insulin ELISA
Plasma insulin concentrations were analysed in chapter 5 using a non­
radioactive human insulin ELISA kit (Millipore, Missouri, USA).
This assay is a sandwich ELISA assay with no cross-reactivity with human 
proinsulin with the major processed intermediate, des-31, 32 proinsulin; 
however, cross-reactivity can be detected with the minor intermediate, des-64, 
65 proinsulin in serum.
In this assay, enzyme activity was determined by spectrophotometer by 
estimating the increase in absorbance at 450nm following the formation of 
acidified products. Absorbance is directly proportional to the amount of the 
captured human insulin. Thus, the concentration can be estimated by 
interpolation from a generated reference curve for the same assay with reference 
standards of known human insulin concentrations. All samples in this assay 
were measured in duplicate and an average taken.
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The limit of sensitivity detected by this assay was 2-pU/mL human insulin with 
a range from 2 pU/mL to 200 pU/mL. QCs were measured at the start and at 
end of each run with an expected range of 8-17 pU/mL for QCl and 31-65 
pU/mL for QC2. The inter-assay CV in the study in chapter 5 was <7 % and 
the intra-assay CV was <5 %.
2.6.4 C-Peptide
Plasma C-peptide concentrations for samples collected from the studies in 
chapter 3 and 4 were analysed by RIA using a commercially available human 
C-peptide RIA kit (Millipore, Missouri, USA). In this method, all plasma C- 
peptide concentrations were measured in duplicate by using the double 
antibody/PEG technique.
A fixed concentration of labelled antigen was used in this assay that competes 
with C-peptide to bind the antibody in the blood sample. In this assay, there was 
a low cross-reactivity to human proinsulin (<4.0%).
The human C-peptide assay has a limit of sensitivity of O.lng/mL and the level 
of linearity was 5.0ng/mL. QCs of this assay were determined at the begging 
and the end of each run. The expected ranges of these QCs were between 0.2- 
0.5 ng/mL for QCl and 1.1-2.3 ng/mL for QC2. The inter-assay CV was <19 
% and the intra-assay CV was <10 %.
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2.6.5 GLP-1 Total ELISA
Plasma GLP-1 concentrations were analysed in chapter 3, 4, and 5 using a non­
radioactive quantification of GLP-1 (Millipore, Missouri, USA). In this 
sandwich ELISA assay, enzyme activity was determined by spectrophotometer 
by increasing absorbance at 450nm that corrected from the absorbency at 590 
nm following acidification of the form products. The absorbance is directly 
proportional to the total amount of the captured GLP-1.The concentration of 
GLP-1 in the sample can be obtained by interpolation from a generated 
reference curve for the same assay with reference standards of known human 
GLP-1 concentrations.
The limit of sensitivity detected by this assay is 1.5 pM total GLP-1 with a 
maximum range of 4.1 pM to 1000 pM total GLP-1.
QCs were measured at the start and at end of each run with expected range of 
24-51 pM for QCl and 144-299 pM for QC2. The inter-assay CV across the 
studies in chapter 3, 4 and 5 was <15 % and the intra-assay CV was <4 %.
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2.7 Measurement of Insulin Sensitivity
Insulin sensitivity can be assessed by a number of direct and indirect methods 
(Muniyappa et aL, 2008; Matsuda, 2010). Direct methods include the 
euglycaemic-hyperinsulinaemic glucose clamp and the insulin suppression test 
(1ST), which determines insulin-mediated glucose disposal under steady-state 
conditions. The gold standard for insulin sensitivity is the euglycaemic- 
hyperinsulinaemic clamp technique (DeFronzo et al., 1979). However, direct 
methods are costly, labour intensive and require medical supervision. Another 
drawback of the clamp, as well as other direct method that use glucose and 
insulin injections or infusions, is that they may create non-physiological 
situations that are not representative of free-living situations. In addition, and 
perhaps most-importantly for nutrition research, these methods are gut- 
independent, as there is no oral challenge. Therefore, several other indirect 
methods that measure insulin sensitivity have been developed that are lower in 
cost and simpler. As such, they can be used for clinical studies (Patarrao et al., 
2014; Singh & Saxena, 2010; Maki, 2012).
Indirect measures to assess insulin sensitivity include the frequently sampled IV 
glucose tolerance test (FSIVGTT) with minimal model analysis, indices derived 
from oral glucose tolerance test (OGTT) or meal tolerance test (MTT), and
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fasting markers for insulin sensitivity, such as fasting insulin concentrations and 
HOMA.
The OGTT typically involves a 75 g glucose load and then measures glucose 
and insulin response at various time points over a 2 h interval. The OGTT is 
technically quite simple to perform and certainly lower in cost; it provides 
useful information about glucose tolerance but not insulin resistance 
(Rijkelijkhuizen et al., 2009). It has also been argued that it is non- 
physiological, as the large simple carbohydrate load often leads to reactive 
hypoglycaemia, a phenomenon rarely seen after meal ingestion in free-living 
individuals (Maki 2012). Therefore, in an attempt to study the ability to regulate 
blood glucose in a more physiological situation than the OGTT, the meal 
tolerance test (MTT) is used to measure the glycaemic/lipaemic profile in 
response to the ingestion of a mixed-meal containing carbohydrates, fat and 
proteins (Patarrao et al., 2014).
The MTT uses a standardized liquid or solid meal, followed by a collection of 
blood samples for the measurement of glucose and insulin over 2 ^  h. This 
method has a number of potential advantages over the OGTT. Firstly, MTT 
provides a physiologic stimulus for the simultaneous assessment of post-load 
lipaemia and for the measurement of incretin hormones (Rijkelijkhuizen et al., 
2010; Maki, 2012). Secondly, the beta-cell response is stronger after a mixed
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meal than after an OGTT with equal carbohydrate quantity, both for classical 
and model-based parameters (Rijkelijkhuizen et al., 2009). Several factors may 
contribute to differences in insulin secretion following the MTT compared with 
the OGTT. The MTT has a lower glycémie index than the OGTT, which may 
lead to lower glucose excursions (Wolever et al., 2006). Moreover, slower 
gastric emptying follows the MTT; the larger volume, solid character and fat 
content will lead to a slower entry of nutrients into the circulation (Doran et al., 
1998; Achour et al., 2001; Cunningham & Read, 2007).
2.7.1 Estimation of Insulin Sensitivity
Obesity is known to be accompanied by insulin resistance, which is then 
compensated by increased insulin secretion. To evaluate the effect of meal 
ingestion on postprandial insulin sensitivity, we evaluated insulin sensitivity 
and insulin secretion using indices derived from the MTT data. Therefore, the 
studies described in this thesis measured insulin sensitivity using the Matsuda 
index during the MTT. The Insulinogenic index as an indirect marker of insulin 
secretion in the first 15 minutes following eating was measured. In addition, we 
measured the disposition index to assess the ability of the B-cells to compensate 
for insulin resistance. The measurement of insulin sensitivity prior to all the test 
meals was also calculated from fasting blood samples using HOMA-IR 
(primarily as a marker of hepatic insulin sensitivity) in order to examine 
whether the participants were in a similar baseline insulin-sensitivity state prior
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to testing. This is important because fasting glucose, for example, can be 
affected by such factors as preceding exercise in the 24 hours prior to the study 
visits and consumption of the evening meal (Shah et al., 2009; Robertson et al., 
2002). Details of the tests used are described below.
2.7.1.1 HOMA IR
The Homeostatic (HOMA) model is a method used for insulin resistance 
assessment. The model links glucose and insulin dynamics that determine 
fasting steady state (3-cell function (% B), insulin sensitivity (% S) and insulin 
resistance (HOMA-IR) from basal fasting plasma glucose and plasma insulin 
(or C-peptide) concentrations (Levy et al., 1998; Matthews et al., 1985; Wallace 
et al., 2004).
2.7.1.2 Matsuda Index
The Matsuda Index of insulin sensitivity is simple to calculate and provides an 
approximation of whole-body insulin sensitivity from the OGTT or MTT 
developed by Matsuda and Defronzo (Matsuda & DeFronzo, 1999).
In this method the OGTT index of insulin sensitivity [ISI (composite)] was 
calculated using both the data of the entire 3 h OGTT and the first 2 h of the 
test. This index was based on insulin values given (in microunits per millilitre
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(pU/mL)) and glucose (in milligrams per decilitre (mg/dL)) obtained from the 
OGTT and the corresponding fasting values (Matsuda & DeFronzo, 1999).
XMatsuda index = 10 000/V (fasting glucose x fasting insulin) (mean glucose 
mean insulin).
This index represents a composite of both hepatic and peripheral tissue 
sensitivity to insulin.
2.7.1.3 Insulinogenic Index (IGI)
A frequently used measurement is the ratio of the incremental insulin 
concentration to the incremental glucose concentration for the first 30 minutes 
after a meal. This measure is called the Insulinogenic Index, IGI (Seltzer et al., 
1967). The IGI is commonly used as an index of P-cell function. It is an index 
of insulin secretion derived from OGTT (Goedecke et al., 2009).
Abnormalities of early phases of insulin secretion are evaluated by the IGI 
(change of insulin divided by change of glucose during the first 30 min of the 
OGTT), IGI = ôinsulin (0-30 min)/8glucose (0-30 min)) (Hyogo et al., 2012). 
The insulinogenic index helps to estimate the level of insulin secretion with a 
more physiological (oral) route of glucose administration (Singh et al., 2010).
100
Najlaa Al-Mana Thesis
2.7.1.4 Disposition Index (DI)
The interaction between insulin sensitivity and acute insulin response, termed 
the Disposition Index (DI), was previously reported as the best predictor of 
future diabetes in the Insulin Resistance Atherosclerosis Study (Lorenzo et ah, 
2010). The DI is a measure of the ability of p-cells to compensate for insulin 
resistance and can be thought of as a measure of P-cell functionality (Bergman 
et ah, 2002).
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2.8 Calculations
The area under the curve (AUG) method was used to calculate the ratio of C- 
peptide to insulin. The ratio was determined for up to two hours after each meal 
(0-120 minutes and 180-300 minutes) and until two hours after the test lunch (0- 
300 minutes) to give a total. This total has been used as a surrogate marker of 
hepatic insulin clearance (Meier et al., 2007) (Chapter 3 and Chapter 4).
In Chapter 4, a comparison between lean and overweight groups was made, and 
a percentage difference between active treatment (resistant starch) and placebo 
was calculated for each individual.
In this thesis, all insulin dynamics (IS by Matsuda index, IR by HOMA-IR, 
early-phase insulin secretion by Insulinogenic Index and the ability of B-cells to 
compensate for insulin resistance by (DI) were compared between 
groups/treatments according to a published web formula/using a spreadsheet 
downloadable from the following the web site: http://mmatsuda.diabetes- 
smc.jp/english.html. Glucose and insulin concentrations at 0, 30, 60, 90, and 
120 minutes were used.
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2.9 Statistical Analyses
All statistical analyses were conducted using SPSS for Windows 18.0 (SPSS 
Inc., Chicago, USA). Statistical significance considered as j?<0.05 (2 tailed). All 
data were checked for normality using the Kolmogorov-Smimov test. Data was 
assumed to be normally distributed if  the p  value was not significant. Therefore, 
parametric tests were used when data were normally distributed, and non- 
parametric tests were used when data were not normally distributed. Non­
normal distributions may be a consequence of the small sample sizes used in 
this research. Values given in the text are mean and standard error of mean 
(SEM), unless otherwise indicated.
Data such as postprandial metabolites, hormone concentrations and subjective 
VAS ratings were analysed using repeated measures ANOVA with time and 
treatment as within subject factors and group as a between subject factors. This 
statistical approach is a form of the General Linear Model (GLM). As such, it 
also provides important information regarding interactions between factors. To 
avoid a multiple comparison bias, we applied a Bonferroni correction where 
appropriate. Anthropometric measurements, body composition parameters and 
dietary intake data were compared using independent sample t-tests. 
Correlations between average calcium intake and body mass index as 
continuous variables were assessed by using spearman’s rank-order correlation 
coefficient. The palatability of the test products was compared using one-way
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ANOVA. The specific statistical tests used in each study, and the factors, are 
stated within the method section in each chapter.
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Chapter 3 The acute effect of Resistant Starch on appetite and satiety in 
overweight men
3.1 Introduction
The prevalence of obesity and being overweight has been widely reported in the 
past 20 years (Al-Sendi et ah, 2003; Seidell & Flegal, 1997; Ng et ah, 2011; 
AlNuaim et ah, 1996; Flegal et ah, 2010). The World Health Organization 
(WHO) has called the worldwide rise in obesity a global epidemic(WHO, 
2013b). Obesity is considered one of the problems not only in high-income 
countries, but also has increased dramatically in the low- and middle-income 
countries, especially in urban areas (Jokela et ah, 2009). However, although 
obesity is a complex chronic condition, lifestyle modifications that include food 
behaviour may be crucial in obesity management (Mozaffarian et ah, 2011).
Several studies have linked increased intake of dietary fibre with improvement 
in the management of body weight (Du et ah, 2010; Slavin, 2005; Howarth et 
ah, 2006; Kendall, Esfahani, Sanders, et ah, 2010). In general, the effect of 
dietary fibre on weight regulation is manifested through different mechanisms 
including changes in blood glucose levels, reduction in food intake, shortened 
gastric emptying time, and alteration of the intestinal hormone response after 
fibre consumption (Papathanasopoulos & Camilleri, 2010; Slavin, 2005). 
Resistant starch (RS) is a different kind of dietary fibre. RS is indigestible in the
105
Najlaa Al-Mana Thesis
small intestine and arrives intact in the large intestine, where it is fermented by 
gut microflora to produce short-chain fatty acids (Nugent, 2005; Phillips, 2013; 
Brown, 2004). It has been demonstrated that RS may act physiologically like 
other types of non-viscous dietary fibres (Bodinham et al., 2013; Willis et al., 
2009; Keenan et al., 2006). Therefore, RS may play an important role in weight 
regulation due to the impact of RS on satiety.
A limited number of studies have investigated the effects of incorporating RS 
into the diet and the effects on appetite in overweight subjects (Bodinham et 
al., 2013). Accordingly, the aim of this study was to investigate the effect of RS 
on appetite and energy intake compared with a placebo supplement in 
overweight men.
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3.2 Aims
The present study aimed to investigate the short-term effects of including a 48g 
resistant starch supplement in the diet of overweight male subjects. Effects on 
appetite visual analogue scores (VAS) ratings, glycaemia, insulinaemic 
response, C-Peptide and gut peptide (GLP-1) involved in satiety and actual food 
intake were examined.
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3.3 Materials and Methods
The present study was conducted according to the guidelines laid down in the 
Declaration of Helsinki, and all procedures involving human subjects were 
approved by the Ethics Committee of the University of Surrey 
(EC/2011/80/FHMS). Written informed consent was obtained from all subjects. 
Postprandial visual analogue scores (VAS) for hunger and satiety were obtained 
and blood analysed for glucose, insulin, and GLP-1 response to the 
consumption of 48g of RS type2 were also measured and compared with an 
energy- and carbohydrate-matched placebo supplement.
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3.4 Participants
Ten healthy, young, overweight male subjects (BMI) (28 -  37 kg/m^), aged (18 
-  32) years were recruited from the student population at the University of 
Surrey using flyers and e-mail advertisement during the period of September 
2010 to March 2011. The suitability of subjects for inclusion was assessed 
during screening (see section 2.1). This included an interview and completion of 
a self-certificated medical questionnaire, and the Dutch Eating Behaviour 
Questionnaire (DEBQ) (van Strien et al., 1986). For inclusion, body mass 
index (BMI) must have been with the 28-37 kg/m^ range. Furthermore, an 
initial fasting blood sample was taken by capillary finger prick to assess fasting 
blood glucose < 6.0 mmol/1, and haemoglobin normal levels (HemoCue, 
Sweden). All subjects had no history of gastrointestinal disease or endocrine 
disorders and had been non-dieters for the period of 3 months.
The exclusion criteria for participating in the study included previous or current 
chronic medical conditions, alcohol intake of more than 21 units of alcohol per 
week, or any prescription medicines or supplements in last 6 months. Restrained 
eaters (Restraint score > 4 as identified by the DEBQ) were also excluded from 
participating in the study. Restrained eaters tend to restrict their food intake, 
although they may eat less than desire, they may also eat more than they require 
which can confound studies on appetite (Johnson et al., 2012; Macht, 2008; 
Poslusna et al., 2009).
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Table 3.1 is outline the baseline participant characteristics. The participants 
included in this study had a mean ± standard error of the mean (SEM) of score 
of 2.1 (0.2) on the emotional scale, 2.5 (0.2) on the restraint scale and 3.2(0.2) 
on the external eating scale.
Table 3.1 Baseline participant characteristics in the screening (n=10)
^ Overall (n =10)
Mean SEM
Age (years) 22 1.18
Height (cm) 176.38 2.17
Weight (kg) 99.7 3.92
BMI (kgm-2) 32 0.92
DEBQ Restrained 2.52 0.70
DEBQ Emotional 2.16 0.77
DEBQ External 3.20 0.71
Fasting glucose (mmol/1) 4.88 0.65
Haemoglobin (g/dl) 16.64 1.52
*BMI: Body mass index, DEBQ: Dutch Eating Behaviour Questionnaire
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3.5 Study Protocol
This study was a randomised subject-blinded, balanced crossover study to 
investigate the acute effect of RS on appetite, glucose, insulin and GLP-1. 
Participants attended on two separate days, at least one week a part. 
Participants consumed either 80g of RS (Hi-Maize 260®composed of 60% RS 
type 2 and 40% rapidly digestible starch) or 32 g of placebo (Amioca -100% 
rapidly digestible starch), which was incorporated into breakfast and lunch 
meals and were assigned in random order.
Prior to each study day, all participants were instructed to restrain from 
strenuous exercise and alcohol consumption to reduce within-subject variability. 
Participants were asked to consume an identical evening meal that was low in 
fibre to avoid any effects due to additional fibre consumption (a low fibre meal 
list was provided) and 24-hour intake was recorded. All clinical investigations 
were carried out at the Clinical Research Centre (CRC) at the University of 
Surrey. Participants remained at the investigation unit for 7 hours and were 
allowed to drink water ad libitum.
On each study day, participants arrived at the CRC at approximately 8am 
following an overnight fast of at least 12 hours (h). Initially anthropometric 
measurements (weight, height, waist circumferences, % body fat, BMI) and 
blood pressure (BP) were taken. Participants were cannulated, then two fasted
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blood samples (time -15and, 0 min) were taken prior to breakfast, and then 
subjects completed two, fasted VAS measures (see chapter 2 for details) Figure 
3.1.
Measurements, 
fasting blood
sample Breakfast 
test meal
Lunch 
test meal Pre-welghed 
large meal
Blood samples and VAS Blood samples and VAS
every 30mins every 30mins Diet
4  ►
Arrival at 
CRC
12pm 4pm 9am
Figure 3.1 Timeline of each study day protocol
Participants were then asked to consume the standardised breakfast at time zero 
(the first study visit), which included 30 g Rice Krispies (Kellogg’s, UK) with 
100 g Semi-Skimmed milk (Tesco, UK) and the first dose of the supplement 
(either RS or placebo) mixed into a mousse (Angel Delight, UK). Following 
breakfast, participants completed a VAS regarding the palatability and 
pleasantness of the mousse. Blood samples were taken and VAS assessments 
were made every 30 minutes following the breakfast until lunch.
3 hours post- breakfast (180) minutes, the test lunch was provided, which 
included a ham sandwich (Tesco Healthy living honey cured roast ham
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(Tesco,UK) or a cheese sandwich (Mild Cheddar Cheese (Tesco, UK), made 
with white bread (Kingsmill white bread (Allied Bakeries, UK) with flora light 
(Unilever foods, UK). Each participant was also given a bag of ready salted 
crisps (Walkers, Walkers snack foods Ltd, UK), an orange drink (Tesco no­
added sugar orange squash, Tesco, UK) and the second dose of the supplement 
(either RS or placebo) mixed into a mousse. Each participant consumed the 
same sandwich filling on each visit. Table 3.2 summarises the energy and 
macronutrient composition of breakfast and lunch meals.
Table 3.2 Nutritional composition of the breakfast and lunch meals consumed on both study days. (Mean 
values with their standard errors (SEM) for ten subjects)
Breakfast Lunch
Mean SFM Mean SFM
Energy (kcal) 442 1.18 1161 59.1
Protein (g) 9.6 0.05 42.6 0.09
Carbohydrate (g) 83.0 0.33 138 0.34
Fat (g) 8.0 0.05 45.1 4.80
Fibre (g) 0.5(24.7*) 0.08(0.15)* 5.9 (30.1*) 0.08 (0.15)*
* Resistant starch meal only.
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On the first visit, the participant was allowed to eat as much or as little of the 
provided lunch as they liked, excluding the test product, which needed to be 
consumed in its entirety. After the lunch, the remaining food was weighed and 
the participant was given the same amount of the food on the subsequent visit to 
match the energy and the macronutrient intake.
At 420 minutes, participants were provided with a large pre-weighed pasta 
meal {ad libitum meal) providing 9665 kJ energy, 83.5g protein, 335.6g 
carbohydrate, 68.1 g fat, and 15.9g fibre (see section 2.4.2 for details). The 
energy and macronutrient composition of the ad libitum test meal is shown in 
Table 3.3. Participants were separated to minimise any effects of social 
interaction prior to food intake and were told to eat until comfortably satisfied. 
All remaining food was reweighed. To prevent over-consumption, participants 
were told they could take home anything they did not want to eat. Following 
the ad libitum meal, subjects were free to leave and were asked to complete a 
food and drink diary for the remainder of the day (until 9am the following 
morning) to document any compensatory or carry-over effects of food intake. 
All food diaries were analysed using Dietplan 6 (Forestfield Software Ltd, 
Horsham, UK). Participants recorded their bowel movements on the day of the 
study and the following day to assess gastrointestinal tolerance of the 
supplements.
114
Najlaa Al-Mana Thesis
Table 3.3 Energy and macronutrients composition of the ad libitum TEST Meal (per 100g)
kJ Kcal Pro (g) CHO(g) Sugar(g) Fat (g) SFA(g) Fihre(g) Na(mg)
Pasta 1460 345 11.5 72.0 2.0 1.0 0.2 3.4 0
Ragu 181 43 1.6 8.7 7.2 0.1 0.0 1.1 420
Cheese 1620
390 25.5 0.1 0.1 32.0 20.8 0.0 700
Oil 3700 900 0.0 0.0 0.0 100.0 7.0 0.0 0.0
*kJ: kilojoule, Kcal: kilocalories, Pro: protein, CHO:carbohydrate, SFA: saturated fat, Na:sodioum
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3.6 Test products and supplements
The RS supplement (Hi-Maize 260®comprising 60% RS type 2 and 40% 
rapidly digestible starch) and the placebo (Amioca, 100% rapidly digestible 
starch) were manufactured and supplied by the National Starch Company, LLC 
(Bridgewater, NJ, USA). Table 3.5 summarises the nutritional content of both 
supplements. The RS and the placebo supplements were mixed into a mousse 
(Angel Delight, UK). To balance the carbohydrate and energy content of the 
two test products 32g of the placebo (16g in each mousse) was used. In 
addition, results from preliminary work showed that 40 g of RS (Hi-Maize) was 
the maximal amount that could be incorporated into a single portion while still 
being acceptable in term of taste and texture (Bodinham et al., 2010). As a 
result, 80g of (Hi-Maize) was divided into two portions over breakfast and 
lunch to give 48 g of RS and 32g RDS in a single 24-hour period (according to 
the measurement of The Association of Official Analytical Chemists for total 
dietary fibre method 991.43) (AOAC, 1995).
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Table 3.4 Nutritional composition of the RS and the placebo supplement
Energy (kJ) Protein (g) CHO (g) Fibre (g)
Amioca lOOg 1674 0.0 100 0.0
32g 536 0.0 32.0 0.0
Hi-Maize lOOg 670 0.0 40.0 60.0
80g 536 0.0 32.0 48.0
Each pre-load was served as a flavoured mousse and participants were asked to 
choose one flavour of mousse (chocolate, raspberry or butterscotch) to be 
consumed consistently at each visit. The glycémie carbohydrate loads for the 
test product were identical and the only difference was in weight and the dietary 
fibre.
117
Najlaa Al-Mana Thesis 
Table 3.5 Nutritional composition of the single portion of the mousse to each supplement
Chocolate Butterscotch Raspberry
RS PL RS PL RS PL
Weight (g) 162.0 138.0 162.0 138.0 160.0 136.0
Energy (kJ) 907 907 911 911 884 884
Energy (kcal) 216 216 217 217 211 211
Protein (g) 4.3 4.3 4.1 4.1 4.1 4.1
CHO (g) 36.9 36.9 36.9 36.9 35.1 35.1
Fat (g) 5.7 5.7 5.9 5.9 6.0 6.0
Fibre (g) 24.5 0.5 24.1 0.1 24.0 0.0
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3.7 Blood analysis
Blood samples were collected every 30 minutes for the 7-hour intervention 
period. Blood samples were collected into potassium EDTA tubes for insulin 
analysis and sodium oxalate tubes for glucose analysis. Potassium EDTA tubes 
containing 200 kalikrein inhibiting units (KIU) aprotinin per ml of whole blood 
(Merck, Millipore) were used for GLP-1 analysis to prevent enzymatic 
degradation. All blood samples collected were stored at 4°C and then 
centrifuged at 1750 g (3000 rpm) for 10 minutes. Aliquots of plasma were 
taken and then stored at -20°C until analysis. All samples were analysed in one 
batch at the end of the study to reduce inter-assay variation.
Plasma glucose was measured enzymatically using a commercially available kit 
(Instrumentation Laboratory, Warrington, UK) for use with the ILab650 
(Instrumentation Laboratory), and the inter-assay variation were < 3 % and the 
intra- assay variation were < 2 %. Plasma insulin and C-peptide were measured 
by radioimmunoassay (RIA) with a commercially available kit (Millipore; 
Missouri, USA). These assays had inter-assay variations of 31.2% and 18.31 %, 
respectively and intra-assay variations of 12.5% and 9.63 % respectively. 
Plasma GLP-1 was measured by a commercially available enzyme-linked 
immunosorbent assay (ELISA) kit (Millipore; Missouri, USA) with an inter­
assay variation of 17.7 % and intra-assay variation of 4.01%. More detailed of
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the blood sample collection and analysis are described in Chapter 2 (Section 
2.5).
3.8 Food diaries
Food diaries were completed on the day prior to and on the study day. All 
participants received instruction on how to accurately record their consumption 
of food for the remainder of the day using food records. These diaries were 
analysed for energy intake, macronutrients, and fibre intake using Dietplan6 
(Forestfield Software Ltd, Horsham, UK). See Chapter 2(Section 2.4.3).
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3.9 Data analysis
The area under the curve (AUC) for postprandial plasma metabolites were 
calculated using the trapezoid rule. The AUC method also was used to calculate 
the ratio of C-peptide to insulin. The AUC for the metabolites and the ratio was 
determined for up to two hours after each meal (0-120 minutes and 180-300 
minutes) and for the total until two hours after the test lunch (0-300 minutes). 
This ratio was used as a surrogate marker of hepatic insulin clearance. To 
evaluate the insulin resistance, insulin sensitivity and P-cell secretion capacity 
several indexes were estimated based on web formula (using a spreadsheet 
downloadable from http://mmatsuda.diabetes-smc.ip/english.html). 
Homeostasis model assessment of insulin resistance (HOMA-IR) was 
determined in the fasting state to assess the insulin resistance. Matsuda Index 
was estimated postprandially after each meal to assess the insulin sensitivity 
(Matsuda & DeFronzo, 1999; Wallace et al., 2004; Matthews et al., 1985; Levy 
et al., 1998). Disposition index, which provides a measure of P-cell function 
was also assessed. The insulinogenic index was estimated to evaluate the early- 
phase of insulin secretion.
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3.10 Statistical analysis
All statistical analyses were conducted using SPSS for Windows 18.0 (SPSS 
Inc., Chicago, USA) and p<0.05 was considered significant. A repeated 
measures analysis of variance (ANOVA) was used to assess the effects of the 
treatment (RS and placebo) and change over time within subjects as a factor. 
Paired t tests were used to compare between groups and the data were checked 
for normality using a Kolmogorov-Smirnov test / Shapiro-Wilk’s test (SW/KS).
The influence of RS supplement compared with placebo on postprandial 
subjective VAS ratings, glucose and insulin was assessed by two-way repeated 
measure ANOVA with starch (RS, PL), and time (15 time points) as 
independent variables and the measurements as the continuous dependent 
variable. The AUC and insulin sensitivity was compared by paired sample t 
tests.
Differences in the effect of RS compared with placebo on energy intake at ad 
libitum meal, energy intake and macronutrients intake over 24 h were assessed 
by paired sample t tests. Non-parametric tests were also used due to small 
number of participants. However, statistical significant did not differ between 
tests, thus parametric tests are reported as the more powerful statistical test.
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One way ANOVA were used to compare the differences in the effect of RS 
compared with placebo on palatability VAS scores.
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3.11 Results
3.11.1 Palatability
The mean VAS scores regarding the pleasantness and palatability of the mousse 
containing either RS or placebo at the breakfast and lunch meals are shown 
Figure 3.10. One-way ANOVA found no significant differences between the 
pleasantness or the palatability of the two supplements for breakfast and lunch 
(pleasant (breakfast {p= 0.86), lunch {p= 0.83) and palatable (breakfast (p= 
0.21), lunch {p= 0.27) respectively).
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Figure 3.2 VAS ratings regarding the pleasantness (A and B) and palatability (C and D) of the 
supplemented mousse containing resistant starch (RS) or placebo (PL).
Analyses were earried out using one-way ANOVA. Values represent means ± SEM, (n= 10).a)-“How 
pleasant is the taste o f this meal right now?” No significant effect o f RS or PL supplements on the 
pleasant of the taste of the item were found at the breakfast (p= 0.86).b)-“How pleasant is the taste of this 
meal right now?” No significant effect of RS or PL supplements on the pleasant o f the taste of the item 
were found at the lunch {p= 0.83).c)-“How palatable is this meal right now?” No significant effect o f RS 
or PL supplements on the palatability of the item were found at the breakfast {p= 0.21).D)-“How palatable 
is this meal right now?” No significant effect o f RS or PL supplements on the palatability of the item were 
found at the lunch {p= 0.27).
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3.11.2 Subjective appetite ratings
The subjective appetite ratings, measured by VAS, revealed no significant 
differences between the two supplements (RS and placebo at any time point
(Figure 3.3).
ouV)
c /5
2
How Hungry Do You Feel?
RS
PL
0 30 60 90 120 150 180 210 240 270 300  330  360  390  420
T im efm in )
Figure 3.3 Subjective appetite ratings in response to the question “how hungry do you feel?” after 
consumption of 48 g resistant starch (RS) compared with a placebo (PL). Values represent mean ± SEM (n 
= 10). Repeated measure ANOVA showed no significant differences between the two supplements (treatment 
(p=0.33), treatment*time (p=0.29)).
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3.12 Metabolite analysis
3.12.1 Glycaemic response
The mean postprandial glycaemic response following consumption of RS and 
placebo is shown in Figure 3.4. RS ingestion resulted in a significant 
treatment*time interaction />=0.004, with repeated measures ANOVA. No 
significant treatment effect of RS compared with placebo was found (p=0.36). 
However, the glycemie variability was evaluated and there were no significant 
differences between RS compared with placebo (parametric (p=0.665), and non- 
parametric {p= 0.799)) Figure 3.5.
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Figure 3.4 Postprandial plasma glucose concentrations after consumption of 48 g resistant starch (RS) 
compared with a placebo (PL). Values represent means ± SEM (n = 10). RS ingestion led to significant 
treatment*time interaction (p=0.004). No significant treatment effect o f RS compared with placebo (treatment, 
(p=0.36)). Comparisons were made with repeated measures ANOVA.
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Figure 3.5 The glycémie variability for the glucose concentrations after consumption of 48 g resistant 
starch (RS) compared with a placebo (PL). Values represent means ± SEM (n = 10). The glycemie variability 
was not significantly different between RS and PL supplements (p= 0.799). Evaluations were made with paired 
sample t-test.
3.12.2 Insulinaemic response
The mean postprandial plasma insulin response following consumption of RS 
and PL is shown in Figure 3.6. The postprandial insulin responses were not 
significantly different between RS and PL supplements (treatment (p=0.463), 
treatment *time (p=0.807).
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Figure 3.6 Postprandial plasma insulin concentrations after consumption of 48 g resistant starch (RS) 
compared with a placebo (PL). Values represent means ± SEM (n = 10). The postprandial insulin responses 
were not significantly different between RS and PL supplements (treatment (p=0.463), treatment *time 
(j3=0.807). Comparisons were made with repeated measures ANOVA.
The mean postprandial plasma C-peptide response following consumption of 
RS and PL is shown in Figure 3.7. There was a trend for higher C-peptide 
concentrations after RS intake compared with PL (treatment *time, =0.089). 
However, no significant treatment effect of RS consumption compared with PL 
(treatment, ^=0.393). The C-peptide response seems to be different only in the 
early stages (30-180) between breakfast and lunch. However, the C-peptide to 
insulin ratio was unchanged following RS intake Table 3.6.
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Figure 3.7 Postprandial plasma C-peptide concentrations after consumption of 48 g resistant starch (RS) 
compared with a placebo (PL). Values represent means ± SEM (n = 10). C-Peptide responses trended towards 
being higher after RS supplements (treatment *time, /)=0.089) compared with PL. No significant treatment 
effect o f RS supplements compared with PL (treatment, p=0393). Comparisons were made with repeated 
measures ANOVA.
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Table 3.6 C-peptide to insulin ratio after consumption of 48 g resistant starch (RS) compared with a 
placebo (PL). Breakfast (B/Fast), 0-120 min, (p=0.54); Lunch 120-180 min, (p=0.90); Total 0-300 min, 
(p=0.74), (n = 10). Comparisons were made with a paired sample t-test and were not significantly different.
RS PL P
Mean SEM Mean SEM
B/fast (0-120) 5.02 0.81 4.68 0.57 NS
Lunch (180-300) 5.13 0.75 5.08 0.72 NS
Total (0-300) 4.93 0.71 4.82 0.63 NS
The AUCs after each meal were compared for insulin and C-peptide. For 
insulin, there were no significant differences between RS and placebo when 
analysed by paired sample Mest for parametric data shown in Table 3.7. For C- 
peptide, trend to significant after breakfast AUG (0-120min) were observed 
after RS supplements compared with placebo (p=0.065). However, The AUCs 
after lunch meal and for the total were not significant differ between RS and 
placebo when analysed by paired sample t-test for parametric (p=0.58, p=0.19 
respectively), data shown in Table 3.8.
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Table 3.7 AUC plasma insulin response for the breakfast (0-120 min), (p=0.60); lunch (180-300 min), 
(p=0.S6); and the total time (0-300 min), (p=0.39) after consumption of RS or placebo (PL), (n = 10).
Comparisons were made by paired sample t-test.
RS PL P
Mean SEM Mean SEM
*AUC 0-120min (pmol/1) 88606 10205 84766 10493 NS
AUC 180-300 min (pmol/1) 96047 14930 97754 15964 NS
AUC 0-300 min (pmol/1) 269460 36671 228746 33646 NS
*AUC Insulin (pmolx min.L)
Table 3.8 AUC plasma C-Peptide response for the breakfast 0-120 min, (p=0.065); lunch (180-300) min, 
(p=0.58) and the total (0-300) min, (p=0.19) after consumption of RS or PL, (n = 10). Comparisons were 
carried out by paired sample t-test.
RS PL P
Mean SEM Mean SEM
*AUC (nmol.L \120 min) 383377 21302 351348 25992 N S
AUC (nmol.L \300 min) 397467 27410 03039 22770 N S
AUC (nmol.L \300 min) 780844 45898 754387 44383 N S
AUC C-peptide (nmolx min.L' )^
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3.12.3 Insulin sensitivity
As shown in Table 3.9, insulin sensitivity and insulin resistance were estimated 
by Matsuda Index and HOMA insulin resistance (IR) methods, respectively 
(Matsuda and DeFronzo, 1999) (see section 2.7 for further details). HOMA 
insulin resistance (IR) estimates did not differ significantly between RS and 
placebo supplements at the start of each study day (p=0.486). There was also no 
significant difference in Matsuda Index values between RS and placebo 
supplements (p=0.677). In addition, there were no significant differences in the 
Insulinogenic Index or the Disposition Index between RS and placebo 
supplements (p=0.378,/?=0.814 respectively). Comparisons were carried out by 
paired Mest when data were normally distributed and by Wilcoxon signed-ranks 
test when non-parametric.
Table 3.9 Insulin sensitivity after consumption of resistant starch (RS) or placebo (PL), (n = 10).
Comparisons were carried out by paired sample t-test.
RS PL P
Mean SEM Mean SEM
Matsuda Index 2.08 0.31 2.16 0.36 NS
Insulinogenic Index 5.15 1.23 5.92 0.94 NS
Disposition Index 12.20 4.27 12.76 3.06 NS
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3.12.4 GLP-1 response
The mean postprandial plasma GLP-1 response following consumption of RS 
and placebo is shown in Figure 3.8. No significant differences were found in 
either fasting or postprandial levels of GLP-1 between treatments (treatment 
(p=0.105), treatment *time (p=0.580).
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Figure 3.8 Postprandial plasma GLP-1 concentrations after consumption of 48 g resistant starch (RS) 
compared with a placebo (PL). Values represent means ± SEM (n = 10). The postprandial GLP-1 responses 
were not significantly different between RS and PL supplements (treatment (p=0.105), treatment *time 
(p=0.580). Comparisons were made with repeated measures ANOVA.
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3.12.5 Test Meal
The mean energy intake of the ad libitum test meal given at the end of the 7 
hour postprandial period is shown in Figure 3.9. The consumption of 48g of RS 
divided between breakfast and lunch resulted in a reduction in energy intake at 
the ad libitum test meal consumed at dinner, compared with placebo (4551 ± 
617 kJ versus 5197 ± 561 kJ respectively />=0.017). Comparison of means was 
made by paired sample t-test.
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Figure 3.9 Energy Intake of the ad libitum test meal after 7 hours postprandial investigation where 
subjects consumed 48 g resistant starch (RS) or a placebo (PL). Values represent means ± SEM (n = 10). 
The energy intake significantly different between supplements (p=0.017). Comparisons were made with a 
paired sample t-test.
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3.12.6 24-hour intake
The mean 24 hour energy and macronutrient intake following RS or placebo 
supplementation is shown in Table 3.10. After consumption of 48g RS, the 
energy intake was not significantly different over the 24 hour period compared 
with placebo (p=0.508). In addition, the effect of RS on protein, carbohydrate, 
sugar, fat, and SFA intakes were also not significantly different than with 
placebo. As expected, total dietary fibre intake was significantly lower with 
placebo, as a direct result of the RS supplement (p=0.005) (Figure 3.10).
Table 3.10 24-hour intakes following supplementation with 48 g RS or PL, (n = 10). Comparisons were 
carried out by paired sample t-test.
RS PL P
Mean SEM Mean SEM
Energy (kJ) 12553 722.52 12955 1198.98 0.77
Energy (Kcal) 2985 171.33 3080 285.69 0.77
Protein (g) 105.47 8.13 111.7 11.75 0.66
Carbohydrate (g) 419.00 24.05 431.9 36.11 0.75
Sugar (g) 102.32 11.62 97.6 12.33 0.81
Fat (g) 97.61 6.75 99.7 11.89 (188
SFA(g) 35.32 2.71 41.1 6.09 0.40
Fibre (g) 63.42 1.05 17.2 1.57 0.005
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Figure 3.10 Dietary fibre (DF) intakes during 24 hour following supplementation with 48 g resistant 
starch (RS) or placebo (PL),(n = 10). Comparisons were carried out by paired sample t-test (p=0.005).
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3.13 Discussion
In this research we demonstrate that RS acutely and significantly (p=0.017) 
reduces food intake at an ad libitum meal in overweight/obese men compared 
with placebo. However, there were no significant effects for RS over 24 hours 
compared with placebo (p=0.508). The present investigation also found that RS 
ingestion led to significantly higher plasma glucose levels (p=0.004) compared 
with placebo, while the postprandial insulin response was not significantly 
different. No significant impact of RS on qualitative feelings of satiety, hunger, 
or palatability was observed.
Our finding that RS reduces overall energy intake at subsequent test meal is in 
agreement with another study in normal weight individuals showing that 
consumption of 50 g of RS (Hi-Maize) incorporated into tomato soup 
significantly reduced energy intake at an ad libitum test meal (Anderson et al., 
2010). They found that following 2 hours (120 min) the amount of RS was 
positively correlated with reduced energy intake. In their study the reduction in 
food intake was associated with higher RS contents in which whole grain soup 
(27 g RS2), high-amylose soup (23g RS2) and regular com soup (19g RS2) 
resulted in 17%, 10% and 10% decline in food intake respectively. They also 
found a trend for reduction in average appetite AUC after RS treatments 
compared with control. Another study in the lean reported a reduction in energy 
intake at an ad-libitum meal as well as over the 24-hour period after ingestion of
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48 g of RS compared with placebo in normal weight subjects (Bodinham et al., 
2010).
The deficit in energy intake in the present study was not maintained over the 
whole 24 hour period, which is in contrast to work in normal weight individuals 
(Bodinham et al., 2010). The energy intake over 24 hour period in the present 
study was obtained from the food provided to the subjects during the study day 
as well as over 24 hour which was recorded by the participants after they left 
the investigation unit. Therefore, as expected the overweight/obese subjects 
would appear to ftilly compensate for a reduced energy intake whilst in the unit, 
while underreporting their food diaries when they self-reported at home, 
whereas the normal weight volunteers did not. Bodinham and colleagues 
(2010) estimated the underreporting in normal weight subjects and found that 
they were not underreporting. Evidence has shown that overweight and obese 
individuals tend to under-report their energy intake more often (30%-40%) 
compared with lean individuals (Chevassus et al., 2010). Also the EPIC 24 hour 
data recall have reported that underreporting was related to the body weight 
amongst both male and female (Ferrari et al., 2002).
Despite the reduction in food intake observed, our data indicate that RS did not 
affect any of the subjective appetite ratings in any of the assessment questions 
which is in agreement with previous data in normal weight subjects. Bodinham 
and colleagues (2010) found that consumption of 80g of RS (60%) divided
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between breakfast and lunch meals in lean subjects had no effect on subjective 
appetite ratings (Bodinham et ah, 2010). Research in humans on the effect of 
RS on energy intake and satiety has thus provided inconsistent results.
A previous study comparing the effect of consumption of 27g of RS (raw potato 
starch) with a control (pregelatinized potato starch) in healthy subjects 
demonstrated a reduction in subjective satiety compared with the control group 
(Raben et al., 1994). However, their preload was given as a mixture of fruit 
syrup drinks, which may have resulted in differences in the texture between the 
meals and changed the palatability of the RS. In addition, the RS preload meal 
given to the subjects was matched by weight of starch and thus varied in energy 
and available carbohydrate content. Therefore, these differences may affect 
gastric emptying and confound their results.
Another study found that consumption of a 25g dose of a RS3 cereal bar 
increased subjective appetite ratings at 15, 30, and 45 minutes postprandial with 
a trend to reduction in satiety over 2-hours compared with a control group 
(Kendall, Esfahani, Sanders, et al., 2010). However, they reported no difference 
in food intake after 2 hours at an ad-libitum test meal. It is possible that a 2- 
hour postprandial period was too short to observe an impact of RS on food 
intake in that study. Willis and others (2009) have shown that subjective satiety 
may be affected by the fibre type administered (Willis et al., 2009). They found 
that RS muffins increase satiety and fullness up to 3-hours postprandial
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compared with com bran and low fibre muffins.
Different satiation effects may be mediated by variability in the supplement 
form, for example, liquid forms have been suggested to have lesser satiating 
effects postprandial compared with solid forms (Mourao et al., 2007). This 
could help to explain why RS administered in different food supplements 
appears to have different effects on satiety. Subjective satiety is affected by 
subject variability indicating that the reduction in food intake may not result 
from increased satiety and vice versa. Therefore, subjective appetite ratings may 
not anticipate energy intake, as we have seen in this study. It should be noted 
that some of the previous studies have shown that RS supplements were less 
palatable compared with the control, which may influence the outcome of these 
studies regarding the effect of RS on food intake (Willis et al., 2009; Kendall, 
Esfahani, Sanders, et al., 2010). In the present study, despite the reduction in 
food intake, no significant differences were observed in the palatability between 
RS and PL, indicating that intake was reduced for a different reason.
The acute reduction in food intake at Ûïq ad libitum meal in the present study 
could be mediated by the fermentation of RS in the colon, to produce SCFA. 
This has been proposed as a mechanism of dietary fibre to alter appetite and 
increase satiety (Pereira & Ludwig, 2001). Consumption of RS has been shown 
to increase SCFA concentrations in rodent studies (Keenan et al., 2006; Zhou et 
al., 2006, 2008). However, the effect of fermentation in the rodent cannot be
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extrapolated to humans due to species differences in gut physiology, the amount 
of RS given to the rodent (higher), and the duration of the experiment in rodent 
(longer). Therefore, analysing serum SCFA concentrations in humans may 
provide a more complete understanding and may confirm the effect of RS on 
fermentation. However, analysing SCFA is not straightforward and we did not 
measure SCFA in the current study. Therefore, it is not possible to determine 
the extent of fermentation in the colon as a result of RS supplementation or to 
assess whether increased fermentation was the reason for reduced energy intake.
Increased SCFA production may result in the increased secretion of 
anorexigenic hormones such as GLP-1 from the colon (Slavin, 2005; Cuche et 
al., 2000; Cherbut, 2003). However, some evidence suggests that either acute 
or chronic ingestion of RS does not elevate the level of GLP-1 in humans 
(Raben et al., 1994; Robertson et al., 2005). In agreement, our data also found 
no effect of RS on GLP-1 in overweight /obese subjects.
Other mechanisms that may lead to increased satiety and reduced food intake 
may include rate of gastric emptying (GE) and the involvement of gut 
hormones. It has been suggested that GE is an important determinate of 
postprandial glycaemia in obese people (Seimon et al., 2013). However, we did 
not measure GE in the present study due to the cost and time constraints. We 
also used a non-viscose RS fibre that would not be expected to delay GE 
compared with viscous fibre (Juvonen et al., 2009). Only one study shows that
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RS3 significantly stimulates GE in 20 healthy subjects when they consumed 
either 15 g RS3 or 15 g RS3 combined with 6 g wheat bran. They reported an 
increase in GE was assessed 6 hours following the ingestion of a preload test 
meal using breath sample collection(De Peter et al., 2007).
It is still remains to be explained why the RS in the current study had an effect 
on energy intake and improved glucose stability but had no effect on either 
insulin response or insulin sensitivity. To our knowledge, this is the first time 
that such an observation has been made following acute administration of RS in 
obese/overweight individuals. A possible explanation of the effect of RS on 
glucose and energy intake is the glucostatic theory. Our results are supported by 
the glucostatic theory in which any changes in blood glucose concentrations are 
detected by glucoreceptors that may affect energy intake. According to this 
theory, a rise in blood glucose concentration may result in increased satiation 
and therefore decrease energy intake (Mayer, 1953).
The current study found no significant differences in the palatability between 
RS supplements and placebo supplements. In addition, no abdominal discomfort 
was reported and RS was well tolerated. This is partly confirmed by a previous 
study by Park and colleagues (2004) that investigated the effect of consumption 
of 24g of RS for 21 days in overweight subjects. Park and colleagues found that 
RS supplements were palatable compared with control supplements and caused 
no bowel discomfort, although theirs was not an acute study. However, no
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effect on food intake was observed in this published study (Park et al., 2004). 
In contrast, Klosterbuer and colleagues (2012) investigated the effect of one of 
four breakfasts containing 25 g of fibre from soluble com fibre or RS. These 
were administered alone or in combination with pullulan (a polysaccharide 
polymer) and were compared with a low-fibre breakfast for effects on appetite 
and satiety in healthy subjects. They found that although RS supplements were 
rated less palatable compared with com fibre, neither supplement nor pullulan 
combination affected satiety or energy intake compared with control. In 
agreement with this, other studies have found that RS was less palatable 
compared with control (Kendall et al., 2010; Willis et al., 2009; Raben et al., 
1994), which may have explained the greater effect of RS on satiety in these 
studies.
Dietary fibre has been suggested to affect palatability, and therefore lead to 
reduction in energy intake (Yeomans, 1998; R. Hyde & Witherly, 1993). 
However, no significant differences between supplements in pleasantness of 
taste and overall palatability were observed in the present study. In addition, RS 
have been rated as having high palatability (Johnson & Gee, 1996). Our results 
indicate that RS supplements may be incorporated into food products at high 
levels without any impact on taste or overall palatability.
The present study also found a significant effect of RS on the postprandial 
glucose concentration (p=0.004). Following supplementation with RS there was
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more “stability” in the plasma glucose level after breakfast, with no evidence of 
reactive hypoglycaemia. In contrast, following supplementation with placebo, 
plasma glucose dropped rapidly to below fasting levels. This “stability” in 
blood glucose levels induced by RS has been noted previously in both human 
and animal models (Zhou et al., 2008; Anderson et al., 2010; Brites et al., 2011; 
Hallstrôm et al., 2011) and may form part of the explanation for the differences 
in food intake documented between the two treatment groups.
Although the significant effect of RS on glucose response, our data indicate no 
differences in glycaemic variability after consumption RS compared with 
placebo. Previous work with dietary fibre has shown a reduction in glycaemic 
variability by 50% after consumption high fibre diet compared with a high 
monounsaturated fat diet (De Natale et al., 2009). However, they fed the high 
fibre diet for a longer period (4weeks), thus, it is possible that chronic 
consumption of dietary fibre may be required to observe the reduced effect on 
the glycaemic variability as was observed in that study.
In this study, both insulin responses and insulin sensitivity were not 
significantly different between RS and placebo supplements, which might have 
been expected in overweight/obese subjects who are insulin resistant (Verdich, 
Toubro, et al., 2001). The insulin secretion maintains blood glucose within the 
normal range. However, most individuals with insulin resistance such as 
overweight and obese subjects in our study may have impaired insulin secretion
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and defective insulin action. In normal weight subjects, Bodinham et al, (2010) 
found no effect of RS on glucose concentrations, but a significant reduction in 
insulin secretion (Bodinham et al., 2010). More recently, it has been noted that 
consuming 15g/d or 30g/d of RS (using RS of an identical botanical source to 
the one used in our study) for 4 weeks may improve insulin sensitivity in 
overweight and obese men and women (Maki et al., 2012). It is possible that 
the effect of RS on insulin sensitivity in the overweight and obese subjects in 
that study was observed due to the chronic consumption of RS with larger 
sample size (n=33) compared with our study. However, it has been suggested 
that the metabolic response may be affected by number of factors such as a 
subject’s characteristics, age, and gender (Hallfrisch & Behall, 2000).
In the present study, there was a trend for higher C-peptide concentrations after 
consumption of RS (p=0.089), which may have resulted from higher prevailing 
glucose levels. It has been suggested that C-peptide concentrations may be a 
more accurate indicator of insulin release because it is not cleared by the liver. 
C-peptide also has a longer half-life than insulin (20-30 minutes compared with 
3-4 minutes for insulin); thus it circulates at higher levels in the systemic 
circulation (Palmer et al., 2004). This may indicate that RS may have increased 
postprandial insulin release predicting lower insulin sensitivity in overweight 
obese subjects. However, the C-peptide to insulin ratio was unchanged 
following RS intake, which may suggest decrease hepatic insulin clearance in
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overweight subjects. Although insulin responses and insulin sensitivity were not 
significantly different between supplements, a larger sample size may result in a 
sufficient power to detect the differences. This has been recently shown after 
chronic ingestion of RS (Bodinham et al., 2012; Robertson et al., 2012).
To our knowledge, this is the first study investigating the acute effect of RS on 
any of the gut hormones, as satiety signals in overweight human subjects. This 
study found no significant differences in either fasting or postprandial levels of 
GLP-1 between treatments (P=0.58).
This finding supports another study by our group reporting that acute 
consumption of 60g of RS (HAM-RS2) 24 hours prior to investigation had no 
effect on GLP-1 concentrations compared with placebo in normal weight 
volunteers (Robertson et al., 2003). Raben and colleagues (1994) found that 
consumption of 27g RS did not change GLP-1 levels compared with placebo 
(pregelatinized potato starch, 0% RS) in normal weight individuals (Raben et 
al., 1994). In the study by Raben, GLP-1 was measured during the 5 hours 
following the test meal. It is possible that the lack of the effect on GLP-1 may 
have been due to the short study duration which may not be long enough to see 
the effect of RS on fermentation since the digestion of RS needs longer time (7- 
12 hours) to be fermented by the bacteria in the large intestine to produce SCFA 
(Cummings et al., 1987). Therefore, it has been suggested that RS might need to 
be exposed over longer period (2-4 days) to observed the stimulatory effect of
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fermentation on GLP-1 in animals and humans (Zhou et al., 2008). In addition, 
the stimulatory effect of RS on GLP-1 may be influenced by factors that affect 
gut microflora and therefore fermentation. These factors include diseases, 
medical procedures, or dietary modulation (Wallace et al., 2011; Guamer & 
Malagelada, 2003; Zhou et al., 2008).
Some evidence suggests that neither acute or chronic ingestion of RS elevates 
the level of GLP-1 in humans (Raben et al., 1994; Robertson et al., 2005). 
Similarly, chronic consumption of novel dietary fibre has no effect on GLP-1 
(Parnell & Reimer, 2009). Parnell and Reimer (2009) shows no effect of 21g of 
oligofructose/d for 12 weeks on GLP-1 secretion in overweight and obese adults 
(Parnell & Reimer, 2009).
It has been suggested that increased glucose concentration may inhibit GLP-1 
release in obese subjects (Ranganath et al., 1996). Therefore, it is possible that 
the lower GLP-1 response observed in the present study was due to increased 
glucose levels caused by RS ingestion. However, glucose concentrations 
remained below fasting levels, so this is unlikely.
A possible explanation for the lack effect of RS on GLP-1 in humans could be 
the neuronal effect of GLP-1 that it is difficult to measure in the circulation. It 
has been suggested that GLP-1 may not appear in peripheral blood at high 
concentrations but may be raised in splanchnic blood (Holst, 2007). Despite the 
effort to prevent degradation, it is also possible that degradation of GLP-1
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occurred both in the blood and in the stored serum samples. This may have 
resulted in inaccurate measurements of GLP-1, although this is unlikely because 
it is commonly measured in stored serum samples. In addition, using a RIA 
technique for analysing GLP-1 that measures only the total amount of the 
peptide rather than bioactive forms, may not be very informative (Delzenne et 
al., 2010). While total GLP-1 may not have been raised, it is possible that the 
ratio of inactive: active forms shifted, giving more of the active form.
Although human data on the effect of RS on GLP-1 are limited, much animal 
data has reported elevated GLP-1 levels after consumption high-dose of RS 
(Zhou et al., 2008; Keenan et al., 2006; Shen et al., 2009). In one study Keenan 
and colleagues (2006) found that feeding a high RS diet to rats for a period of 1 
month increased GLP-1 levels (Keenan et al., 2006). The researchers concluded 
that elevated GLP-1 was a result of increased concentrations of short chain fatty 
acids. However, this effect on GLP-1 was not associated with any effect on food 
intake, CCK or ghrelin levels. Some studies have also demonstrated increased 
GLP-1 gene expression in the caecum and large intestine in response to RS 
ingestion (Zhou et al., 2008; Keenan et al., 2006). However, it is not possible to 
apply these findings to humans because these studies were conducted in rodents 
undergoing chronic feeding. Thus, studies looking at long-term consumption of 
RS in humans are needed to show how RS influences GLP-1 levels (Robertson, 
2012). One published work on humans reported that 9-12 months are needed for
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a higher fibre diet (24g/day) to raise plasma GLP-1 concentrations(Freeland et 
al., 2010).
The present study found that although RS consumption reduced energy intake, 
no significant effect of RS on subjective appetite ratings was reported. It has 
been shown that GLP-1 may reduce energy intake, improve the sensation of 
fullness and reduce feelings of hunger in lean and obese subjects (Flint et al., 
2000, 1998). That we found no increase in GLP-1 could explain why subjective 
feelings of satiety were not improved in the present study. Obese subjects have 
been shown to have a slightly lower sensitivity to GLP-1 release compared with 
lean (Adam & Westerterp-Plantenga, 2005). The authors concluded that when 
galactose/guar gum was added to the breakfast meal, this was not reflected by a 
subjective feeling of satiety in obese subjects compared with lean (Adam & 
Westerterp-Plantenga, 2005).
An important difference between the present study and previous studies 
investigating the effect of RS is that we used RS as a part of mixed meal. We 
then compared this with a placebo meal that was matched for available 
carbohydrate and energy load. In contrast, most of the studies investigating the 
effect of RS on appetite and satiety have used supplements which differed in the 
amounts of glycaemic carbohydrate that have resulted from replaced 
proportions of carbohydrate with the RS (Bodinham et al., 2010). These 
differences in study design may explain the differences in the results.
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Overall, the findings of the present and the previous investigations appear to 
indicate that acute consumption of RS does not increase GLP-1 concentration. 
A recent review showed that gut hormone levels may be affected by subject 
variability; thus, the reliability of the findings of the study investigating gut 
hormones may be unclear (Klosterbuer, Greaves, & Slavin, 2012). In addition, 
differences in the types and the doses of fibre used in these studies may also 
affect the results. It should be noted that the control treatments may also affect 
the outcomes of these studies, making it difficult to assess the impact of 
supplementations themselves. All these differences may also mask the exact 
impact of the fibre on the concentrations of the gut hormones.
One of the limitations of this study is the small sample size used. However, a 
within-subject crossover study design is applied in this appetite study, 
increasing its power. Since the primary outcome for this study was the food 
intake, the study was sufficiently powered to detect significant differences 
between groups. However, metabolic effects were only secondary outcomes, 
which the study was underpowered to detect. Further investigations may 
involve the effect of different gut hormones in addition to GLP-1 on appetite. It 
should be noted that individual gut hormones are not secreted separately after 
the meal. Accordingly, hormones may secreted in coordination with other 
hormones and may act together to regulate appetite and the energy intake. 
Particular combinations of gut hormones may have an additive impact on
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outcomes such as reduced food intake and increased satiety (Klosterbuer et ah, 
2012). Therefore, the investigation of only one hormone in this study may not 
has provided a complete picture. Another limitation of this study is that the 
inclusion criteria restricted to only overweight males (as this study building on 
previous work in normal weight males), thus it is not possible to generalize the 
findings to overweight females. One other factor to note is that ethnicity may 
also affect the satiety factors and lead to variations in the metabolic response. 
However, we were not able to investigate this aspect in the current study due to 
the small sample size.
A strength of this study is that we have changed only one component of the diet; 
fibre. Future chronic investigations in larger, more heterogeneous populations 
are required to assess the long-term effect of RS on appetite regulation and food 
intake in females and those from different ethnic populations. In the future, we 
may also need to measure SCFA and GE to draw a more informed opinion on 
the impact of RS on appetite, which we did not account for in the current study.
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3.14 Conclusions
In summary, the current study found that supplementation with 48g of RS split 
between breakfast and lunch meals caused a reduced acute dietary intake at the 
ad libitum meal compared with placebo, (p=0.017). This finding could be 
beneficial in weight management; however, the reduction of food intake only 
occurred directly following meals high in RS.
Another finding of the present study was that RS ingestion led to significantly 
higher plasma glucose levels (p=0.004) compared to placebo, while the 
postprandial insulin responses were not significant different. It was also found 
that there was a trend for higher C-peptide following RS supplementation. This 
may indicate an increased secretion of insulin but the lack of effect on the 
insulin: C-peptide ratio indicated no up-regulation of hepatic insulin clearance. 
This is in contrast to the majority of findings in normal weight individuals in 
which RS led to lower insulin response with an increase in the molar ratio of c- 
peptide to insulin.
The present study did not show any changes in subjective feelings of hunger 
and fullness, while the changes in subsequent meal intake suggest that RS play 
important role in appetite control and body weight regulation. Also our results 
found that RS supplements did not affect the palatability of the food; thus RS 
can be a useful ingredient for increasing dietary fibre intake and could be used 
in a dietary weight management approach.
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In conclusion, the findings from this study suggest further long-term studies to 
determine the mechanisms by which RS decreases food intake. The 
relationships between RS and insulin secretion, appetite, weight, and fat mass as 
an obesity-related marker also require further investigation. Longer duration 
studies will also help to confirm if  the effect of RS can be maintained for long­
term weight management. At present, our findings do not support a role of RS 
in regulating metabolic response. This however could be a product of the small 
sample sizes used in this study, under-powering it to detect metabolic 
differences.
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Chapter 4 The impact of body mass index status on appetite responses 
and food intake following acute consumption of resistant starch
4.1 Introduction
Obesity is considered one of the problems not only in high-income countries, 
but has also increased dramatically in the low- and middle-income countries, 
especially in urban areas (WHO, 2006; Jokela et ah, 2009). The prevalence of 
obesity has increased in many human populations regardless of age, gender, 
ethnicity, and socioeconomic status. For example, in Saudi Arabia, it has been 
estimated that 35% are obese and 37% are overweight adult citizens (Al-Nozha 
et al., 2005). The prevalence of childhood obesity is also high in the Middle 
Eastern, as well as Central and Eastern European countries. For instance, in 
Saudi Arabia, one in every six children aged 6-18 years old is obese (A1 Nuaim 
et al., 1996). However, although obesity is a complex condition, changes in 
lifestyle and dietary habits will play a vitally important role in the development 
of obesity. Therefore, it is crucial to identify which changes in food choices will 
be the most effective in reducing, preventing, or delaying obesity now and in 
the future.
Epidemiological studies often use body mass index (BMI) to assess the 
relationship between weight and morbidity, and current public health
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recommendations related to weight status are based on the BMI. The BMI has 
been widely used in the assessment of disease risk and the detrimental health 
outcomes associated with BMI, which include ethnicity, age range, sex, 
socioeconomic status, and mortality (Havas et al., 2009). The variation in BMI 
among populations may reflect diversities in body composition, fat distribution, 
and/or genetic susceptibility.
Numerous studies have linked higher intake of dietary fibre (DF) to improved
management of body weight (Kendall, Esfahani & Jenkins, 2010). The effect of
fibre on weight regulation may potentially be manifested through different
mechanisms that include stability in blood glucose level, reduction in food
intake, altered insulin level, prolonged gastric emptying time, and the intestinal
hormone response after fibre consumption reducing subsequent appetite (Slavin,
2005). It has been demonstrated in cohort studies that there is a correlation
between DF intake and body weight (Howarth et al., 2003; Liu et al., 2003).
However, intervention studies are often far from impressive in their findings.
For example. Tucker and Thomas, (2009) stated that increasing consumption of
DF by 1 g over a 20-month period could reduce the body weight of an
individual by 0.25 kg (Tucker & Thomas, 2009). In a prospective cohort study
of 89,432 subjects from five European countries, consumption 10 g/d of cereal
fibre resulted in a small change in body weight (77 g/y) and in waist
circumference (0.10 cm/y), while consumption of 10 g/d total dietary fibre was
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associated weight change of 39 g/y that stand for 34% of the mean weight 
change in their study population (115 g/y), indicating that increased total dietary 
fibre intake by 10-g/d may prevent weight gain by 10% (Du et ah, 2010). This 
study was a part of the DiOGenes (Diet, Obesity, and Genes) project, with 
subjects who were taking part in the European Prospective Investigation into 
Cancer and Nutrition (EPIC).
Dietary manipulations play a crucial role in energy-restricted diets for 
overweight individuals. However, appetite studies are frequently conducted 
only in lean, healthy control subjects (Rebello et al., 2013; Bodinham et al., 
2010; Anderson et al., 2010; Lyly et al., 2009). It could be argued that due to 
inherent differences in glucose metabolism, obese individuals are more likely to 
be insulin resistant (Greenfield & Campbell, 2004). Also lower basal levels of 
appetite hormones are noted in obesity (Neary & Batterham, 2009). It has also 
been reported that obese individuals are more likely than lean individuals to 
exhibit eating restraint or emotional eating behaviours (Macht, 2008). 
Therefore, the outcomes and importantly conclusions derived from normal 
weight subjects might not be directly transferable to overweight /obese subjects 
(Shiiya et al., 2002).
157
Najlaa Al-Mana Thesis
4.2 Aim
The aim of this investigation was to compare the effect of ingestion of 48 g of 
RS on subjective (appetite ratings) and objective {ad libitum energy intake) 
markers of eating behaviour and postprandial changes in plasma glucose, 
insulin, and GLP-1 between lean and overweight healthy males. The primary 
outcome was a difference in energy intake from an ad libitum meal after 
ingestion of RS or placebo. Secondary outcomes were visual analogue scores 
(VAS) of components of eating behaviour, 24-h food intake as assessed by food 
diary and biochemical parameters: plasma glucose, insulin, C-peptide, and 
postprandial GLP-1.
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4.3 Materials and Methods
This study was carried out in accordance with the Declaration of Helsinki and 
approved by the Ethics Committee of the University of Surrey. Prior to 
participation, an explanation of the study procedures was provided for each 
individual and each participant gave written, informed consent. The study 
design, protocols and the biochemical measurements have been described 
previously in chapter 3. Data relating to the effect of RS on appetite in lean has 
been reported previously (Bodinham et al., 2010). The effect of RS on appetite 
and satiety in overweight and obese has been investigated in chapter 3.
4.4 Subjects
Thirty healthy, male subjects participated in this investigation; twenty of normal 
weight and ten overweight/obese. All subjects were aged between 18 - 32 y in 
both studies. Subjects were within ideal range for body mass index (BMI) 
(20.1-24.7 kg/m^) in study I, and of the overweight and obese range (28 - 
37kg/m^) in study 2. Subjects were recruited from the student population at the 
University of Surrey using flyers and email advertisement. All subjects were 
asked to complete the Dutch Eating Behaviour Questionnaire (DEBQ) during 
the recruitment (van Strien et al., 1986). Individuals with a restraint score of <4 
(DEBQ) were recruited with highly restrained eaters excluded from the study.
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No subjects had a history of gastrointestinal disease or endocrine disorders and 
all were weight stable for 3 months prior to inclusion.
4.5 Protocol
Subjects participated in two study days at the clinical research centre (CRC), 
allocated in random order but at least one week apart. At these visits, 
participants consumed either the RS or placebo, both of which were 
incorporated into separate breakfast and lunch meals giving a total of 48 g DF 
or Og DF respectively. Prior to each study day, all participants restrained from 
strenuous exercise and alcohol consumption, and consumed an identical 
evening meal.
On each study morning, blood pressure and anthropometric measurements 
(weight, height, hip, and waist circumferences) were taken. Following these 
measurements, subjects were cannulated and blood samples were taken every 
30 minutes for 7 hours. VAS measures were also conducted at the same time 
points. On each visit, participants consumed standardised breakfast and lunch 
meals that included the supplements mixed into a mousse (Angel Delight, UK). 
The standardised breakfast, composed of 30 g Rice Krispies (Kellogg’s, UK) 
with 100 g semi-skimmed milk (Tesco, UK) and the first dose of the 
supplement (either RS or placebo) mixed into a mousse was given at time zero.
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After 3 hours (180 minutes), the test lunch was served, which included a ham or 
cheese sandwich, crisps, orange squash, and the second dose of the supplement 
mixed into a mousse. The same sandwich filling was served on each visit; 
however, on the first visit, the participants could adjust their consumption at 
lunch (excluding the test product which they needed to consume in full on all 
visits). After the first visit, remaining foods were weighed and the participant 
was given an identical amount of the food on the next visit.
After 7 hours (420 minutes), participants were provided with a large pre- 
weighed pasta meal ad libitum. The meal, if eaten in full provided 9665 kJ 
energy, 83.5g protein, 335.6g carbohydrate, 68.Ig fat, and 15.9g fibre. 
Participants were told to eat until comfortably satisfied and the remaining food 
was weighed. To prevent overconsumption, participants were told they could 
take home anything did not want to eat. Following the ad libitum meal, the 
subjects were free to leave and were asked to complete a food and drink diary 
for the reminder of the day (until 9 am the following morning) to document 
later and potentially compensatory intake. All food diaries were analysed using 
Dietplan6 (Forestfield Software Ltd, Horsham, UK). Participants recorded their 
bowel habits on the day of the study and the following day to assess the 
gastrointestinal tolerance of the supplement.
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4.6 Test Meal
The RS supplement HAM-RS2 (Hi-Maize 260®comprising 60% RS type 2 and 
40% rapidly digestible starch) and the placebo (Amioca -100% rapidly 
digestible starch) were manufactured and supplied by National Starch LLC. To 
balance the carbohydrate and energy content of the two test products, 32g of the 
placebo (16g in each mousse) was used. In addition, from initial development 
work, it was known that 40 g of Hi-Maize was the maximal amount that can be 
incorporated into a single portion and remain acceptable (Bodinham et al., 
2010). As a result, 80g of Hi-Maize product was used divided into two portions 
over breakfast and lunch to give 48 g of RS in a single 24-hour period. The 
participants were asked to choose one flavour of mousse and had to consume 
the same flavour at each visit. The glycaemic carbohydrate loads for the test 
product were identical and the only difference was in weight and the dietary 
fibre content.
4.7 Blood analysis
Blood samples were collected every 30 min for the 7-h intervention period. 
Blood samples were collected in potassium BDTA tubes for insulin analysis, 
sodium oxalate tubes for glucose analysis, and potassium EDTA tubes
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containing 200 kalikrein inhibiting units (KIU) aprotinin per ml of whole blood 
(Millipore; Missouri, USA) for C-peptide and GLP-1 analysis.
Plasma glucose was measured enzymatically using a commercially available kit 
(Instrumentation Laboratory, Warrington, UK) for use with the ILab650 
(Instrumentation Laboratory). Plasma insulin and C-peptide were measured by 
radioimmunoassay (RIA) with a commercially available kit (Millipore; 
Missouri, USA). Plasma GLP-1 was measured using a commercially available 
enzyme-linked immunosobent assay (ELISA) kit (Millipore; Missouri, USA).
4.8 Food Diaries
Food consumption over 24-h was monitored by the food diaries which 
documented on the day prior to the study day, from the food provided on the 
experimental day and for the remaining of the study day. An explanation on 
how to record the food intake for the reminder of the study day has been 
provided to all participants. Dietary analysis for energy intake, macronutrients 
and fibre intake were performed using Dietplanb (Forestfield Software Ltd, 
Horsham, UK). See Chapter 2 (Section 2.4.3).
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4.9 Data Analysis
The ratio of C-peptide to insulin was estimated by utilising the area under the
curve (AUC) method. The area under the curve (AUC) for the ratio of C-
peptide to insulin was estimated by utilising the trapezoid rule. Estimation of
the AUC for the ratio was carried out for the first two hours after each meal (0-
120 minutes and 180-300 minutes) as well as the total up to two hours after the
test lunch (0-300minutes). The Homeostasis model assessment of insulin
resistance (HOMA-IR) in the fasting state was used to determine the insulin
resistance (IR). Matsuda Index was used as a surrogate index of postprandial
insulin sensitivity (IS) (Matsuda & DeFronzo, 1999; Wallace et al., 2004;
Matthews et al., 1985; Levy et al., 1998). We also estimated the insulinogenic
index as a surrogate index of early-phase of insulin release. Disposition index,
as a measure of p-cell response to insulin sensitivity was also assessed as it
proposed that increase p-cell release due to increase insulin resistance to avoid
impaired glucose response (Bergman et al., 2002). All indices for insulin
sensitivity and P-cell function were compared between groups by utilising a
web formula (using a spreadsheet downloadable from http://mmatsuda.diabetes-
smc.ip/english.html). To compare between lean and overweight/obese groups, a
calculation of the percentage difference between the treatment (resistant starch)
and placebo was used for each participants and used in the analysis o f insulin
sensitivity and 24-h energy intake. Data for GLP-1 have been analysed and then
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expressed as the absolute change from the fasting levels.
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4.10 Statistical analysis
All statistical analyses were conducted using SPSS for Windows 18.0 (SPSS 
Inc., Chicago, USA) with an alpha value of 0.05. A repeated measures analysis 
of variance (ANOVA) was used to assess differences in the postprandial 
subjective VAS ratings and glycaemic responses between groups with starch 
(RS, PL) and time (15 time points) as within-subject factors, and the group as 
between subject factors (lean, obese). Independent sample t tests were used to 
compare energy intake and characteristics between groups. Due to very small 
sample size, normality cannot be accurately determined, thus, between-group 
differences in anthropometries, energy intake at the ad libitum meal, and 
macronutrient intake over 24 hours were assessed non-parametrically using the 
Mann-Whitney U test. The time of peak or nadir for postprandial response was 
determined by identifying the time-point at which the greatest response 
occurred.
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4.11 Results
4.11.1 Anthropometries
Table 4.1 shows the mean baseline anthropometric measurements in lean and 
obese subject-groups at recruitment. As expected, there were significant 
differences in all anthropometric measurements between lean and obese 
subjects, with the exception of systolic blood pressure and measures of 
emotional and external eating assessed by DEBQ.
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Table 4.1 Anthropometric measurements for lean subjects (n=20), and obese subjects (n = 10).
Comparisons were carried out by independent sample t-test and Mann-Whitney U test.
Lean (n=20) Obese (n=10)
P
Mean SEM Mean SEM
Weight (kg) 76.2 2.53 99.8 3.92 <0.001
BMI (kg/m^) 23.2 0.66 32.0 0.92 <0.001
Waist circumference 
(cm) 84.8 2.08 105 3.20 <0.001
Hip Circumference (cm) 97.4 1.46 111 2.56 <0.001
Body fat (%) 15.0 1.24 26.8 3.61 0.006
Systolic Blood Pressure 
(miuHg) 121 1.6 124 5.1 NS
Diastolic Blood 
Pressure (mmHg) 73 2.3 63 3.7 0.036
Emotional DEBQ 1.98 0.13 2.01 0.18 NS
External DEBQ 3.06 0.11 3.17 0.22 NS
Restrained DEBQ 2.09 0.22 2.52 0.22 0.091
BMI=Body Mass Index; BP=Blood Pressure; DEBQ=Dutch Eating Behaviour Questionnaire. NOTE; BP was averaged 
using 3 separate and % body fat was determined by bio-impedance.
As expected overweight subjects had higher body weight, BMI, waist and hip 
circumference (p<0.001), and percent body fat as determined by bioimpedance 
(p=0.006). Once highly restrained individuals had been pre-excluded during the 
screening process, the DEBQ scores for emotional and external eating were 
similar in lean and obese subjects, while DEBQ for restrained eating was higher 
in the obese compared with the lean Table 1.1. There was a trend towards a
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significant difference in restrained DEBQ scores (p=0.091) in obese and lean 
subjects.
4.11.2 Subjective Appetite Ratings
Analysis of VAS scores by repeated measures ANOVA revealed no significant 
differences in any of the VAS appetite ratings for the treatment and control 
supplements in either lean or obese subject-groups. . However, the subjective 
appetite ratings did reveal that there were significant differences between the 
subject groups. Figure 4.1 shows a significant group effect for hunger, 
prospective food consumption. For feelings of fullness there was a trend toward 
significant for the group interaction (p=0.057). After consumption of RS, there 
were no differences in hunger, fullness, or prospective consumption compared 
with placebo. However, the obese group had higher fullness and lower hunger 
ratings and prospective consumption compared with the lean group. There was 
a significant group interactions for desire to eat something savoury (p=0.002), 
sweet and salty (p=<0.001), desire to eat something fatty (p=0.003), and thirst 
(p=0.014).
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Figure 4.1 Subjective appetite ratings in response to the question (a)”how hungry do you feel”, (h) “how
full do you feel” and (c) “how much you can eat”?. Values represent mean ± SEM (lean n=20), (obese n =10) 
of each group. Each group of participants was supplemented with resistant starch (RS) or placebo (PL) Repeated 
measure ANOVA showed no significant differences between supplements. The group interaction was 
significant for hunger and prospective consumption and almost significant for fullness (/?=<0.001, ^=0.057) 
respectively.
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4.12 Blood analysis
4.12.1 Glycaemic response
The mean postprandial glycaemic response following consumption of RS and 
placebo for lean and obese groups is shown in Figure 4.2. There was no effect 
of the RS supplement on the glycaemic response between lean and obese groups 
when analysed using repeated measures ANOVA (time*group* treatment 
/7=0.18). Also, no significant effect of time by group or time* treatment 
interaction were found (/?=0.90, /?=0.91).
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Figure 4.2 Postprandial plasma glucose concentrations for the lean group (n=20) compared with the 
obese group (n = 10) after treatment with resistant starch (RS) or placebo (PL). Values represent mean ± 
SEM. No significant effect on the glycaemic response between lean and obese groups was observed 
(time*group* treatment /?=0.18, time*group ^=0.91). Comparisons were made with repeated measures 
ANOVA.
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4.12.2 Insulinaemic response
The mean postprandial plasma insulin response following consumption of RS or 
placebo for lean and obese groups is shown in Figure 4.3. The postprandial 
insulin responses were not significantly different for RS and placebo within lean 
and obese groups when analysed using repeated measures ANOVA 
(time*group* treatment p=0.99). However, the time by group interaction was 
significant (p<0.001). Obese group had higher postprandial insulin response 
compared with lean group, regardless of supplementation. Peak postprandial 
insulin response occurred at 30 and 210 minutes and corresponded with 
breakfast and lunch.
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Figure 4.3 Postprandial plasma insulin concentrations for the lean group (n=20) compared with the obese 
group (n = 10) after treatment with resistant starch (RS) or placebo (PL). Values represent mean ± SEM. 
No significant effect on the insulinaemic response between lean and obese groups was observed (time*group* 
treatment p=0.99). The time by group interaction was significant (p<0.001). Comparisons were made with 
repeated measures ANOVA.
The mean postprandial plasma C-peptide response following consumption of 
RS or placebo for lean and obese groups is shown in Figure 4.4. Fasting or 
postprandial C-peptide concentrations were not significantly different after RS 
supplementation compared with placebo within weight groups (time*group* 
treatment />=0.33). However, the time by group interaction was significant 
(p<0.001). Subjects in the obese group had higher fasting and postprandial C- 
peptide response compared with those in the lean group. The peak postprandial 
C-peptide response occurred at 30 post- breakfast and 210 minutes post- lunch 
in both group.
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Figure 4.4 Postprandial plasma C-peptide concentrations for the lean group (n=20) compared with the 
obese group (n=10) after supplement with resistant starch (RS) or placebo (PL). Values represent mean ± 
SEM. There were no significant effects on C-peptide responses after RS or placebo supplementation 
(time*group* treatment p=0.33). The time group interaction was significant (p<0.001). Comparisons were 
made with repeated measures ANOVA.
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The C-peptide to insulin ratio was signifieantly higher in the obese group 
compared with the lean group (Figure 4.5; /><0.001).
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Figure 4.5 a) C-peptide to insulin ratio following consumption of a) RS or b) placebo for the lean group 
(n=20) compared with the obese group (n = 10).
Comparisons were made with a paired sample t-test (p<0.001). AUC B/FAST (0-120 min), AUC/ LUNCH 
(180-300 min), TOT AUC (0-300 min).
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4.12.3 Insulin sensitivity
The meal related insulin sensitivity and fasting insulin resistance (at recruitment 
only) were estimated by Matsuda Index and HOMA-IR, respectively (Matsuda 
& DeFronzo, 1999; Wallace et al., 2004; Matthews et al., 1985; Levy et al., 
1998). Estimated HOMA-IR was significantly different between lean and obese 
groups (p<0.001), as would be expected due to the difference in BMI. The 
percentage difference for fasting HOMA-IR was higher in the obese group 
compared with lean group (2.12[SEM0.40] for the lean, and 6.20[SEM0.87] for 
the obese group).
There was also a significant difference in Matsuda Index between lean and 
obese groups (p=0.04). However, comparison of the change in the insulinogenic 
index and Disposition Index after RS feeding was determined and no significant 
difference between lean and obese groups was observed (p=0.89, />=0.30 
respectively). Comparisons were carried out by unpaired t-test when normally 
distributed and by Wilcoxon signed ranks test when non-parametric. Data 
shown in Table 4.2 are expressed as percentage changes between groups.
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4.12.4 GLP-1 response
The mean postprandial plasma GLP-1 response following consumption of RS 
or placebo is shown in Figure 4.6. Analysis by repeated measures ANOVA 
indicated no significant differences in GLP-1 between lean and obese groups 
(time*group* treatment p=Q.19). However, the time by group interaction was 
significant (p=0.009).
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Figure 4.6 Postprandial plasma GLP-1 concentrations for the lean group (n=20) compared with the obese 
group (n = 10) after treatment with resistant starch (RS) or placebo (PL). Values represent mean ± SEM. 
There were no significant differences in GLP-1 response after RS supplementation (time*group* treatment 
p=Q.19). The time by group interaction was significant (/?=0.009). Comparisons were made with repeated 
measures ANOVA.
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Due to significant differences in baseline values between the weight and 
treatment groups, data were expressed as change from baseline for all 
conditions in order to investigate the treatment effect further (Figure 4.7).
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Figure 4.7 Change from baseline in GLP-1 concentrations in a) lean (n=20) and b) obese (n=10) subject 
after treatment with resistant starch (RS) or placebo (PL). Values represent means ± SEM. There were no 
significant differences in GLP-1 response after RS supplementation neither in lean (p= 0.31) nor obese 
(p=0.10). Comparisons were made with repeated measures ANOVA.
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Intake at the ad libitum test meal
The mean energy intake at the ad libitum test meal at the end of the 7 hours 
postprandial period is shown in Table 4.3 .The mean for energy intake and 
weight was 5605.8[SEM344.8] kJ, 821.9[SEM48.0] g for the lean group and 
5198.0[SEM561.1] kJ, 797.7[SEM89.1] g for the obese group. Comparative 
analysis using an independent sample t-test for parametric data and a Mann- 
Whitney U test for non-parametric data indicated no significant differences in 
energy intake between groups. As shown in Table 4.3, there were also no 
significant differences in percentage change in energy intake between lean and 
obese groups. However, the obese group recorded less energy intake compared 
with the lean group after either RS or placebo.
Table 4.3 Energy and quantity intake and percentage change in intake (g, kJ) after consumption of the 
RS supplement compared with placebo in lean (n=20) and obese (n=10) subjects.
Lean group Obese group
Placebo RS % change Placebo RS % change P
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Weight
(g)
821 48.0 775 46.2 -7.1 3.2 797 89.1 703 88.5 -13 .6 6.5 NS
Energy
(kJ)
5606 344 5241 312 -7 .5 3.0 5198 561 4552 17.2 -14 .8 5.2 NS
Analysis was carried out by independent samples t-test for parametric data and 
Mann-Whitney U test for non-parametric data. No significant differences were 
found between treatment groups.
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4.12.6 24-hour intake
The food intake for the full 24-hour study period is shown in Table 4.4. There 
were no significant differences in energy intake and macronutrient intake 
between groups.
Percentage change in intake between the RS and placebo groups was calculated 
to assess the impact of actual food intake. There were no significant differences 
in the effect of the RS on 24-hour food quantity, energy or nutrient intakes 
between the weight groups (obese vs. lean), see Figure 4.8.
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Figure 4.8 Percentage change in energy, quantity, and macronutrient intake after consumption of RS in 
lean (n=20) versus obese (n=10) subjects.
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4.13 Discussion
The present investigation compared appetite ratings, ad libitum food intake, and 
GLP-1 concentrations after consumption of 48 g of RS in lean and overweight 
males. To our knowledge, this is the first study that has investigated appetite 
responses to dietary fibre including resistant starch in healthy lean compared 
with overweight individuals. The importance of demonstrating the impact of 
body mass index (BMI) on appetite and satiety is that any weight loss strategy 
involving dietary fibre would be aimed at overweight and obese individuals as 
targeted group.
As expected, the present study found significant differences in all 
anthropometric measures except for a diastolic blood pressure, which was not 
significant. As all the subjects in both groups were healthy and normotensive, 
this is not an unusual finding. The groups used in the study were therefore 
sufficiently distinct in terms of both adiposity and insulin resistance as 
determined by HOMA-IR, for use to determine the impact of BMI on the 
satiating effects of RS.
The present study found no significant differences in fasting or postprandial
glucose concentrations between obese and lean groups. Also, no significant
differences were observed in postprandial insulin response following RS.
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However, obese subjects had a greater insulin concentration over the 
postprandial period (group effect, ;?=0.001).
It has been suggested that obesity is correlated with abnormalities in insulin 
sensitivity, and insulin and glucose metabolism (English et ah, 2002). In 
agreement with this, obese subjects in the present study had greater peak values 
for insulin and glucose, which is expected in overweight individuals who are 
insulin resistant. Therefore, our finding may indicate the presence of 
postprandial insulin resistance in the obese group with higher fasting HOMA 
values.
At 7 hours postprandial, insulin values in the lean group had returned to 
baseline levels, while the insulin levels in the obese group were still elevated. 
This may reflect impaired insulin clearance in the obese group. Although there 
were no significant differences in glucose response between groups, C-peptide 
values were significantly higher in the obese group, which has been suggested 
as an indicator for insulin release (Palmer et al., 2004). Therefore, our data 
indicates that the obese subjects were insulin resistant.
It has been suggested that insulin may play an intermediate role between satiety 
sensations and the reduction in energy intake at an ad libitum meal in normal 
weight but not in overweight individuals (Flint et al., 2007; Verdich et al., 
2001). A study by Verdich and colleagues (2001) showed that insulin
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concentrations may account for 67% of the energy intake at ad libitum 
variations in normal weight subjects (Verdich et al., 2001). However, our 
findings may not support this notion since the insulin response did not correlate 
with either energy intake or appetite ratings in the lean group.
The role of insulin as an inhibitor of ghrelin has previously been reported 
(Flanagan et al., 2003; Murdolo et al., 2003). Decreased appetite sensations in 
these studies may therefore be mediated by the effect of raised insulin on 
ghrelin; causing its suppression. However, as we did not measure ghrelin 
concentrations or activity, we are not able to confirm this hypothesis.
The stimulatory effect of GLP-1 on insulin secretion has also previously been 
reported (Flint et al., 2001). However, research has shown that insulin response 
may be inversely correlated to GLP-1 concentrations in obese subjects (Flint et 
al., 2001; Verdich et al., 2001; Chanoine et al., 2008). In agreement with this 
research, the present study found an inverse relationship between insulin and 
GLP-1 response in the obese group, whereby lower GLP-1 levels correlated 
with higher insulin levels in the obese versus the lean.
Given that our data and the research of others indicate that lower GLP-1 
concentrations are associated with higher insulin concentrations in overweight 
subjects (Chanoine et al., 2008; Carroll et al., 2007), we expected that increased 
insulin levels would correlate with reduced food intake. However, we did not
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find such a relationship. It is possible that higher insulin levels may affect the 
appetite over a longer period, which would correspond with the view of insulin 
as a long-term satiety signal (Havel, 2001).
Insulin infiision studies in humans have found no effect on appetite or satiety 
(Chapman et al., 1998). Changes in appetite may still be explained by an 
insulin-effect as well as the action of gut hormones and the stability of the 
glucose response. In agreement with previous studies (Verdich et al., 2001; 
Speechly and Buffenstein, 2000), our findings may confirm that insulin plays a 
crucial role in appetite regulation. Since insulin is a satiety hormone, the 
relationship between energy intake, appetite sensations, and insulin response in 
the obese group may suggest defective appetite regulation in this group.
The primary finding in agreement with the literature is that overweight 
individuals have lower baseline and postprandial concentrations of GLP-1 
compared with lean individuals. Our results showed that postprandial plasma 
GLP-1 concentrations changed with time (p<0.001) and that there were no 
significant interactions for time by fibre (p= 0.31). However a significant effect 
of the group was observed (p=0.009). In our study, fasting GLP-1 
concentrations seemed to vary between lean and obese groups. The GLP-1 
response increased 30 minutes after breakfast in both lean and obese groups, 
and then at 60 minutes the GLP-1 response in both groups reduced. In obese
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group, GLP-1 concentrations stayed lower for 3 hours (lunch), while in lean 
was normalised at the same period (3hour). After the lunch, GLP-1 increased in 
obese subjects but remained lower than in lean subjects. Also GLP-1 
immediately before the ad lihitum meal was lower in the obese group compared 
with the lean and remained lower after the meal.
This finding is in line with previous studies that reported a lower fasting and 
postprandial of GLP-1 concentration in overweight/obese individuals compared 
with lean individuals (Carroll et al., 2007; Chanoine et al., 2008). A study by 
Carroll and colleagues (2007) examining the effect of BMI on postprandial 
hormone response after consumption of a chocolate soy drink,showed lower 
GLP-1 concentrations in the obese compared with the lean (Carroll et al., 2007). 
Chanoine and others (2008) demonstrated that GLP-1 concentrations were 
reduced after a liquid test meal in overweight participants compared with lean 
participants (Chanoine et al., 2008). However, the age range of the participants 
was different than ours, as they included male adolescents. In addition, the 
main outcome of their study was to investigate the effect of physical activity on 
GLP-1 concentrations as an appetite marker, which may mask the findings.
Other studies have indicated that there are no differences in either fasting or 
postprandial GLP-1 levels between overweight or normal weight individuals 
(Wadden et al., 2013; Damgaard et al., 2012; Feinle et al., 2002; Adam and
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Westerterp-Plantenga, 2005). One such study indicated no differences in the 
plasma GLP-1 response between obese and lean individuals during duodenal 
infusion of glucose and fat (Feinle et al., 2002). Adam and Westerterp- 
Plantenga (2005) indicated no differences in fasting GLP-1 concentrations 
between overweight and lean subjects after consumption of a galactose/guar 
gum load compared with water and a standardised breakfast. Although 
overweight subjects had lower GLP-1 concentrations after water, galactose/guar 
gum load consumption resulted in no differences between both groups (Adam 
and Westerterp-Plantenga, 2005). Likewise, a recent study by Damgaard and 
colleagues (2012) found no significant differences of oleic acid or olive oil on 
postprandial release of GLP-1 between overweight or lean groups (Damgaard et 
al., 2012). Most recently, a cohort study examined the GLP-1 response to 7-day 
overfeeding in young men and found that GLP-1 levels increased significantly 
in both overweight/obese and normal weight subjects. They concluded, 
however, that there were no significant differences in fasting GLP-1 
concentration between overweight/obese and lean individuals. Thus, they 
suggested that GLP-1 may play a role as a protective factor but not as an 
obesity-indicating factor (Wadden et al., 2013).
Our data indicate no relationship between GLP-1 and appetite rating, which
agrees with other research that reports no connection between BMI status and
concentrations of GLP-1 and markers of hunger or satiety (Chanoine et al.,
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2008). It has also been demonstrated in a meta-analyses that only 20% of 
reduced energy intake can be explained by the administration of GLP-1 
(Verdich et al., 2001). Therefore, it is still not clear if increased GLP-1 can 
elevate satiety. The lack of the relationship between GLP-1 concentrations and 
appetite may be due to the modest effect of GLP-1 in appetite regulation.
Some evidence shows that GLP-1 administration results in increased satiety and 
reduction in food intake in the short-term in lean individuals (Flint et al., 1998; 
J. P. Gutzwiller et al., 1999; Steinert et al., 2010), and obese subjects (Naslund 
et al., 1999; Flint et al., 2001). In the present study, we expected that lower 
GLP-1 levels would result in decreased appetite ratings. However, no such 
relationship was found in either weight group. Despite that, GLP-1 levels were 
lower in obese subjects compared to lean subjects and obese subjects reported 
greater fullness and food prospective with lower hunger. Although some studies 
have shown no differences (Adam and Westerterp-Plantenga, 2005) or 
increased fasting and postprandial GLP-1 concentrations in overweight 
individuals (Bowen et al., 2006), neither situation was associated with any 
effect on appetite ratings or energy intake.
The present study investigated two groups with significant differences in body 
weight and BMI. It is possible that the lower GLP-1 concentrations in obese 
subjects may be explained by leptin resistance. It has been suggested that leptin
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is a stimulator of GLP-1 secretion and has been shown that leptin resistance was 
associated with lower GLP-1 concentrations in obese subjects which may 
explain the impaired GLP-1 in individuals with higher BMI (Anini & Brubaker, 
2003). However, we did not measure leptin levels in the present study, so this 
hypothesis cannot be confirmed in our obese group. The differences between 
groups in body weight and the BMI may indicate the onset of leptin resistance 
in our obese subjects as the increased adiposity has been linked with the 
development of leptin resistance (Vasselli, 2012).
Another explanation of the lower GLP-1 in the obese group is variation in the 
gut microbiota profile between lean and obese individuals. It has been 
suggested that obesity may correlate with changes of the gut microbiota both in 
composition and functional properties (Ley et al., 2005). Evidence in humans 
has shown that the composition and metabolic activity of gut microbiota 
appears to be different in obese compared with lean individuals (Schwiertz et 
al., 2010; Tumbaugh et al., 2009). A recent review has also shown differences 
in the gut microbiota in terms of bacteria or their metabolites of obese compared 
with lean individuals in response to dietary intervention (Contemo et al., 2011).
Animal data has indicated that differences in gut microbiota between obese and 
lean mice has been observed after ingestion of RS (Zhou et al., 2009). The 
assumption was that while specific types of microbiota may be stimulated by
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RS in lean mice, the lack of those types of bacteria in the obese mice might 
inhibit the fermentation of RS. Therefore, our data may indicate that the 
fermentation of RS was different in obese and lean subjects, which may explain 
the differences in the GLP-1 response between groups. SCFA produced 
through bacterial fermentation of the RS would be a potent stimulator of GLP-1 
release from the colonic L-cell following stimulation of the GPR-43 receptor.
It has been suggested that GLP-1 release in the small intestine is affected by the 
rate of gastric emptying (Schirra et al., 1996). It is possible that different rates 
of gastric emptying caused the difference in GLP-1 response between our obese 
and lean subjects; however, this cannot be confirmed since gastric emptying 
rates were not measured. Moreover, studies investigating the relationship 
between rates of gastric emptying and GLP-1 levels in overweight and normal 
weight individuals have reported inconsistent findings. One study reported that 
reduced GLP-1 was associated with faster gastric emptying in overweight 
subjects (Naslund et al., 1998), while another found that although GLP-1 
response was lower in overweight individuals, no differences in gastric 
emptying between lean and overweight was observed (Verdich et al., 2001).
Our research showed that obese had lower GLP-1 response compared with lean 
group. This finding may indicate an important difference in the appetite and
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satiety regulation in obese subjects. Therefore, further studies are needed to 
clarify the relationship between body weight and the GLP-1 response.
The present investigation found that 48 g of RS supplementation split over two 
equal doses served at breakfast and lunch did not influence quantitative or 
subjective appetite measures in the normal weight group nor the overweight 
group. However, there were significant effects of BMI group on appetite 
sensations with overweight individuals rating less hunger and prospective food 
consumption and reporting more fullness compared with lean subjects. It is 
possible that overweight subjects may have difficulty in rating their sense of 
hunger. This is in agreement with a previous study reporting that satiety and the 
sensation of hunger were associated with the energy intake at an ad libitum test 
meal (Flint et al., 2007).
Overweight/obese subjects had higher score for dietary restraint that was 
inversely correlated with appetite ratings in this group. Dietary restraint has 
been hypothesised to reflect an individuaPs perception to monitor or limit food 
intake in order to maintain body weight (Herman & Mack, 1975). Thus, it is 
possible that the awareness of overweight individuals of their higher BMI may 
have caused them to report lower appetite ratings. However, determining 
objective appetite sensations and dietary restraint values in subjects with higher 
BMI and restrained may be challenging.
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The present investigation was surprising in that lean subjects ate more at the ad  
libitum test meal than overweight and obese subjects even when supplemented 
with placebo, although this was not significant. In terms of energy 
requirements, it might have been expected that overweight individuals would 
have eaten more under the same conditions. There are several possible 
explanations for this finding. For example, cognitive, sensory, and 
psychological factors have been suggested to affect appetite regulation and may 
lead to reduced energy intake at an ad libitum meal (Blundell, 1990). 
Furthermore, the study environment may influence the overweight subjects 
more when compared with lean subjects, because overweight individuals are 
more conscious about their food intake causing them to eat less.
Palatability of the placebo and RS supplements was rated the same in the obese
group, but obese subjects rated less hunger and prospective consumption with
increased satiety, reflecting the smaller amounts eaten. In agreement, one study
found that subjects rated lower hunger and more fullness five hours after
consumption of a palatable test preload compared with eating a less palatable
preload. They indicated that the sensory properties of the preload did not have
an impact on the food intake at the ad libitum lunch, despite the reduction in the
hunger observed (Warwick et al., 1993). De Graaf and collègues (1999)
indicated that two hours following the consumption of a preload, the palatability
of the meal did not affect either the hunger ratings or the food intake (De Graaf
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et al., 1999). Our data indicated that palatability of the preload had no effect on 
either satiety or food intake. However, we did not measure the effect of the 
palatability in the lean group, thus we are not able to make any assumptions 
about the effect of palatability between the two groups.
To our knowledge this is the first demonstration that compared the appetite 
response between overweight/obese and lean subjects following consumption 
RS compared with placebo. We provided an identical preload that differed only 
in dietary fibre which was matched for available carbohydrate and energy load. 
Previous studies comparing either food intake, appetite ratings and/or the 
metabolic responses between overweight and lean individuals have used 
different study designs with different preloads in which the type and/or the dose 
of the supplement were varied. Most of these studies were comparing both 
male and female overweight and lean subjects (Adam & Westerterp-Plantenga, 
2005; Carroll et al., 2007), or adolescents subjects (Chanoine et al., 2008), 
which may mask the findings. In addition, the main outcomes of these studies 
were different than our work and the investigation of the effect of the BMI on 
appetite response was a secondary outcome, therefore these differences between 
studies may affect the results and the overall findings.
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Our study has several limitations. Firstly, the sample was relatively small 
particularly for overweight group. Another limitation is that we only included 
young men aged (18-32  y). The data from the present study was obtained from 
two studies that was performed separately in different times of the year and then 
the data were combined for the comparison. This may be considered as a 
limitation as different time of the year may have an impact on the food intake 
and appetite. Our study did not include women, so we are not able to generalize 
the results to women. Similar investigations are required in females and 
individuals of different ages and ethnic groups, as differences in satiety 
responses have been reported (Brownley et al., 2012; Carroll et al., 2007; 
Macintosh et al., 1999). In addition, our study included lean, overweight, and 
moderately obese males only. It is possible that if severely obese subjects were 
included, different findings may have been obtained. Therefore, further long­
term investigations with a more diverse study population are needed to 
understand the role of BMI in appetite regulation and satiety response.
We also used a set meal size for all subjects, which may have resulted in
alterations in glycaemic and hormone responses due to differences in the total
kcal load to BMI ratio. Although subject’s could leave as much as they liked at
the first meal, thus they can choose to eat according their maximum intake and
were not forced to eat a set meal. Estimating the caloric requirement for each
subject based on body weight may help to ensure that subjects are matched to
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their actual requirement. Despite these considerations, every effort was made to 
ensure that the energy and macronutrient intake was identical at both visits. This 
was achieved by weighing the leftover food in the first visit and provides the 
subject with an equal amount in the next visit.
For future investigations, it should be noted that other gut peptides may have an 
impact on energy intake and satiety, such as leptin, ghrelin CCK, PYY and 
adiponectin. These and other parameters such as triglyceride levels were not 
measured in the present study but would be interesting components to measure 
in upcoming research.
In this study, we measured only the total human GLP-1 rather than active form, 
which has been suggested to have very short half-life. Whereas total GLP-1 is 
considered as an indicator of secretion from intestinal L-cells. However, it has 
been suggested that total GLP-1 may positively correlate with active GLP-1 (7- 
36amide) concentrations, meaning that our results are still valid (Heijboer et al., 
2011).
In conclusion, both fasting and postprandial responses of GLP-1 and insulin 
were significantly different in the obese group compared with the lean group. 
The findings of the present study may indicate a weak relationship between 
satiety and GLP-I secretion that is different in obese individuals compared with 
lean individuals. The observed differences after consumption of RS in the
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current study may play a role in body weight regulation in groups with varied 
BMI. Future research is needed to understand the mechanisms for the 
variability in pre- and post-prandial glycaemic and hormonal responses in 
individuals with different body mass. Understanding these factors could help in 
the development of new treatments for obesity.
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Chapter 5 The acute effect of consumption of a fenugreek fibre- and 
calcium-enriched drink on appetite and satiety in overweight women
5.1 Introduction
Obesity has become an epidemic throughout the world (WHO, 2013b). In many 
countries, westernisation and urbanisation has correlated with dietary patterns of 
high intake of high-energy dense foods. Evidence has shown that the prevalence of 
obesity has reached alarming levels in Middle Eastern countries (Musaiger, 2011). 
For example, in Saudi Arabia, it has been estimated that 66% of men and 71% of 
women are either overweight or obese (Ng et al., 2011).
Obesity results from an excessive energy intake compared with energy 
expenditure. However, components of the diet not normally regarded as providing 
“excess energy” such as low dietary fibre intake (Liu et al., 2003), and insufficient 
dietary calcium (Ca), have been associated with obesity (Pereira et al., 2002; Riedt 
et al., 2005). Specifically, a lower intake of dietary fibre has been reported in the 
Saudi population, where obesity is prevalent (Al-Shagrawi, 1998; Alissa et al., 
2005; Alissa and AlKadi, 2011). The intake of dietary Ca also has been reported to 
be lower than the recommended dietary reference level in Saudi Arabia (Al-Assaf 
& Al-Numair, 2007; Washi & Ageib, 2010). Recently, it has been reported that 
there is an inverse relationship between dietary Ca intake in Saudi Women and
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BMI, which has been attributed to the lower intake of milk and dairy products 
compared with Western populations (Al-Daghri et ah, 2013).
The current intake of dietary fibre as well as micronutrients such as Ca is far below 
the recommended intake in most parts of the world (Al-Assaf & Al-Numair, 2007; 
Alissa et ah, 2005; Beydoun et al., 2008). Therefore, lifestyle modifications may 
need to be applied to increase the intake of these important nutrients. Fenugreek 
has been used in the Middle East as a traditional medicine for centuries. For 
example, in Saudi Arabia, fenugreek was shown to be among the most common 
herbs used among people with diabetes (Al-Rowais, 2002). Fenugreek fibre is a 
source of the water-soluble dietary fibre galactomannan (Youssef et al., 2009). 
Galactomannan from fenugreek may enhance satiety by forming a viscous gel in 
the stomach, which increases the viscosity of the gastrointestinal contents and 
slows gastric emptying, thus enhancing fullness. A recent study has reported that 
fibre powder from fenugreek can increase satiety and decrease energy intake in 
obese subjects (Mathem et al., 2009).
In addition to fibre, some data suggest that Ca consumption could play a 
considerable role in the maintenance of a healthy body weight. Under free-living 
conditions, a inverse association between daily Ca intake and adiposity markers 
has been observed (McCarron et al., 1984). Growing evidence also suggests that 
increasing Ca intake decreases the risk of obesity (Zemel et al., 2000). One
199
Najlaa Al-Mana Thesis
suggested hypothesis is that the level of Ca in the diet may affect appetite and food 
intake, although the mechanism of action is unknown. Ca may participate in 
eliciting hormonal responses that impact on these physiological functions. 
Therefore, it may be instructive to measure the response of mediators of food 
intake, such as ghrelin, cholecystokinin (CCK), peptide YY (PYY), and glucagon­
like peptide-1 (GLP-1), to Ca intake. Few studies have assessed the direct impact 
of Ca consumption on appetite and food intake (Lorenzen et al., 2007; Jacobsen et 
al., 2005; Gilbert et al., 2011; Gonzalez et al., 2013) and when it has been 
investigated, it has been as Ca within dairy products. Such foods contain other 
potential bioactive components, importantly dairy protein that could impact on 
satiety and so the role of Ca per se still remains to be established.
This study was therefore designed to investigate the effects of fenugreek and Ca 
supplementation on actual food intake, glycaemic response, and the hormone GLP- 
1 involved in satiety and to assess qualitatively the effects on appetite by subjective 
measures through the use of visual analogue scales (VAS). We also hypothesised 
that the combination of these substances (fenugreek and Ca) might result in a 
combined or additive effect.
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5.2 Aims and Objectives
The overall aim of the study was to investigate the short-term effects of fenugreek 
and Ca on appetite and satiety in overweight women compared with a placebo and 
to elicit the potential biological response mechanism. A secondary aim of this 
study was to investigate the acute effect of Ca supplementation on appetite and 
satiety compared with placebo.
The objectives of this study are as follows.
1. To assess the quantitative effects on food intake, glycaemic response, and GLP- 
1 and the qualitative effects on appetite using subjective VAS, when:
a. 6 g of fenugreek supplement as a component of dietary fibre is included in a 
controlled meal.
b. 500 mg of a Ca supplement is included in a controlled meal.
c. Both 6g fenugreek and 500 mg of Ca supplement are simultaneously included 
in a controlled meal.
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5.3 Materials and Methods
The present study was conducted according to the guidelines laid down in the 
Declaration of Helsinki, and all procedures involving human subjects were 
approved by the University of Surrey’s Ethics Committee (EC/2011/80/FHMS). 
The study took place between December 2011 and May 2012, and was conducted 
in the Clinical Research Centre (CRC) at the University of Surrey. Written 
informed consent to participate in the study was obtained from all subjects. 
Hunger, satiety, glucose, insulin and GLP-1 levels were measured postprandial to 
the consumption of 6 g of fenugreek, or 500 mg of Ca, or a combination of the two 
in a standardised breakfast meal. Parameters were compared with those measured 
after consumption of a placebo breakfast meal containing neither fibre or calcium.
5.3.1 Participants
Ten healthy, overweight, pre-menopausal women were recruited to this pilot study 
from the student population of the University of Surrey through the use of flyers 
and advertisements (emails and university Facebook) during December 2011 to 
May 2012. Subjects’ suitability for inclusion in the study was assessed during the 
screening period, which involved the completion of a self-certificated medical 
questionnaire, the Extended Health & Lifestyle Questionnaire, the Food Frequency 
Questionnaire, and the Dutch Eating Behaviour Questionnaire (DEBQ). In
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addition, an initial capillary blood sample was taken by capillary finger prick to 
assess baseline blood glucose and haemoglobin levels.
For inclusion, participants were required to have a body mass index (BMI) of 25 to 
37 kgm^, with stable weight for >3 months, fasting blood glucose <6.0 mmol/1, an 
eating restraint DEBQ score <4. Participants were required to be taking a 
contraceptive pill or have regular menstrual cycles.
Exclusion criteria included no previous or current medical conditions, including 
heart disease, diabetes, gastrointestinal diseases (for example Crohn’s disease, 
Coeliac disease, irritable bowel syndrome), liver disease, kidney diseases, and 
endocrine disease. Participants were also excluded if they had a history of kidney 
stones. Alcohol consumption of > 21 units of alcohol per week or the receipt of 
any prescription medicines or dietary supplements in last 6 months were also 
criteria for exclusion.
5.3.2 Test products and supplements
Two different supplements were used in the 4-way crossover study. The fenugreek
(Fen) supplement (Fenulife) was purchased from Frutarom (FenuLife® Frutarom
Inc, Belgium) and the Ca supplement (Calcium-Sandoz® Syrup, Alliance
Pharmaceuticals) was supplied by the Royal Surrey County Hospital pharmacy.
During the placebo leg, no supplement was added to the meal. Table 5.1 shows the
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nutritional composition of the test supplements (FenuLife® and Calcium- 
Sandoz® Syrup).
Table 5.1 Nutrition composition of the supplements
Nutrient FenuLife® 
(per 100)
FenuLife® 
(per 6g)
Calcium-Sandoz® 
Syrup (per 24ml)
Energy (kJ) 184 11.04 -
Energy (kcal) 44 2.6 -
Protein (g) <10 <0.6 -
Carbohydrate (g) 8.3 0.5 -
Fat (g) 0 0.0 -
Total dietary fibre (g) 85 5.1 -
Soluble dietary fibre 
(galactomannan) (g)
75 4.5
Calcium (mg) - - 500
Prior to the beginning of the study, the supplements were tested for incorporation
into orange juice to produce an acceptable taste and texture. Six g of fenugreek was
determined as the optimal amount for inclusion into 450ml of orange juice (Tesco
100%, Not from Concentrate Pure Squeezed Smooth Orange Juice). Twenty four
ml of Calcium -Sandoz syrup is equivalent to 500 mg of Ca. Of note, the UK
reference nutrient intake (RNI) for Ca for adults aged over 19 years is 700 mg/d
and the lower reference nutrient intake (LRNI) is 400 mg/d (UK Department of
Health, 1991). Therefore, the amount used in this study was based on Estimated
Average Requirement (EAR) which is 500 mg. The 500 mg calcium used in this
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study is 25% above the estimated UK LRNI value (UK Department of Health, 
1991).
5.3.3 Study Protocol
The study was performed as a randomised single-blind balanced crossover study. 
This was a 4-way crossover study where participants needed to attend four separate 
study days at least 1 week apart in order to allow for washout. All participants were 
randomised to fenugreek, Ca, combined fenugreek and Ca or placebo (no added Ca 
or fenugreek).
Prior to each study day, all participants were asked to refrain from strenuous 
exercise and alcohol consumption in order to reduce within-subjects variability. 
Participants were asked consume a low-fibre and low-Ca diet and to approximately 
replicate their 24 h intake prior to each study day. Subjects were also requested to 
fast overnight for 12 h. Information and suggestions for lunch were provided to 
give an overview of the main foods to avoid and alternatives that would achieve 
low-fibre and low-Ca intake. A standardised evening meal (pre-selected low-fibre, 
low-Ca ready meal and desert) was provided and 24 h intake was recorded.
To control the hormonal fluctuations throughout the menstrual cycle, which is
important in appetite regulation (Brennan et al., 2009), participants not using a
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combined contraceptive pill or implant were asked to attended visits at the same 
stage of the follicular phase in their menstrual cycle. However, most of the 
participants were using hormonal contraceptive methods, so this was largely 
unnecessary.
All study days were carried out at the CRC at the University of Surrey. Participants 
were required to stay at the investigation unit for the entire duration of the study 
and they were allowed to read, write, work on their computers or watch television, 
but avoiding any stimuli food cues.
Upon arrival at the CRC, various anthropometric measurements (weight, height, 
waist circumference, % body fat, and BMI) and blood pressure were taken. 
Participants were then cannulated and two fasted blood samples (15 minutes prior 
to breakfast (-15 min), breakfast time (0 min)) were taken. Prior to each blood 
sample, participants were asked to complete VAS to subjectively assess appetite 
and gastrointestinal symptoms.
Participants were provided with the breakfast pre-load at time zero, which
consisted Scotch pancakes with jam and a drink of orange juice containing the
supplement (or placebo), which they were asked to consume within 15 min.
Breakfast consisted of 2 pancakes (Free From, Tesco UK), Strawberry Jam (20 g)
and the supplements mixed into 450 ml orange juice (Tesco 100%, Not from
Concentrate Pure Squeezed Smooth Orange Juice). Following breakfast,
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participants completed VAS regarding the palatability and pleasantness of the 
juice. The energy and nutrient composition of this meal is shown in Table 5.2.
Table 5.2 Energy and nutrient composition of the breakfast meal consumed on all study days\
Energy/Nutrient Breakfast
Energy (kJ) 1838
Energy (kcal) 432
Protein (g) 5.9
Carbohydrates (g) 93.7
Fat (g) 2.7
Total dietary fibre (g) 0.6
Ca (mg) -
•Excluding fenugreek and Ca supplements
Blood samples were taken every 30 min for the following 3 hours until lunch. In 
addition, VAS were completed prior to each blood sample at half hourly intervals. 
After these 3 hours (time 180 min) participants were given a large pre-weighed 
pasta meal ad libitum providing 9760 kJ energy; 83.4g protein; 335.6g 
carbohydrate; 71 g fat; 15.9g fibre. Prior to, and during the meal, participants were 
separated to minimise any effects of social interaction on food intake and were 
asked to consume the meal ad libitum until they felt comfortably full. The 
participants were informed prior to the meal that they could take any left-over food 
home to prevent over consumption. Once the meal was finished, the participants 
were free to leave the research centre and resume their normal activities.
207
Najlaa Al-Mana Thesis
Participants were asked to complete a diet diary for the remainder of the day (until 
9am the next morning), to monitor later intake. All food diaries were analysed 
using Dietplan6 (Forestfield software Ltd, Horsham, UK). The timeline for the 
study day is shown in Figure 5.1. Participants were instructed to record their 
bowel symptoms on the study day and the following day to assess gastrointestinal 
tolerance of the supplements. The participants returned on three further occasions 
to repeat the study day with each supplement in randomised order.
Arrive at CRC
Breakfast
Body measurements & 
2 Fasting blood
Blood samples & 
VAS every 30 minutes
Pre-weighed
Diet diary
-Sam -9am -12 noon -9am
Figure 5.1 Timeline of the study day
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5.4 Blood analysis
Blood samples were collected every 30 min for the 3-h intervention period. Blood 
samples was collected into potassium EDTA tubes for insulin and TG analysis; 
sodium oxalate tubes for glucose analysis; and potassium EDTA tubes containing 
200 kalikrein inhibiting units (KIU) aprotinin per ml of whole blood for GLP-1 
analysis to prevent enzymatic degradation (Sigma-Aldrich company Ltd, 
Gillingham, Dorset, UK). All collected samples were stored at 4°C and then 
centrifuged at 1750 g (3000 rpm) for 10 minutes. Plasma was aliquoted and stored 
at -20° C until analysis. All samples were analysed by batched analysis at the end 
of the study to reduce inter-assay variation.
Plasma glucose was measured enzymatically using a commercially available kit 
(Instrumentation Laboratory, Warrington, UK) for the ILab650 (Instrumentation 
Laboratory). The inter-assay coefficient of variation (CV) was < 3 % and the intra­
assay CV was < 2 %.
Plasma TG was measured enzymatically using a commercially available kit 
(Instrumentation Laboratory, Warrington, UK) for the ILab650 (Instrumentation 
Laboratory). The inter-assay CV was < 1 % and the intra- assay CV was < 0.80 %.
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Plasma Insulin was measured using a commercially available ELISA kit 
(Millipore; Missouri, USA) with an inter-assay CV of < 7 % % and intra-assay CV 
of < 5%.
Plasma GLP-1 was measured using commercially available ELISA kit (Millipore; 
Missouri, USA) with inter-assay CV of < 15 % and intra assay CV of < 4%.
5.5 Food Diaries
Food and drink intake during 24-h was recorded by food diaries completed on the 
day before the study day and for the remainder of the each investigation day. Food 
diary entries included the food that was provided on the study day. These diaries 
were analysed for energy intake, fibre and other macronutrient intake using 
Dietplan6 (Forestfield Software Ltd, Horsham, UK). See Chapter 2 (Section 2.4.3).
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5.6 Data Analysis
Insulin resistance (IR) was estimated using the Homeostasis Model Assessment of 
Insulin Resistance (HOMA-IR) in the fasting state. Postprandial insulin sensitivity 
(IS) was estimated by Matsuda Index as a surrogate index of IS (Matsuda & 
DeFronzo, 1999; Wallace et al., 2004; Matthews et al., 1985; Levy et al., 1998). In 
addition, the insulinogenic index was used as a surrogate index of early-phase of 
insulin release. The disposition index was also assessed as a measure of the ability 
of P-cells to respond to insulin. Comparisons between treatments were made for 
all insulin dynamics (glucose and insulin concentrations from 0-120 minutes) using 
a web formula and a spreadsheet downloadable from http://mmatsuda.diabetes- 
smc.in/english.html.
5.7 Statistical analysis
All statistical analyses were conducted using SPSS for Windows 18.0 (SPSS Inc., 
Chicago, USA) and significance was determined by two-sided test with p<0.05. 
The data were checked for normality using a Kolmogorov-Smirnov test / Shapiro- 
Wilk's test (SW/KS). When data were not normally distributed (as a result of small 
sample size), data were log-transformed (base 10) using SPSS to generate a normal 
distribution for analyses. Postprandial and VAS measurements were analysed 
using repeated measures two-way analysis of variance (ANOVA) to assess
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differences between the four treatments. Post hoc tests with Bonferroni correction 
factor were carried out only where significant effects were found with repeated 
measures ANOVA Treatment (Fen, Ca, FenCa, PL), time (7 time points), and the 
time-treatment interaction were included as within-subject factors to assess if  time 
effect was different between treatments. Average ad libitum pasta intake on the 
study day, energy and macronutrient intake from food diaries were analysed using 
a one-way ANOVA. Differences in the palatability of the test products compared 
with PL were assessed by using one-way ANOVA. Post hoc tests with correction 
factors were used when multiple comparisons were made by Student’s t tests or 
Mann Whitney U tests.
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5.8 Results
5.8.1 Comparison of the differences between 4 treatment conditions 
(Fenugreek, Ca, FenCa, and placebo)
5.8.1.1 Participants
All women (n=10) who participated in this study completed all 4 beverage 
conditions (placebo, n=10; Fen, n=10; FenCa, n=10; Ca, n=10). The women 
were on average young, with mean age of 24 years and overweight or obese 
with a mean BMI of 29.06 kg.m'^ [SEM 0.91], but were otherwise healthy. The 
mean restraint score of the participants was 3.11 [SEM 0.16], 3.21 [SEM 0.26] 
on the emotional scale and 3.67 [SEM 0.17] on the external eating scale from 
the results of the DEBQ. Table 5.3 outlines the mean baseline characteristics of 
the participants.
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Table 5.3 Baseline participant characteristics
Overall (n=10)
Mean SEM
Age, years 24 2.4
BMI, kg.m-2 29.6 0.97
Waist circumference, cm 97.2 3.3
Body fat, % 38.8 1.5
Systolic BP, mmHg 114 3.5
Diastolic BP, mmHg 67 2.3
DEBQ Restraint score 3.1 0.16
DEBQ Emotion score 3.2 0.26
DEBQ External score 3.6 0.17
Fasting blood glucose, mmol/1 5.2 0.01
Haemoglobin, g/dl 14.8 0.43
BMI; Body mass index; DEBQ: Dutch Eating Behaviour Questionnaire; BP=Blood Pressure
NOTE: BP was averaged using 3 separate measures and % body fat was determined by bio-impedance (Tanita TBF-300, Tanita, UK).
5.8.1.2 Palatability
Figure 5.2 displays the mean VAS scores obtained regarding the pleasantness 
and palatability of the preload drink containing Fen, FenCa, Ca, or placebo at 
the breakfast meal. Ratings of palatability and the pleasantness did not differ 
among treatments by one-way ANOVA (p=0.21 and/>=0.86, respectively).
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Figure 5.2 VAS ratings regarding the pleasantness (A) and palatability (B) of the preload beverages 
containing one of 4 treatments (Fenugreek (Fen), Calcium, Fenugreek + Calcium (FenCa), Calcium (Ca) 
or placebo (PL). Analyses were carried out using one-way ANOVA. Values represent means ± SEM, (n=10). 
The question in a) was “How pleasant is this meal right now?” No significant effect o f either Fen, FenCa, Ca, or 
PL supplements on the pleasantness o f the taste o f the pre-load drink was found at the breakfast meal (p=0.86). 
For b)-“How palatable is this meal right now?” no significant effect o f Fen, FenCa, Ca, or PL supplements on 
the palatability o f the item was found at the breakfast meal {p= 0.21).
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5.8.1.3 Subjective Appetite Ratings
5.8.1.3.1 Prospective food consumption
Repeated measures ANOVA showed a treatment effect on prospective food 
consumption (p=0.017). Post hoc analysis by Bonferroni correction method 
revealed this to be due to a significant treatment effect of Ca (p=0.03), and a 
significant treatment*time effect of FenCa (p=0.05) compared with placebo. 
Prospective food consumption reduced after consumption of all preload test 
beverages with all treatments reaching the nadir time at 30 min, Figure 5.3 (a).
At 30 min following breakfast, participants felt that they could eat less 
following FenCa consumption compared with placebo consumption. Figure 5.3 
(b). After consumption of the breakfast preload containing the Ca 
supplementation, subjects felt that they could eat less compared with placebo.
Figure 5.3 (c).
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Figure 5.3 Subjective ratings in response to the question “how much do you think you can eat?” (a) 
Fenugreek (Fen), Fenugreek or Ca (FenCa), and Ca, compared with placebo (PL), (b) FenCa compared 
with PL (c) Ca compared with PL. Values represent mean ± SEM (n = 10). Repeated measures ANOVA 
showed a treatment effect on prospective food consumption (/?=0.017). Post hoc analysis by Bonferroni 
correction method found a significant effect o f treatment with Ca (p=0.03) and treatment*time with FenCa 
(p=0.05) compared with placebo.
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5.8.1.3.2 Hunger
The subjective appetite ratings measured by VAS show a trend towards a 
significant treatment effect on hunger (p=0.068). Post hoc analysis by 
Bonferroni correction method revealed that this effect was driven by a 
significant treatment effect of FenCa (p=0.006) compared with placebo. Ratings 
of hunger decreased after consumption of all preload beverages, reaching the 
nadir point at 30 minutes, Figure 5.4 (a). At 30 minutes post breakfast, subjects 
felt less hungry after consumption of the preload containing FenCa 
supplementation compared with placebo. Figure 5.4 (b).
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Figure 5.4 Subjective ratings in response to the question “how hungry do you feel”? (a) fenugreek (Fen), 
fenugreek or Ca (FenCa), and Ca compared with placebo (PL), (b) FenCa compared with PL. Values 
represent mean ± SEM (n = 10). Repeated measures ANOVA showed a trend towards a significant treatment 
effect on hunger (p=0.068). Post hoc analysis by Bonferroni correction method found a significant effect o f 
treatment with FenCa (p=0.006)) compared with placebo.
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5.8.1.3.3 Desire to eat sweet foods
The subjective appetite ratings measured by VAS showed a trend towards a 
significant effect on the desire to eat sweet food (p=0.086). Post hoc analysis 
revealed no significant effect of treatment after application of the Bonferroni 
correction factor (treatment, p=026  for Fen, /?=0.36 for FenCa and /?=0.13 for 
Ca) (data not shown).
5.8.1.3.4 Desire to eat savoury foods
The subjective appetite ratings measured by VAS showed a trend towards a 
significant effect of the desire to eat savoury food (p=0.061). However, no 
significant effect of treatment was found when post hoc analysis was performed 
using the Bonferroni correction factor (treatment, p=0.15 for Fen, /?=0.73 for 
FenCa and/?=0.18 for Ca) (data not shown).
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5.8.1.4 Metabolite Analysis
5.8.1.4.1 Glycaemic response
The mean postprandial glycaemic response following consumption of Fen, 
FenCa, Ca, and PL is shown in Figure 5.5. Repeated measures two-way 
ANOVA showed a significant treatment*time effect (p=0.007). Post hoc 
analysis by Bonferroni correction method indicated that this was due to a 
significant treatment*time effect of Fen and FenCa compared with placebo 
(p=0.02 and j9=0.01 respectively). However, no significant treatments effect of 
supplementations with either Fen or FenCa compared with placebo (treatment, 
j9=0.0.1 and p=Q3l respectively). There was no significant effect of the Ca 
supplement on postprandial glucose response compared with placebo 
(treatment, treatment*time; p=0.81 ,p=0.2\ respectively). The peak postprandial 
glucose response occurred at 30 minutes post-breakfast in all treatments. Figure 
5.5(a). Glucose response after consumption of the preload containing Fen was 
lower at 30 minutes, but increased and remained higher between (60-180) 
minutes compared with placebo. Figure 5.5(b). In addition, glucose response 
was also lower following consumption the preload containing FenCa at 30 
minutes and slightly higher at 180 minutes compared with placebo. Figure 
5.5(c).
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Figure 5.5 Postprandial plasma glucose concentrations after consumption of fenugreek (Fen), fenugreek 
and Ca (FenCa), or Ca compared with placebo (PL), (a) Fen, FenCa, Ca compared with PL, (b) Fen 
compared with PL (c) FenCa compared with PL. Values represent means ± SEM (n=10). Fen and FenCa 
ingestion led to significantly higher plasma glucose levels following 30 minutes postprandial (treatment*time 
interaction p=0.Q2, Treatment*time interaction /7=0.01, respectively). No significant effect o f treatments 
(treatment,/>=0.0.1 for Fen and /?=0.31 for FenCa). Comparisons were made with repeated measures two-way 
ANOVA.
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5.8.1.4.2 Insulinaemic Response
The mean postprandial plasma insulin response following consumption Fen, 
FenCa, Ca, and PL is shown in Figure 5.6. Repeated measures two-way 
ANOVA showed a significant treatment and treatment*time effect (both 
/?<0.001). However, post hoc analysis using the Bonferroni correction method 
revealed that no significant treatment effect of Fen, FenCa, or Ca 
supplementation (p=0.61, p=022, ;?=0.18 respectively). Also no significant 
treatment*time effect was observed of Fen, FenCa, or Ca supplementation 
(p=0.11, p=0.22, p=0.10 respectively). The peak postprandial insulin
response occurred at 30 minutes post-breakfast in all treatments, while the nadir 
was at 150 minutes after consumption FenCa (Figure 5.6).
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Figure 5.6 Postprandial plasma insulin concentrations after consumption of either fenugreek (Fen), 
fenugreek and Ca (FenCa), or Ca compared with placebo (PL). Values represent means ± SEM (n=10). No 
significant treatment effect o f Fen, FenCa, or Ca supplementation (/7=0.61, p=0.22, />=0.18 respectively). No 
significant treatment*time effect of Fen, FenCa, or Ca supplementation (jy=0.11, p=0.22, p=0.10 respectively). 
Comparisons made with repeated measures two-way ANOVA.
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5.8.1.4.3 TG Response
The mean postprandial plasma TG response following consumption of Fen, 
FenCa, Ca, and PL is shown in Figure 5.7. Repeated measures two-way 
ANOVA showed a significant treatment*time effect (p=0.02). Post hoc analysis 
by Bonferroni correction method revealed this to be due to a significant 
treatment*time effect of FenCa and Ca supplementation (p=0.003 and p=OS)A 
respectively). However, no significant effect of supplementation fortified with 
FenCa and Ca were observed (treatment, p=0.91 and /?=0.64 respectively). The 
peak postprandial TG response occurred at 30 minutes post-breakfast after 
consumption of the preload containing Fen, and at 60 minutes after the Ca 
supplementation (Figure 5.7(a)). The nadir point occurred at 120 minutes after 
consumption the FenCa preload (Figure 5.7 (a)). TG response was lower at 60 
minutes after the FenCa preload and remains lower until 180 minutes compared 
with placebo (Figure 5.7(b)). In addition, TG response after Ca preload was 
lower at 90 minutes and remains lower until 180 minutes compared with 
placebo (Figure 5.7(c)).
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Figure 5.7 Postprandial plasma triglyceride concentrations after consumption of fenugreek (Fen), 
fenugreek and Ca (FenCa), or Ca compared with placebo (PL), (a) Fen, FenCa, Ca, compared with PL, 
(b) FenCa compared with PL (c) Ca compared with PL. Values represent means ± SEM (n=10). FenCa and 
Ca ingestion led to significantly lower plasma TG levels (treatment*time interaction p=0.003 for FenCa; /?=0.04 
for Ca). No significant effect o f treatments (treatment, p=0.91 for FenCa and />=0.64 for Ca). Comparisons 
made with repeated measures two-way ANOVA.
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5.8.1.4.4 Insulin Sensitivity
As shown in Table 5.4, IS and IR were estimated by Matsuda Index and 
HOMA-IR (Matsuda & DeFronzo, 1999; Wallace et ah, 2004; Matthews et ah, 
1985; Levy et ah, 1998). Estimated HOMA-IR was not significantly different 
among treatments (p=0.S7). Similarly, no significant difference in Matsuda 
Index scores was observed among treatments (p=0.90). The insulinogenic index 
and disposition index were also estimated but again, no significant different was 
observed between the Fen, FenCa, Ca or PL supplements (p=0.50, p= 0.42, 
respectively).
Table 5.4 Insulin sensitivity after consumption of either Fen, FenCa, Ca or PL, (n=10). Comparisons were 
carried out by one-way ANOVA.
Fen FenCa Ca PL
P
Mean SEM Mean SEM Mean SEM Mean SEM
Matsuda Index 13.8 2.31 14.6 2^6 12.3 2.19 13.2 1.98 NS
Insulinogenic Index 1.3 0.46 1.0 0.18 0.9 0.11 1.9 0.90 NS
Disposition Index 15.8 5^3 16.3 4.56 10.3 2.09 30.5 17.22 NS
HOMA IR 1.2 0.26 1.1 0.23 1.2 0.26 1.0 0.18 NS
228
Najlaa Al-Mana Thesis
5.8.1.4.5 GLP-1 Response
The mean plasma GLP-1 response following consumption of Fen, FenCa, Ca, 
or PL is shown in Figure 5.8. Repeated measures two way ANOVA showed a 
significant treatment effect (p<0.001) and treatment*time effect (p=0.002). Post 
hoc analysis by Bonferroni correction method indicated this to be due to a 
significant treatment effect of the Ca supplement (p=0.05). The peak for plasma 
GLP-1 response occurred at 30 minutes post-breakfast after consumption of the 
preload containing Ca, while the nadir point occurred at 90 minutes after 
consumption of the preload with Fen, (Figure 5.8).
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Figure 5.8 Postprandial plasma GLP-1 concentrations after consumption of fenugreek (Fen), fenugreek 
and Ca (FenCa), or Ca compared with placebo (PL). Values represent means ± SEM (n=10). A significant 
treatment effect (/?<0.001) and treatment*time effect (p=0.002). Ca supplement ingestion led to a significantly 
lower GLP-1 response (Treatment ^ =0.05). Comparisons made with repeated measures two-way ANOVA.
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5.8.1.4.6 Test Meal
The mean energy intake of the ad libitum test meal at the end of the 3 hour 
postprandial period is shown in Figure 5.9. The energy intake at the ad libitum 
test meal was lower after consumption of all pre-load beverages compared with 
placebo. Mean (SEM) intake at the ad libitum luneh was 1122 (66.98) kcal, 908 
(32.18) kcal, 976 (27.64) kcal, and 1006 (43.80) kcal for placebo. Fen, FenCa, 
and Ca pre-load beverages, respectively. One-way ANOVA showed a 
significant treatment effect on energy intake (p=0.01). Post hoc analysis by 
Bonferroni correction method revealed this to be due to a significant treatment 
effeet of Fen compared with placebo where the energy intake dropped by 214 
kcal (908 (SEM 32.18) kcal versus 1122 (SEM 66.98) kcal; jf?=0.030).
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Figure 5.9 Energy intake at the ad libitum test meal at 3 hours postprandial where subjects consumed 
fenugreek (Fen), fenugreek and Ca (FenCa), Ca or placebo (PL). Values represent means ± SEM (n=10). 
Fen supplement ingestion led to significantly lower energy intake (/?=0.03). Comparisons made with one-way 
ANOVA.
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5.8.1.4.7 24 hour intake
After consumption of a preload drink containing Fen, FenCa, or Ca, the energy 
intake was not significantly different compared with placebo over a 24 hour 
period (p=0.65). Table 5.5. In addition, the effect of Fen, FenCa, or Ca on 
protein, carbohydrate, fat, and fibre intakes was not significantly different to 
placebo (protein p=0.522, carbohydrates, p=0.622; fat, />=0.583; and fibre, 
j9=0.110, respectively). As expected, Ca intake was significantly higher in those 
receiving Ca supplementation as a direct result of the Ca supplement (p<0.001)
Table 5.5 24 hour intake following supplementation with either Fen, FenCa, Ca, or PL, (n=10). 
Comparisons made with one-way ANOVA
Fen FenCa Ca PL
P
Mean SFM Mean SFM Mean SFM Mean SFM
Energy (Kcal)
3153.4 303.07 2835.9 108.24 3111.0 266.80 3255.9 254.22 NS
Protein (g)
109.3 13.39 92.1 4.90 109.8 10.16 102.2 7.20 NS
Carbohydrate
(g)
459.5 43.53 419.2 15.58 489.9 41.64 488.7 39.91 NS
Sugar (g)
142 9.67 146 9.04 146 9.46 152 12.87 NS
Fat (g)
94.2 9.77 80.7 5.47 92.9 9.34 95.3 8.21 NS
Fibre (g)
25.3 1.83 21.3 0.67 18.9 2.14 21.6 2.09 NS
Ca (mg)
835.2 113.91 1238.1 47.00 1361.8 105.91 862.9 88.22 p<0.001
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5.8.2 Secondary Outcome: Effects of Acute Ca Intake
A secondary hypothesis to this chapter was that acute intake of calcium per se 
would affect food intake and qualitative sensations of appetite and so the 
calcium versus placebo data has been looked at in isolation, in order to compare 
with the limited literature available of this topic.
5.8.2.1 Palatability
Mean VAS scores regarding the pleasantness and the palatability of the preload 
drink containing either Ca or PL at the breakfast meal are shown in Figure 5.10 
and Figure 5.11, respectively. Ratings indicated that the pleasantness and 
palatability did not significantly differ from placebo (p= 0.61 and p= 0.16, 
respectively by one-way ANOVA).
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Figure 5.11 VAS ratings regarding the 
pleasantness of the preload drink, in answer to 
“How pleasant is the taste of this drink right 
now”? No significant difference was observed for 
Ca versus PL supplements on the pleasant of the 
taste of the preload drink was found at the 
breakfast {p= 0.61). Analyses were carried out 
using one-way ANOVA. Values represent means ± 
SEM, (n=10).
Figure 5.10 VAS ratings regarding the 
palatability of the preload drink, in answer to 
“How palatable is this drink right now”? No
significant difference was observed for Ca versus 
PL supplements on the palatability o f the preload 
drink was found at the breakfast {p= 0.16). 
Analyses were carried out using one-way 
ANOVA. Values represent means ± SEM, 
(n=10).
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5.S.2.2 Subjective Appetite Ratings
5.8.2.2.1 Prospective food consumption
Consumption of a standard breakfast containing the Ca supplement significantly 
reduced prospective food consumption compared with placebo (treatment, 
j[?=0.012) by repeated measure ANOVA. Prospective food consumption reduced 
after the preload test beverage containing Ca, reaching the nadir point at 30 min 
(Figure 5.12). Participants felt they could eat less after Ca consumption 
compared with placebo. However, no significant interaction for treatment*time 
was found.
S.8.2.2.2 Hunger
The subjective appetite ratings measured by VAS revealed a trend towards a 
significant treatment effect on hunger (p=0.07) and a significant treatment*time 
effect (p=0.05). Following breakfast with Ca preload beverages, participants felt 
less hungry at 90, 120, and 150 minutes compared with placebo (Figure 5.12).
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S.8.2.2.3 Desire to eat sweet foods
A standard breakfast containing a drink fortified with Ca decreased the desire to 
eat sweet foods compared with placebo (treatment effect, (p=0.04)). Desire to 
eat sweet food was lower after consumption of Ca preload beverages, reaching 
the nadir point at 30 min (Figure 5.12). Participants recorded a lower desire to 
eat something sweet following a Ca preload drink than placebo. However, no 
significant interaction was found for treatment*time for the desire to eat sweet 
food (p=0.87).
S.8.2.2.4 Desire to eat savoury foods
Analyses for the subjective appetite ratings for the desire to eat savoury foods 
indicated a trend towards a significant treatment effect (p=0.06). Desire to eat 
savoury food was lower after consumption of the Ca preload drink compared 
with control, with the nadir point occurring at 30 min (Figure 5.12). However, 
no significant interaction was found for treatment*time for the desire to eat 
savoury (p=0.26).
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Figure 5.12 subjective appetite ratings following Ca (green), PL (purple), in response to the 
questionr(a) “How much you can you eat”? , (h) “How hungry do you feel?”, (c) “would you like to 
eat something sweet?”, (d) “would you like to eat something savoury?”. Values represent mean ± 
SEM (n = 10). Repeated measures ANOVA show for (a) significant effect o f treatment (/?=0.012), for (b) 
a trend to significant treatment effect (p=0.07), and a significant treatment*time effect (/?=0.05), for (c) a 
significant treatment effect (/?=0.04) and for (d) a trend towards a significant treatment effect (p=0.06).
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S.8.2.3 Metabolite analysis
5.8.2.3.1 Plasma glucose response
Repeated measures two-way ANOVA revealed no significant differences in the 
postprandial glycaemic response between the Ca and placebo supplements. 
Furthermore, no significant treatment*time effects were observed, (treatment 
j9=0.87, treatment*time j9=0.21), (data not shown).
S.8.2.3.2 Insulinaemic response
Insulin response was slightly higher at 90 minutes and then increased towards 
the end of postprandial at 150 minutes compared with placebo. However, no 
significant effect of ingestion of Ca-infused preload drink on plasma insulin 
levels (treatment /?=0.18) versus control. Following breakfast with Ca preloads 
also no significant treatment*time was observed (p=0.70), (data not shown).
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S.8.2.3.3 TG response
Repeated measures two-way ANOVA showed a significant treatment*time 
effect of the Ca supplement compared with placebo (p=0.01). There was a trend 
to significantly lower plasma TG levels following ingestion of Ca at the 
breakfast meal at 90, 120, 150, and 180 minutes versus control (time,/?= 0.07), 
reaching the nadir point at 150 minutes. However, no significant effect for 
treatment was observed (treatment,/>= 0.64), (data not shown).
5.8.2.3.4 Insulin sensitivity
Estimates of IS and IR were made by Matsuda Index and HOMA-IR methods, 
respectively. There was no significant difference in Matsuda Index between the 
Ca preload drink and placebo (p=0.75). Estimation of HOMA-IR also indicated 
no significant differences between Ca preload drink and placebo (p=0.46). In 
addition, the insulinogenic index as a surrogate index of the early-phase of 
insulin release was estimated and was not significantly different between Ca 
and placebo (/?=0.26). The disposition index was used as a measure of p-cell 
response to insulin sensitivity and again, there was no significant difference 
between the two treatments {p= 0.23) (data not shown).
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5.8.2.3.S GLP-1 response
The mean postprandial plasma GLP-1 response following consumption Ca or 
PL is shown in Figure 5.13. Acute consumption of the Ca preload drink 
resulted in a significant reduction in GLP-1 response compared with placebo 
(Treatment effect,/>=0.01). In addition, a significant treatment*time interaction 
was observed after ingestion Ca compared with placebo (p<0.001). GLP-1 
responses slightly increased at 60 minutes following breakfast then reduced to 
below placebo levels at 120, 150, and 180 minutes.
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Figure 5.13 Postprandial plasma GLP-1 concentrations after consumption of Ca compared with placebo 
(PL). Values represent means ± SEM (n=10). Ca supplement ingestion led to lower GLP-1 response (Treatment 
effect,/7=0.01 and treatment*time /?<0.001). Comparisons made with repeated measures two-way ANOVA.
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S.8.2.4 Test meal
The consumption of a Ca preload drink with breakfast resulted in a significant 
acute reduction in energy intake at the ad libitum lunch meal compared with 
placebo, (p=0.017). Following consumption of the Ca preload, participants 
consumed 116 kcal less than those who received placebo (1006 (SEM 43.8) 
kcal versus 1122 (SEM 66.98) kcal, respectively). Analyses were conducted 
using paired sample t-test (Figure 5.14).
1400 -
1200 -
« 400
B PL 
M Ca
PL Ca
Time (min)
Figure 5.14 Energy intake the ad libitum test meal after 3 hours postprandial. Values represent means ± 
SEM (n=10). Ca supplement ingestion led to significantly lower energy intake versus placebo (PL) (p=0.017). 
Comparisons made with paired sample t-test.
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S.8.2.5 24 hour intake
The energy intake following the preload drink supplemented with Ca did not 
differ significantly during the 24 hour period compared with placebo (p=0.93).
In addition, Ca supplementation had no significant effect on protein, 
carbohydrate, fat, or fibre intakes compared with placebo (p=0.36, p=0.86, 
p=0.97, p=0.5I, respectively). However, as expected, Ca intake was 
significantly higher as a direct result of ingesting the Ca supplement (p=0.002) 
(data not shown).
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5.8.3 Secondary Outcome 2: Does adding Ca to fenugreek fibre provide 
added benefit?
The present section was designed to investigate the additive effect of combining 
fenugreek fibre with Ca into a preload drink. Despite the beneficial effects 
found with calcium alone, analysing the data resulted in no significant effect of 
the combination FenCa compared with fenugreek fibre only. No added benefits 
for adding the two components together were found.
No significant treatment differences were observed in self-reported means, peak 
or nadir times for hunger, desire to eat, prospective food consumption, or 
fullness ratings over 3 hours postprandial between FenCa compared with Fen 
(Figure 5.4, 5.3). Furthermore, energy intake at the ad libitum meal was not 
further reduced when using the combined supplement, with no differences 
found between the test pre-load drinks (Figure 5.9). Similarly, following the 
breakfast with the FenCa pre-load drink, the daily energy and macronutrient 
intake did not differ compared with Fen (908(SEM 32.18) kcal versus 976 
(SEM 27.64) kcal, (p=0.6)) respectively. When developing the pre-load drinks, 
the goal was to match them on the palatability and pleasantness scales. The 
palatability and pleasantness of the drinks were similar, which indicate a lack of 
additive treatment effect.
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Repeated measures two-way ANOVA was carried on all postprandial values for 
plasma glucose, insulin, TG, and GLP-1 and revealed no differences between 
treatments (Figures 5.5, 5.6, 5.7 and 5.8). Likewise, estimation of IS and IR was 
not significantly different between FenCa and Fen. Consequently, the 
insulinogenic index (as a surrogate index of the early-phase of insulin release) 
and the disposition index (as a measure of p-cell response to insulin) were been 
determined. There were no significant difference in these indices s between the 
FenCa and Fen pre-load drinks (Table 5.4).
The present study does not support the superior efficacy of a combined 
fenugreek fibre and Ca supplement used in beverages for appetite control 
compared with fenugreek alone.
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5.9 Discussion
The present investigation demonstrates the acute effect of consumption of 
fenugreek fibre (Fen), a combination of fenugreek and calcium (FenCa) and 
calcium (Ca) alone compared with placebo (PL) in overweight/obese females. 
In this study we incorporated each supplement into orange juice and serve it 
with breakfast meal.
5.9.1 The effect of Fenugreek fibre, calcium, combination of fenugreek and 
calcium vs. Placebo
The present investigation found that consumption of 6g of fenugreek fibre with 
the breakfast meal reduced energy intake significantly at an ad libitum meal and 
improved the glucose response in overweight/obese women compared with 
either calcium, combination calcium with fenugreek or placebo.
Our finding regarding the acute effect of fenugreek enriched drink on reducing 
energy intake at ad libitum meal is in line with previous work that reported 
reduced short-term energy intake after ingestion of 8g of fenugreek fibre 
compared to 4g or Og in obese men (Mathem et al., 2009). We used 6g of 
fenugreek and it was effective in reducing food intake. The reduction in energy 
intake observed in the present study after fenugreek could be explained by the 
presence of the viscous fibre in the fenugreek.
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Increased meal viscosity has been suggested to slow gastric emptying time, 
reduce gut motility and hence reduce the rate of nutrient absorption from the 
small intestine which inhibit the absorption of glucose and reduces appetite due 
to increased feelings of subjective fullness (Slavin & Green, 2007; Hannan et 
al., 2003). Indeed, fenugreek galactomannan has been shown to slow gastric 
emptying in animals (Hannan et al., 2007). However, our data showed that 
fenugreek fibre had no effect on GLP-I and did not reduce the glucose response 
as would have been expected because having four groups, rather than just two 
may result in reduce the power, thus the subsequent reduction in food intake is 
unlikely to be affected solely by the fibre viscosity.
Interestingly, the present study actually found that following consumption of 
fenugreek fibre the plasma glucose levels was elevated after breakfast, 
compared to the placebo, and remained above fasting levels by the end of the 3h 
postprandial period. This finding, combined with our reduction in food intake 
is more consistent with glucostatic theory of food intake regulation being a 
potential mechanism (Mayer, 1953). The theory hypothesizes that any reduction 
in blood glucose can activate the ‘feeding centre’ located in the lateral 
hypothalamic area (LHA) in the brain, and increases the food intake. Thereafter 
post-prandial hyperglycemia can also stimulate the “ satiety centre” in the 
ventromedial hypothalamus (VMH) in the brain, which increase satiety by
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inhibiting the ‘feeding centre’ terminating the meal (Levin et aL, 2006; Chaput 
& Tremblay, 2009a).
Another possible mechanism for the effect of glucose on food intake is the 
glycaemic index (GI) of the test meal (de Graaf et al., 2004). Evidences have 
shown that lower-GI foods may lead to more stable pattern of glucose 
concentrations, increased satiety and reduce energy intake (Brand-Miller et al., 
2002). Low-GI foods slower the rate of glucose absorption following a meal 
which prolonged the feedback to the satiety centre in the brain via signals such 
as cholecystokinin and GLP-1 (Lavin et al., 1998; Chaput & Tremblay, 2009b). 
It has been shown that mixed meals with low GI increase cholecystokinin 
release, which increase satiety over a 3hours period and reduce energy intake 
(Holt et al., 1992) Therefore, as fenugreek fibre has been shown to have 
lowering effect on GI, hence this may explain the effect on food intake and 
satiety observed.
Although an acute effect of fenugreek was found during the energy intake at the
ad libitum meal, this effect did not last; in fact, 24h intakes between the
fenugreek and placebo meals were non-significantly different indicating that
after fenugreek, participants may have compensated with increased energy
expenditure later in the day. This highlights the beneficial effect of fenugreek
on appetite regulation in the short-term/single-meal basis only and so may prove
to limit its usefulness in terms of obesity prevention/treatment.
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The present study found that consumption of fenugreek fibre did not affect the 
insulin response in overweight and obese women when compared to the 
placebo. Although our results indicate an increased insulin response after 
fenugreek fibre at the end of the postprandial period (150,180 minutes), this was 
not significant. Since fenugreek fibre contains 4-hydroxyisoleucine, a free 
amino acid that has been known to increase insulin secretion in animal models 
(Broca et al., 2004), an effect may have been expected. An increase in insulin 
response has previously been observed after consumption of 8g of fenugreek 
fibre in obese subjects (Mathem et al., 2009). Thus, 8g of fenugreek seems to be 
threshold for a significant increase in insulin response in obese subjects, as in 
the current study, 6g had no effect.
The present study found a significant treatment effect and treatment time effect 
on the GLP-1 response between treatment groups. Although, the effect of 
fenugreek fibre on plasma GLP-1 was not statically significant after applying 
post hoc analysis, GLP-1 concentrations increase after consumption fenugreek 
fibre but then reduced, and at the end of the postprandial (150,180 minutes) 
decreasing below baseline. Our finding is in line with a previous study that 
showed a reduction in GLP-1 concentrations below fasting levels after ingestion 
of a mix of viscous fibre and protein (psyllium 23g,soya 18.4g) (Shirani & 
Ganesharanee, 2009). Fenugreek fibre contains protein (25-30%), although as
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we used extract of fenugreek that contained little amount of protein (0.18g), 
thus this is unlikely to be of relevance.
5.9.2 Calcium enriched preload drink compared with placebo
The current investigation has shown that calcium enriched drink 
supplementation reduced energy intake at ad libitum meal and gave lower 
subjective appetite ratings and reduce GLP- response after breakfast in 
overweight/obese women.
Ingestion of calcium-enriched drink led to reduction in energy intake at ad  
libitum (p=0.017) compared with placebo. However, this reduction of energy 
intake was not maintained for the whole 24-h period although the total calcium 
intake over this period differed significantly between the treatment groups. This 
finding indicates that acute calcium intake plays a role on the short-term satiety, 
however the total intake over a 24h period did not show such a relationship.
To our knowledge this is the first study that has examined the acute effect of 
calcium supplementation per se on appetite regulation in overweight /obese 
females. Few studies have investigated the role of dairy calcium on appetite 
regulation and food intake and have found conflicting results (Gonzalez et al., 
2013; Lorenzen et al., 2007; Ping-Delfos & Soares, 2011). Although some of
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these investigations have reported that a high-calcium meal from a dairy source 
resulted in a reduction in the energy intake at a buffet meal and over 24 hours 
(Ping-Delfos & Soares, 2011), others have indicated no significant changes in 
energy intake or appetite sensation ratings (Lorenzen et ah, 2007). However, 
importantly, these studies were looking at the effect of the dairy calcium, or 
diary calcium/supplement combined with vitamin D, which may affect the 
findings and confound the results with the bioactive component of the dairy 
(protein, probiotics etc) and vitamin D, that may have different or 
complementary effects.
The present investigation found that incorporation of 500 mg of calcium into 
orange juice influenced subjective appetite ratings compared with placebo. The 
calcium enriched drink lowered feelings of prospective food consumption 
(treatment p=0.01), reduced feelings of hunger (treatment p=0.07, 
treatment*time p=0.05), reduced desire to eat sweet (treatment ^=0.04) and a 
trend to decrease desire to eat savoury (p=0.06). Our finding is in line with 
recent study, which show reduction in appetite sensation following calcium 
consumption. Gonzalez and colleagues (2013) have shown that consumption of 
meal containing dairy calcium increases feelings of fullness (Gonzalez, 
Rumbold, & Stevenson, 2013). However, this study was an exercise study in 
physically active males and so again, interpretation of the data is confounded by
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the effect of exercise on satiety rather than the potential effect of calcium per se 
on appetite and satiety.
Several potential explanations can be put forward as to why the calcium 
enriched drink could have suppressed appetite and energy intake in this study. 
The reduction in energy intake could be as a result of ‘calcium-specific 
appetite’ control. This hypothesis was previously proposed by Tordoff (2001), 
which suggests that Ca-deficient animals would tend to increase their 
consumption of Calcium-rich beverages (Tordoff, 2001). This hypothesis may 
explain the relationship between calcium intake, appetite ratings and food 
intake. However, the mechanism by which dietary calcium may affect food 
intake and appetite regulation is still unknown. It is possible that calcium 
influences hormonal responses such as GLP-I (Teegarden et al., 2008). 
Evidence from rodent models have shown that changes in intracellular calcium 
levels may be linked to GLP-I release in endocrine L-cells through calcium 
sensing receptors (Mace et al., 2012). Therefore, it has been suggested that 
calcium intake increases the calcium concentrations in the K-and L-cells and 
lead to increase GLP-I (Gonzalez & Stevenson, 2013), however our data is 
inconsistent with this proposed mechanism.
The present study found that calcium enriched drink actually lowered the 
postprandial GLP-I curve, GLP-1 slightly increased after the breakfast and then
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reduced. To our knowledge only two studies investigated the effect of calcium 
intake on GLP-1 and have inconsistent results. Lorenzen and collegeues (2007) 
found no effect on GLP-1, while Gonzalez and Stevenson (2013) found 
increased in GLP-1. It is entirely possible that the meal size explains the GLP-1 
differences in these studies. In the first study, the high energy content of the test 
meal resulted in an increase in the hormonal distraction which masked the 
findings and no significant effect on GLP-1 was reported (Lorenzen et al., 
2007). On the other hand, Gonzalez and Stevenson (2013) reduced the energy 
contents of the test meal which resulted in higher calcium concentrations in the 
gastrointestinal tract and thereby increased in GLP-1 was observed. Therefore, 
it is possible that we might need to give test meal lower in energy to observe an 
effect of calcium intake on GLP-1.
Our data indicates no significant effects of calcium supplementation on either 
insulin or glucose response. Our finding is in line with previous work which 
reported that supplementation with calcium alone did not have any significant 
effect on glycaemia, whilst the combination of vitamin D and calcium improved 
pancreatic beta cell function (Mitri et al., 2011).
In the present study, the calcium enriched drink resulted in reduction in TG 
levels in overweight and obese female compared with placebo. However, this 
reduction was small with no peak of TG, which is not surprisingly as our
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breakfast meal was low in fat. Thus, in the future to investigate the potential 
effects of calcium on postprandial lipid metabolism we would need to combine 
with a high-fat meal, with the concomitant measurement of both chylomicron 
and VLDL-TG levels. It has been suggested that increasing intracellular 
calcium levels would promote triglyceride storage in adipocytes by activation 
of either receptor or calcium channels that stimulates expression and activity of 
fatty acid synthesis (FAS) which inhibit lipogenesis and stimulate lipolysis 
(Zemel et al., 2000).
5.9.3 Fenugreek and calcium preload compare with fenugreek preload 
alone
The present study reported data testing the acute effect of ingestion a 
combination of fenugreek fibre and calcium compared with fenugreek fibre 
only drink on food intake and satiety in overweight/obese women. In this study 
6g of fenugreek fibre and 500 mg of calcium were chosen to enable a 
combination of fenugreek fibre and calcium to be incorporated into orange 
juice. To our knowledge this is the first study investigate the effect of the 
combination of fenugreek fibre and calcium enriched drink on appetite.
The enriched beverage was specifically designed to enhance satiety by mixing
the gel forming properties from the viscous fibre and the addition of the
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calcium. Individually, and as discussed previously, both the fenugreek and the 
calcium independently have been shown to increase satiety and reduce food 
intake. We hypothesized this drink may give an additive effect on satiety and 
appetite compared to the only fibre drink.
In the present study, our results were clear and no significant treatment 
differences were observed in subjective appetite ratings, food intake, glucose, 
insulin or GLP-1 over 3 hour postprandial period. In addition, 24-hour energy 
intake did not differ between the two supplementations. All these negative 
findings would lead us to reject the hypothesis that a fibre and calcium enriched 
drink would give an additive effect and in future may require more 
consideration about either the dose, type of fibre and/or methodology.
Dietary fibre has been suggested to inhibit calcium absorption (Heaney et al., 
2003, 1990; Guéguen & Pointillart, 2000). A possible explanation for the 
absence of an additive effect in the combination drink could be mediated by the 
presence of phytic acid in the fibre and potential inhibitory effects on calcium 
bioavailability. The phytate can form insoluble complexes with calcium, thus 
reducing in vivo absorption. For example, consumption of 1-30 g/day of wheat 
bran fibre that also contains phytic acid has been estimated to reduce calcium 
availability by 6-10% (Weaver, 1998).
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However, some types of dietary fibres have been shown to enhance the 
absorption of calcium (Flamm et ah, 2001). For example, indigestible but 
fermentable carbohydrates including RS or oligosaccharides and inulin, has 
been shown to increases calcium absorption in animals (Demigné et al., 1989; 
Ten Bruggencate et al., 2004; Bhide et al., 2013). SCFA produced by the 
microbial fermentation can decrease the pH of the luminal contents and thus 
increase the calcium solubility. In animal, fermentation results in enlargement 
of the caecum and colon, which increases the absorptive area and can increase 
calcium absorption (Mineo et al., 2001). Whether this is relevant for humans 
though is unknown. Therefore, to take this forward, we might need to use a 
fermentable carbohydrate combined with calcium to have an additive effects 
without any inhibitory impacts on calcium absorption potentially caused by 
phytate. However, it would not be expected to produce immediate effects on 
calcium absorption as they rely on changes to the intestinal flora thereby these 
effects could be achieved only in the long-term consumption.
Calcium solubility is an important factor that has been suggested to effect
calcium absorption (Guéguen & Pointillart, 2000; Heaney et al., 1990).
Therefore, the suggested mechanism to enhance calcium absorption is to
prevent the formation of insoluble calcium phosphates in the gut. In the present
study, we used Calcium Sandoz Syrup which contains calcium glubionate and
calcium lactobionate that have been widely used in food fortification, are freely
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soluble and well tolerated (Bushinsky & Monk, 1998; Keating, 1998; Weaver & 
Heaney, 2006). It has been estimated that calcium glubionate has an absorption 
efficiency of 36.8% compared with calcium citrate 37.9%, therefore it is 
unlikely that the lack of the effect o f the combined drink in the present study 
was related to the calcium solubility (Weaver & Heaney, 2006).
Another factor that has been proposed to affect calcium absorption is the load of 
the meal, which is inversely correlated to the absorption. As a result, divided 
doses throughout the day will provide more absorbable calcium than a single 
large dose (Weaver, 1998). Therefore, we might need to give the calcium in two 
doses to increase the calcium absorption.
The current study presented some novel findings that a combination of the 
fenugreek fibre and calcium enriched drink does not promote satiety compared 
to fenugreek enriched drink and did not produce any additive effect. Further 
research may require to test different fibre/calcium combination that might 
produce better understanding of the effect of satiety enhancing beverages on 
appetite and satiety both in short and long term which may help the consumers 
to promote their energy intake and thus optimising successful weight control.
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5.10 Limitations
The present study was a controlled study in which we changed one factor only; 
the type of nutrient provided either the calcium or the fibre. The test breakfast 
was equivalent for all subjects except for the type of the supplement given. 
Despite attempts to conduct this study carefully, this was a pilot study with 
several limitations.
The primary limitation of this study was the small sample size, which may not 
allow firm conclusions about the effect of GLP-1 on appetite. Therefore, a 
cause and effect relationship may not be assumed. In addition, gender 
differences in satiety responses have also been noted in previous studies. Our 
study included only young women and that may limit the ability to generalise 
the finding to men.
One limitation of the study was the effect of hormonal variations through the 
menstrual cycle. However, participants who were not using contraceptive 
methods that regulate hormone levels were informed to attended at the same 
point in their menstrual cycle (luteal phase) for each visit in order to control the 
hormonal fluctuation.
Another limitation is the short duration of this study, making it only possible to
investigate the acute effect of these supplements on appetite. Therefore, further
studies are needed to investigate the long-term impact of fenugreek and calcium
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on appetite and satiety. Larger scale studies are required to investigate the effect 
of Ca enriched drink on appetite regulation and fat metabolism and to see the 
effect on chylomicron and VLDL levels.
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5.11 Conclusion
Overall, there was a greater reduction in food intake after consumption 
fenugreek enriched drink and this was accompanied by increased stability in 
glucose levels. In addition, calcium enriched drink caused a reduction in dietary 
intake and this was in agreement with the effects on subjective appetite 
sensations measured with VAS, which could be beneficial in weight 
management. Also calcium enriched drink reduced TG and GLP-1. The effects 
on TG may suggest a decrease in fat absorption or lipoprotein secretion by the 
liver. However, no significant differences were found between both fenugreek 
and calcium fibre combination. Thus, our hypothesis that combining calcium 
and fenugreek fibre will produce an additive effect was rejected.
Together, these acute effects provide some confirmation of the effect of dietary 
fibre on appetite regulation and suggest that dietary fibre may not necessarily 
act via increased secretion of GLP-1. Previous research on the relationship 
between fibre and GLP-1 is inconsistent due to differences in population 
groups, the study design, the way fibre is administrated (liquid, solid, semi 
solid) and the dose used in these studies. The acute effect of calcium enriched 
drink on energy intake and appetite observed in this study may confirm the 
importance of the ‘calcium appetite’ control theory. Further studies are
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required to determine the mechanisms for the effect of calcium supplementation 
on food intake and appetite regulation.
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Chapter 6 Association between dietary calcium intake and body 
composition in pre- and post menopausal UK South Asian women
6.1 Introduction
The prevalence of obesity has been suggested to be a result of the dietary habits 
(Byers & Sedjo, 2007). Dietary calcium may play a crucial role in bone health 
and is involved in vascular contraction and vasodilatation, muscle contraction, 
neural transmission and glandular secretion (Otten et al., 2006). Evidence has 
shown the beneficial effects of calcium on metabolic syndrome, hypertension as 
well as the control of body weight (Torres et al., 2011, 2010). A recent study 
has shown that daily calcium intake in different countries did not meet the 
current recommendation of this nutrient (Rodriguez-Rodriguez et al., 2010).
In recent years, data has suggested that body weight may be affected by the 
food intake and food composition, which include macronutrients as well as 
other micronutrients such as calcium (Trowman et al., 2007; Zemel et al., 
2004). Some clinical and epidemiological investigations have shown an inverse 
association between calcium intake and body mass index (BMI) (Zemel et al., 
2000, 2004; Lin et al., 2000; Davies et al., 2000). Whereas others have not 
found this relationship between calcium intake and body composition or body 
weight (Boon et al., 2005, 2007; Winzenberg et al., 2007; Michael B Zemel et 
al., 2005).
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NHANES-I data analysis have reported previously, a negative relationship 
between calcium intake and body fat gain (McCarron et ah, 1984). Further 
analysis of the NHANES-III database has confirmed that body mass index was 
negatively associated with calcium intake (Zemel et al., 2000). A re-analysis of 
observational trials has indicated that calcium intake is inversely correlated with 
body weight (Davies et al., 2000). In this study, an increase in daily calcium 
intake by 300 mg was associated with a reduction in body weight (Davies et al., 
2000). In addition, it has been demonstrated in the CARDIA study, an inverse 
relationship between the consumption of calcium or dairy and obesity and 
insulin resistance (Pereira et al., 2002). Animal studies also have shown that 
ingestion of calcium resulted in a reduction in body weight (Shi et al., 2001; 
Bursey et al., 1989).
The mechanism of the effect of calcium on obesity is still not clear. However,
Zemel and colleagues (2000) proposed a mechanism that may explain this
correlation. They suggest that an increase in the consumption of dietary calcium
may lead to reduction in intracellular calcium [Ca2+], thus increasing lipolysis
(Zemel et al., 2000). However, lower calcium intake may stimulate the blood
parathyroid hormone (PTH) and 1,25 -dihydroxyvitamin D concentrations and
may lead to increase in intracellular calcium [Ca2+] concentrations in human
adipocytes, which may increase the lipogenesis (Zemel et al., 2000; Shi et al.,
2000). It has been suggested that 1,25(OH) 2D, and PTH have been correlated
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positively with body weight (Landin-Wilhelmsen et ah, 1995). Therefore, the 
risk of obesity in individuals who have lower dietary calcium intake may 
mediated by the relation between serum PTH and l,25(OH) 2D concentrations 
which are regulated by calcium intake (Varenna et ah, 2007). Another potential 
mechanism that calcium may stimulate increased faecal energy losses by the 
formation of nonabsorbed calcium and fat complexes (Jacobsen et ah, 2005).
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6.2 Aims:
The principal aim of the present study was to examine the association between 
daily calcium intake, body composition and body mass index in both 
premenopausal and premenopausal UK South Asian women. The specific 
objective was to determine if lower calcium intake in dependent age women of 
South Asian origin was associated with a higher body weight, body mass index 
and waist to hip circumference.
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6.3 Materials and Methods
6.3.1 Purpose of the original DFINES study
The purpose of the D-FINES study was to investigate the interaction between 
dietary intake and sunlight exposure on vitamin D status in Caucasian and 
South Asian women.
6.3.2 Ethical Approval for the study
The D-FESfES study was conducted according to the guidelines laid down in the 
Declaration of Helsinki, and all procedures involving human subjects were 
approved by Ethical Approval from South-West Surrey Local Research Ethics 
Committee (SWSLREC) (06/Ql909/1), the University of Surrey’s Ethics 
Committee (EC/2006/19/SBMS), followed by Ethical Approval from the NHS 
PCT (06/Q1909/1).
6.3.3 The D-FINES study participauts selectiou
Random sampling from 12 GP surgeries in the Surrey area was obtained to
ensure a representative sample from the local female population in the south of
England. GPs were asked to provide a list of Asian women aged 19-40 years
and 55 to 70 years on their database, who were not suffering from any condition
or taking medication likely to affect their bone metabolism. The exclusion
criteria list was provided. The Asian women recruited on the current study were
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of South Asian origin (75% partly-veiled Pakistani women with the other 25% 
being made up of Indian and Bangladeshi women).
However, the lack of response from subjects through GP’s lead the investigator 
of D-FINES study to contact the local Asian networks which include the 
Woking Asian Women’s Association (WAWA); the Khidmat Group, Woking; 
the Islamic Resource Centre (IRC) in Kingston; The Guildford Asian Society; 
and the Thornton Heath Asian Society. A total of 96 Asian women were 
recruited at the start the study and 70 South Asian women remained at the end 
of the 12 months period. The study power required to show a 0.6 SD size effect 
of a change in vitamin D status was 28 premenopausal South Asian women and 
28 postmenopausal South Asian women for 90% power (n=56) and 21 subjects 
per group for 80% power (n=42 total). In addition, a further 45% were initially 
recruited to allow for drop-outs (n=26 total, n=13 premenopausal and n=13 
postmenopausal). At baseline, a total of 96 women were recruited to allow for 
any additional increases in drop-out. In the end, these were not required and a 
total of 70 South Asian women completed the study.
The mean age of the premenopausal South Asian women was (37.9, 8.9) and 
postmenopausal Asians was (60.1, 5.9). The mean BMI of the premenopausal 
Asians was (26.9, 5.0) and postmenopausal Asians was (30.02, 6.1).
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6.3.4 Selection of data for current study
The data for the current study was obtained from the D-FINES study as detailed 
above. The data from a total of 55 South Asian women are analysed in which 32 
were post-menopausal age (50-77) y and 23 pre-menopausal age (19-40) y. 
These women were chosen as they had completed a full food diary for the 
assessment of the nutrient intake as well as anthropometric measurements. The 
South Asian women represented 78.6% of the South Asian subjects who 
completed the D-FINES study (n=70) and thus represented the South Asian 
cohort well.
The winter 2006 measurements were chosen to represent the time period when 
vitamin D status was least likely to be affected by UVB exposure. An area for 
future research will be to see if these PhD findings are confirmed in another 
season (please see page 267, discussion).
6.3.5 Study Design and Exclusion Criteria
The data in this analysis was obtained from a longitudinal study in which 
women had been asked to attend at the four seasons, only data from winter in 
the year 2006-2007 has been analysed.
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The general exclusion criteria were as follows: steroid use or other medication 
likely to affect vitamin D metabolism or if women had a history of any disorder 
of calcium homeostasis. Also, women who were currently taking vitamin D 
supplements or cod liver oil supplements were also excluded or asked to refrain 
from use 3 months prior to the start of the study.
The bone related medications included in the exclusion criteria were 
(bisphosphonates, oral corticosteroids, being on Selective oEstrogen Receptor 
Modulator drugs (SERMS; e.g. Tamoxifen) or chemotherapy or hormone 
treatments for cancer, or being Hormone Replacement Therapy (HRT) users. 
Also, persons having been diagnosed with osteoporosis or osteomalacia, liver 
disease or poor renal function, severe rheumatoid arthritis, Pagets disease, 
conditions causing gastro-intestinal malabsorption (e.g. coeliac, crohns) or 
untreated thyroid disease were excluded. Pregnant women, or planning for 
pregnancy in near future, or having given birth in the three months prior to 
study, or who were currently breastfeeding also were excluded.
Participants who met the inclusion criteria and were willing to participate in the 
study were invited to attend the Clinical Investigation Unit at the University of 
Surrey (CIU). On the first visit, anthropometric measurements were undertaken 
(weight, height, waist and hip) and a 25 ml fasting blood sample was taken for 
subsequent analysis of vitamin D status, parathyroid hormone, serum calcium.
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6.3.6 Materials
6.3.6.1 Dietary assessment
Participants were given full instructions on how to record their food intake 
properly by using a 4-day estimated EPIC food diary (Welch et ah, 2001). 
Therefore, participants were provided with the food diary which included food 
photographic portion sizes. Food diaries were completed for three weekdays 
and one weekend day. Dietary analysis of energy intake and dietary calcium of 
the diets as well as other micronutrients and macronutrients were examined 
using the WinDiets 2005 software package (The Robert Gordon University, 
Aberdeen, 2005).
Calcium intake was initially presented as crude calcium intake. For example, 
the total amount of calcium consumed in the diet as measured by 4 day 
estimated food diaries. However, this does not adjust for the total amount of 
energy consumed. Calcium intake is positively correlated with energy intake; 
therefore energy intake is a confounder. To take account of this, it is possible to 
adjust for total energy intake in order to reduce the impact of under or over 
reporting and help to control other dietary aspects (Poslusna et al., 2009).. This 
is done by calculating the total calcium intake (in mg) and then dividing it by 
total energy intake (per 1000 kcal) (Willett ,1998). Thus, calcium intake is 
adjusted for energy intake.
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6.4 Statistical Analysis
All statistical analyses were conducted using SPSS for Windows 19.0 (SPSS 
Inc., Chicago, USA). All data are reported as means, standard deviations, 
standard error of means median and interquartile range (IQR). The data were 
checked for normality using Kolmogorov-Smimov test. Weight, height, waist 
circumference, BMI and energy intake in kJ were normally distributed. Age and 
hip circumference were found to be not normally distributed; therefore, non- 
parametric test was used for this data. Due to missing data points the number of 
participants were different in each variable, thus non-parametric test was used 
for all the study analysis. All tests were two-tailed. Statistical significance was 
set at P=0.05 (two-tailed).
Anthropometric measurements, body composition parameters and dietary intake 
data were compared using independent sample t tests. In addition, correlations 
between average calcium dietary intake and BMI as continuous variables were 
assessed by using spearman's rank-order correlation coefficients.
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6.5 Results:
6.5.1 Anthropometric and body composition
Descriptive data for the subjects are shown in Table 6.1. The mean baseline 
anthropometric measurements and body composition in premenopausal and 
postmenopausal women are identified. As expected, there were significant 
differences between groups in the age, BMI and height (p<0.001, />=0.03, 
p=0.005) respectively. A significant difference was also observed in the hip 
circumference (p=0.05). However, no significant differences were found in 
body weight and waist circumference (p= 0.25, p= 0.16, respectively).
The postmenopausal South Asian women were significantly shorter but were 
similar in body weight to the South Asian premenopausal women, which may 
reflect increased BMI in the postmenopausal group. Also, the premenopausal 
women were significantly lower in their hip circumference compared (almost 
6cm) in comparison to the premenopausal South Asian women.
The mean values of the weight of the women in the premenopausal groups was
(67.43, [2.36] kg) and in the postmenopausal women (71.42, [2.36] kg). The
results revealed that there was an increase in body weight with increased age.
However, this was not significant (p=0.25). BMI of the subjects revealed that
the women in postmenopausal group were overweight when compared to an
ideal BMI of <25 kg/m^ (WHO, 2013a). The postmenopausal group had
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significantly higher BMI as compared to premenopausal group (p < 0.05). The 
mean BMI of the women in premenopausal groups and the postmenopausal 
group was 27.0 kg/m^ and 30.0 kg/m^, respectively.
The mean waist circumference of the women in premenopausal groups and the 
postmenopausal group was [89.4 cm], [93.73 cm] respectively. However, no 
significant difference in the waist circumference was found between groups 
(p=0.16). The postmenopausal group had significantly higher hip circumference 
as compared to premenopausal groups. The mean hip circumference of the 
women in premenopausal groups and the postmenopausal group was [104.62 
cm] and [110.05 cm], (p < 0.05), respectively.
Table 6.1 Differences in anthropometric measurements in both premenopausal and postmenopausal 
women.
Pre-m enopausal South A sian W om en  
(n=23)
P ost-m enopausal South A sian w om en  
(n= 32)
Mean SD Median IQR SEM Mean SD Media IQR SEM P
A ge (y) 37.98 8.97 39.00 11 1.28 60.14 5.95 59.00 6 0.89 <0.001
B M I (k g W ) 26.95 5.09 26.78 6.80 0.96 30.02 6.15 29.34 5.72 1.00 0.03
W eight (kg) 67.43 12.79 65.80 16.45 2.46 71.42 14.60 68.00 14.20 2.36 0.25
H eight (m) 1.58 0.05 1.58 0.08 0.01 1.54 0.05 1.54 0.08 0.00 0.005
W C (cm ) 89.40 11.61 88.00 15 2.32 93.73 11.63 93 15 2.02 0.16
H C (cm) 104.62 9.82 104.50 14 1.92 110.05 10.75 107.00 16 1.87 0.05
WCrwaist circumferences, HC:hip cercumferences
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6.5.2 Calcium intake
As can be seen in table 6.2, there were no significant differences in crude 
calcium intake between postmenopausal and premenopausal South Asian 
women, but a trend was observed for a crude calcium intake (p=0.09). 
However, when the calcium was adjusted for energy intake (Ca/perlOOO kcal), a 
significant difference was observed between the two group (p < 0.01). The 
premenopausal women were significantly lower in their calcium intake by 
almost 93.38 mg compared with the premenopausal South Asian women.
Table 6.2 Ca intake in premenopausal women compared with postmenopausal women
Pre-menopausal (n= 23) Post-menopausal (n= 32)
Mean SD SEM Mean SD SEM P
Crude Calcium intake (mg) 688.22 280.15 66.03 820.55 261.20 45.46 0.09
Energy adjusted Ca intake 
(Ca/kcal)
405.22 99.87 23.54 498.60 131.90 22.96 0.01*
*Significant effect
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6.5.2.1 Calcium intake and BMI
Figure 6.1 shows the eorrelation between energy adjusted Ca intake 
(Ca/perlOOO kcal) and the BMI in premenopausal women. A significant 
correlation was found between energy adjusted Ca intake (Ca/perlOOO kcal) and 
the BMI in premenopausal women (n=18,r= - 0.51, ^ <0.03).
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Figure 6.1 The correlation between calcium intake and BMI in premenopausal women
Table 6.3 shows the correlation between energy adjusted for Ca intake 
(Ca/perlOOO kcal) and the anthropometries in premenopausal and 
postmenopausal South Asian women. No significant correlation was found 
between energy adjusted Ca intake (Ca/perlOOO keal) and the body mass index 
(BMI) (n=33, r=-0.178,/?=0.3) in postmenopausal South Asian women.
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Table 6.3 The association between anthropometric and energy adjusted for Ca intake
Pre-menopausal South Asian Women (n=23) Post-menopausal South Aslan women (n= 32)
Ca
adjusted
(perlOOO
kcal)
WT (kg) HT(m) BMI (kgW ) WC HC WT(kg) HT(m) BMI (kg/m:) WC HC
0.03 NS 0.03 NS NS NS NS NS NS NS
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6.6 Discussion
There is a high prevalence of obesity in Asian females with a focus on their 
eating habits and their lower calcium intake. The present study was aimed to 
evaluate the correlation between calcium intake, body composition and obesity. 
Our findings demonstrate that increased calcium intake was inversely associated 
with a reduction in body mass index in premenopausal South Asian women, but 
not in the postmenopausal South Asian women.
A review has shown that both human and animal studies investigating the role 
of calcium intake on body weight have shown inconsistent results (Dougkas et 
al., 2011). This finding was consistent with findings from previous studies. 
Evidences have suggested this relationship standing on an analysis of the 
NHANES III database conducted by Zemel and colleagues (2000) that have 
shown that dietary calcium intake was inversely correlated with body weight 
and the risk of obesity, after adjusting for age, sex, race and energy intake 
(Zemel et ah, 2000). They indicated that a 400-1000 mg/d increase in the 
calcium intake over 1 year may result in a reduction in body fat by 4.9 kg in 
obese African-American men. In another study conducted by Davies and 
colleagues (2000), in which they reanalysed three calcium intake studies, an 
inverse correlation between body mass index and the dietary calcium intake in 
premenopausal women and a significant weight loss in older women was
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reported. They indicated that differences in calcium intake by 1 g was linked 
with a change in body weight by 8 kg (Davies et ah, 2000).
The present study found no differences of crude calcium intake between both 
groups, but when we adjust the calcium for energy intake there was a significant 
differences in the intake between the premenopausal and postmenopausal 
women. We found that the premenopausal women had lower calcium intake 
compared with the postmenopausal women.
It has been suggested that 3% of the differences in body weight may be 
mediated by the calcium intake (Heaney, 2003). An increase in body weight by 
0.4 kg/yr at mid-life has been suggested to be lacking in women with a high 
consumption of dietary calcium (Heaney, 2003). Despite that the 
postmenopausal women group has higher calcium intake, this was not 
correlated with their BMI. It is possible that postmenopausal women may have 
lower calcium absorption. This reduction in calcium absorption in 
postmenopausal women has been shown to be a result of the reduced effect of 
oestrogen on the calcium transport in the gastrointestinal tract (Van Cromphaut 
et al. 2003).
Several mechanisms have been proposed that may explain the effect of dietary 
calcium consumption on BMI and body weight. One possible mechanism that 
may explain the effect of calcium intake on body weight mediated by an
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increased parathyroid hormone and 1,25-Dihydroxyvitamin D levels as a result 
of the lower calcium intake, therefore affect the metabolism of the adipose cell 
to reduce the lipolysis and stimulate the lipogenesis, which leads to increased 
fat storage (Shi et al., 2001; Zemel et al., 2000). Another proposed mechanism 
is that increased calcium intake may result in increased faecal excretion of fat 
either by the formation of insoluble calcium fatty acid soups in the gut or via 
bile acids binding that may lead to impair micelles formation. It is possible that 
after absorption, the fat circulates in the blood in the form of TGL-rich 
lipoprotein (chylomicron). Therefore, it is possible that TGL may reduce as a 
result of inhibition of fat absorption by calcium. However, low intake of dietary 
calcium would be expected to increase TGL, although we did not measure TGL 
to confirm this (Lorenzen et al., 2007; Jacobsen et al., 2005).
Our data have shown that dietary calcium intake is significantly related to BMI 
in the pre-menopausal; however, this relationship does not exist in the 
postmenopausal women. This finding may be explained by the productive age 
or the status of oestrogen in the older women compared with the younger 
women.
There are number of differences between the present analysis and other
was
adiposity measures, we controlled for energy intake as a confounder. Other
investigations. In our study, as the primary outcome of our analysis
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prospective studies did not present body weight as the primary factor and 
examined CVD or type 2 diabetes, hypertension or bone biomarker. Some of 
these studies also investigated the effect of calcium on body weight during an 
energy restricted diet. In addition, these studies did not control for energy 
intake. For example, a study by Zemel and others (2000) investigated the effect 
of dietary calcium on adiposity in obese African-American men, not women. 
Another double -blind study by Shapses and colleagues (2004) investigated the 
effect of calcium on body weight during weight loss in pre-menopausal and 
post-menopausal Caucasian women rather than our South Asian women. It has 
been suggested that the response of body weight to calcium intake may be 
affected by some factors, such as gender and the initial adiposity (Heaney, 
2003). Thus, this may explain the differences in the finding between studies.
The current investigation has a few limitations. Our findings may not be
generalised due to the small sample size, which is not representative of the
overall South Asian Women in the UK. Another limitation is the use of 24 hour
diet diaries, which rely on the individuals self-report and are more likely to have
errors by either underreporting or overestimation of total energy intake.
However, several steps were taken to ensure the accuracy of these diaries using
well-trained dieticians, screening for subjects’ notes and comments, although
the present results may not be affected by this factor, as the dietary calcium was
adjusted for total dietary energy intake.
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The present cohort study has found that consumption of dietary calcium when 
adjusted for energy intake was significantly correlated to BMI in pre­
menopausal women. Therefore, further research are required to confirm the 
effect of calcium on body weight with larger sample size and in another season.
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Chapter 7 General Discussion
The prevalence of obesity has risen globally. It is associated with a number of
chronic disorders, such as cardiovascular disease, hypertension and type 2
diabetes. Obesity-prevention and treatment strategies require modification of
food components or both energy intake and energy expenditure. This may be
achieved by modifying the macronutrient composition of the diet through the
use of functional food ingredients that can reduce energy intake by increasing
satiety. Dietary fibre is one of the macronutrients that appears to affect energy
intake potentially by increasing satiety (Slavin & Green, 2007; Lyly et al., 2009;
Mathem et al., 2009). Dietary calcium intake has also been suggested to be
inversely related to body weight by potentially regulating appetite (McCarron,
Morris, Henry, & Stanton 1984; Tordoff, 2001; Zemel, Shi, Greer, Dirienzo, &
Zeme 2000). The current intakes of both dietary fibre and calcium have been
shown to be lower than the recommended intake in most parts of the Middle-
East (Al-Assaf & Al-Numair 2007; Alissa, Bahijri, & Ferns 2005; Beydoun et
al. 2008). Thus, there may be a demand for lifestyle modifications in order to
increase these dietary nutrients in the diet whilst tackling the increasing rates of
obesity. The aims of this research were to investigate the acute effect of RS and
fenugreek as sources of dietary fibre, as well as calcium per se on sensations of
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appetite and voluntary food intake in in both male and female overweight/obese 
individuals, with the view that, if positive effects could be confirmed, these 
could be beneficial for the prevention/treatment of obesity. Our research has 
shown that ingestion of a high dose of RS acutely over breakfast and lunch 
resulted in a reduction in the short-term dietary intake, although no significant 
carry-over effect beyond these meals was observed. We found that RS 
consumption had a significant effect on the postprandial glucose concentration 
and resulted in more “stability” in plasma glucose levels, with no evidence of 
reactive hypoglycaemia. This so-called glucostatic theory (Mayer, 1953) may 
form part of the explanation for the food intake effects between treatment 
groups.
Following consumption of RS, there was also a trend for higher C-peptide 
levels, while no differences in insulin levels were observed. As C-peptide 
concentrations have been suggested to be a more reliable indicator of insulin 
secretion (Polonsky et al., 1988), our data suggest that RS may have increased 
insulin secretion. This is in line with previous works that found increased 
insulin secretion following RS consumption in overweight individuals 
(Bodinham et al., 2012). The lack of effect on the insulin: C-peptide ratio, 
however, suggested no up-regulation of hepatic insulin clearance in 
overweight/obese subjects. This is in contrast with works in normal weight
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subjects, which found an increased molar ratio of c-peptide: insulin following 
RS consumption, indicating increased hepatic insulin clearance (Bodinham et 
al., 2010; Robertson et al., 2003).
Although improvement in insulin sensitivity following chronic ingestion of RS 
in overweight and obese males and females has been demonstrated (Maki et al., 
2012; Bodinham et al., 2012; Robertson et al., 2012) (Maki et al., 2012), our 
acute research did not show any effect of RS consumption on meal insulin 
sensitivity in overweight and obese individuals. Thus, chronic feeding may be 
required to see the effect on insulin sensitivity.
The lack of an effect of RS on insulin sensitivity in the present research is in 
line with previous works conducted on overweight and obese subjects that have 
shown no effect of 40g of RS on insulin sensitivity after 4 weeks (Bodinham et 
al., 2012). However, many works found improvement in first-phase insulin 
secretion. This may indicate that a longer consumption of RS may affect insulin 
sensitivity. Johnston and colleges have shown improvement in insulin 
sensitivity in overweight subjects following chronic consumption of 40g of RS 
for 12 weeks (Johnston et al., 2010). Therefore, our data, together with previous 
works, indicate that chronic exposure may be required to observe any effect on 
insulin sensitivity in overweight and obese subjects who are insulin resistant
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(Maki et al., 2012; Robertson et al., 2012; Bodinham et al., 2012; Johnston et 
al., 2010) for a time-frame longer than 4 weeks.
In our research, we compared RS with a placebo that was matched in energy 
and available carbohydrate, resulting in an identical glycaemic load between 
supplements. The effect of RS on appetite has been investigated previously. 
However, these studies have replaced a proportion of carbohydrate with RS. 
Thus, the supplements were varied in terms of the amount of the glycaemic 
load, which may have affected the results (Raben et al., 1994; De Roos et al., 
1995). In these instances, RS consumption reduced the subjective feeling of 
satiety. However, this was a result of comparing two drinks that were differ in 
texture, energy and available carbohydrate (Raben et al., 1994), or lower in 
proportions of available carbohydrates (De Roos et al., 1995). Accordingly, the 
interpretation of this data has several limitations.
Data for the effect of RS on appetite and GLP-1 from direct human research are 
limited. However, consistent positive evidence of an effect of RS on appetite 
from rodent studies has shown elevated GLP-1 concentrations following the 
consumption of higher doses of RS (Zhou et al., 2008; Keenan et al., 2006; 
Shen et al., 2009), as well as an increase in proglucagon gene expression in the 
caecum and colon (Zhou et al., 2008; Keenan et al., 2006; Zhou et al., 2006). 
However, it is not possible to translate these findings directly into humans, as
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these were chronic feeding studies in rodents using both doses of RS, which 
would not be tolerated by humans, for a time-scale that formed a significant 
portion of the animals predicted lifespan. Also, often the RS feeding 
commenced in young growing animals. Thus, it might be predicted that chronic 
exposure to RS in humans may be needed to see an effect on GLP-1 
concentrations. Indeed, work on other dietary fibres has shown an increase in 
GLP-1 concentration after chronic consumption of wheat fibre, but this is only 
evident after one year (Freeland et al., 2010), which is much longer than a 
typical feeding study.
Our data indicates no significant changes in either fasting or postprandial levels 
of GLP-1 in overweight and obese subjects following consumption RS. This is 
possibly explained by the lower sensitivity to GLP-1 release in overweight and 
obese subjects (Adam & Westerterp-Plantenga, 2005). There is however, some 
evidence that GLP-1 secretion is not impaired in obese compared to lean 
subjects (Wadden et al., 2013; Damgaard et al., 2012; Feinle et al., 2002). This 
finding was further explored to address the possibility that impaired GLP-1 
secretion might be explained by body weight. Therefore, we conducted a 
subgroup analysis according to BMI. We compared the impact o f the 
consumption of RS on appetite, food intake and postprandial changes between 
overweight/obese and lean individuals.
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Our finding suggests that BMI does indeed influence GLP-1 secretion, as GLP- 
1 response was significantly reduced in overweight subjects while this remained 
the same in the lean subjects (group effect). This finding is in line with previous 
works indicating reduced postprandial GLP-1 levels in obese, rather than lean, 
subjects (Ranganath et al., 1996; Verdich, Toubro, et al., 2001; Carroll et al., 
2007; Adam & Westerterp-Plantenga, 2005; Naslund et al., 1998). Postprandial 
GLP-1 secretion was also found to be inversely proportional to BMI (Muscelli 
et al., 2008; Toft-Nielsen et al., 2001). This may be a result of dysregulated 
levels of incretin hormones and/or a reduction in their insulinotropic potency.
Some data suggest that GLP-1 secretion may be reduced because L-cell 
responsiveness to carbohydrates is impaired in those with obesity (Ranganath et 
al., 1996). This impairment may be due to the inhibition of GLP-1 secretion by 
circulating free fatty acids (Ranganath et al., 1999). However, we are not able to 
confirm that this is the mechanisms, as we did not measure NEFA. Recently, it 
has been shown that the reduced ability of the pancreatic p-cells to respond to 
incretin may result from insulin resistance and lipotoxicity to the p-cells caused 
by obesity (Knop et al., 2012). Some studies have shown that leptin resistance 
was combined with lower GLP-1 secretion in obese subjects. This may explain 
the impaired GLP-1 secretion in obese individuals (Anini & Brubaker, 2003).
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Thus, leptin resistance might also contribute to reduced levels of GLP-1 in those 
with obesity, because a lack of leptin induces GLP-1 release (Anini & 
Brubaker, 2003).
Our investigation in Chapter 4 may present a novel finding on the dietary 
responses and appetites of lean and obese subjects after RS ingestion. Both the 
obese and lean groups were provided with a preload differing only in dietary 
fibre content. The comparison of food intake, appetite ratings and metabolic 
challenge after consumption of RS indicated that, although there was no 
significant difference in appetite ratings in overweight/obese individuals 
(chapter 3), when compared with lean individuals, overweight and obese 
subjects rated lower in terms of hunger and prospective consumption and 
increased fullness. This is possibly explained by the more restrained eating of 
obese individuals compared with lean individuals, who tend to limit their food 
intake in order to maintain their body weight (Herman & Mack, 1975). While 
the obese group reported lower appetite ratings, there were no significant 
differences in energy intake between BMI groups. This finding is possibly 
explained by the effect of the cognitive, environmental and physiological 
factors. These factors could affect appetite regulation and may affect 
overweight individuals more than lean individuals (Blundell, 1990).
286
Najlaa Al-Mana Thesis
Although the effect of viscous fibre (guar gum) on appetite has been examined 
previously, few studies have investigated the acute effect of the viscous fibre 
fenugreek on appetite and satiety. Our research has found that acute 
consumption of 6g of fenugreek with a breakfast meal reduced energy intake at 
an ad libitum meal, which is in line with previous work in obese men (Mathem 
et al., 2009). No significant effect was observed during the 24 hour period. This 
indicates that the role of fenugreek fibre on appetite regulation is only relevant 
in the short-term, with no carry-over effects.
The presence of viscous fibre in the fenugreek would be expected to reduce 
food intake. This is due to the ability of viscosity to slow gastric emptying, 
decrease gut motility and reduce the nutrient absorption rate from the small 
intestine. It also has inhibitory effects on glucose absorption (Slavin & Green, 
2007; Hannan et al., 2003). However, our findings found no reduction in the 
glucose response and no effect on GLP-1 concentrations following fenugreek. 
Thus, the reduction in food intake observed is unlikely to be a result of the fibre 
viscosity. Therefore, our research finding that the reduction in short-term food 
intake was combined with the stability in the blood glucose levels, suggesting 
more likely to be consistent with the glucostatic theory of food intake regulation 
(Mayer, 1953).
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In addition to the role of fibre on appetite, emerging evidence also indicates a 
possible involvement of calcium in appetite regulation. Therefore, in the current 
research we compared the acute effect of the consumption of three enriched 
drinks that differ only in either the fenugreek fibre or calcium enrichment.
Our research presents two novel findings on the appetite responses of 
overweight and obese females following consumption of calcium. The first 
finding involves the acute effect of calcium per se on appetite regulation, 
indicating a reduction in energy intake at an ad libitum meal associated with 
lower subjective appetite ratings despite paradoxically decreased postprandial 
GLP-1 postprandial levels. However, as no significant effect for the whole 24 
hour period was observed (only for the meal containing the calcium), it is 
unclear whether this could be applied to obesity prevention. Our finding is in 
line with only a few studies of the acute effect of calcium on appetite. However, 
these studies demonstrated the effect of either dairy calcium (Lorenzen et al., 
2007; Gilbert et al., 2011; Gonzalez et al., 2013) or calcium combined with 
vitamin D (Major et al., 2009; Ping-Delfos & Soares, 2011), which may 
confound the findings. This is due to the presence of other bioactive 
components, which may have completely independent effects.
Despite the limited data on calcium and human appetite, work in rodents has 
shown that changes in intracellular calcium levels are linked to GLP-1 secretion
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in endocrine L-cells where GLP-1 is released via calcium channels or calcium 
receptors (Mace et ah, 2012). Our data, however, indicate a lowering effect of 
calcium intake on GLP-1, which may result from our meal size. For example, 
previous work investigating the effect of dairy calcium consumption has shown 
that, when the energy content of the test meal was increased, no effect on GLP- 
1 was obtained (Lorenzen et ah, 2007). A complementary study also 
investigating the effect of dairy calcium found that, when the energy contents of 
the test meal was reduced, GLP-1 was increased (Gonzalez et ah, 2013). 
Therefore, it is possible that lowering the energy contents of the meal (and so 
reducing the confounding effects of other ingested nutrients on GLP-1 
secretion) would increase the relative calcium concentrations in the 
gastrointestinal tract and lead to an elevated GLP-1 response. Taking into 
consideration the lower sensitivity to GLP-1 secretion found in overweight and 
obese individuals, we might need to reduce the energy content in our test meal 
in order to confirm the potential effect of calcium intake on GLP-1.
Our work found no significant differences in either glucose or insulin response 
following consumption of a calcium-enriched drink. This finding is in 
agreement with previous work, when supplementation with calcium alone did 
not have any effects on the glycaemic response (compared with calcium 
supplementation combined with vitamin D) (Mitri et ah, 2011).
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Supplementation with vitamin D improved pancreatic beta cell function, while 
supplementation with calcium only did not result in any significant differences 
(Mitri et ah, 2011).
Despite both the fenugreek fibre and the calcium enriched drinks separately 
resulting in a reduction in food intake, our second novel finding indicates that a 
combination of the fenugreek fibre and calcium did not produce the additive 
effect we had originally hypothesised. Several explanations for the absence of 
an additive effect in the combination drink have been examined in this study. It 
is possible that the presence of the phytic acid in the fibre potentially inhibits 
the calcium absorption by forming insoluble complexes with calcium in the GI 
tract (Weaver, 1998). Therefore, to investigate the additive effect of fibre and 
calcium on appetite and food intake we might need to use an alternative dietary 
fibre, such as RS or inulin, which have been found to enhance calcium 
absorption in animal models (Demigné et al., 1989; Ten Bruggencate et al., 
2004; Bhide et al., 2013). This effect would not be expected to affect calcium 
absorption on the short term. Therefore, long-term consumption would be 
required to achieve any potential changes in calcium absorption as a 
consequence of alternating intestinal microflora and the production of a 
prebiotic effect.
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Another possible explanation for the lack of the effect of the combination in the 
present investigation is the load of the meal, which has been shown to inversely 
correlate to calcium absorption (Weaver, 1998). Accordingly, partial dosages 
over the day may be more effective in the absorption of calcium than a single, 
larger dose.
Our research indicates that acute calcium intake reduced food intake and 
lowered satiety. In order to confirm the effect of calcium on appetite and 
(consequently) on body weight, which would be the ultimate clinical endpoint 
in any appetite research, we further explored the chronic effect of calcium 
intake and bodyweight using data from the DEFINES study. These cohort data 
reveal that consumption of dietary calcium (after adjustment for energy intake 
as a potential cofounder) was significantly related to BMI in pre-menopausal 
women. Therefore, further research studies are required to investigate the 
beneficial effects of calcium intake to place these observations on a firmer 
footing and to confirm using larger numbers.
Generally, our research suggests that dietary fibre did not increase GLP-1 
concentrations or improve insulin sensitivity when consumed acutely. The acute 
studies reported in this thesis may suggest that the effect of dietary fibre on 
appetite regulation does not act via increased GLP-1 secretion. Also, the level
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of GLP-1 has been shown to be higher in the hepatic portal vein, and may not 
appear in peripheral blood at high concentrations (Holst, 2007). Therefore,
GLP-1 measured in the general circulation may not be very indicative.
However, data linking dietary fibre and GLP-1 response are notoriously 
inconsistent in humans. This could be due differences in either the study design, 
population group, fibre form or the dose administered. Therefore, investigating 
different types of fibre on GLP-1 with higher doses and in different population 
groups may elicit different effects (A. S. Klosterbuer et al., 2012).
There were a number of limitations with the investigations reported in this 
thesis. The sample sizes used in all studies in this thesis were relatively low. 
However, the study designs for all our appetite investigations used a crossover 
design, which has been shown to increase the relative power of the study. The 
ad libitum food intake was the primary outcome for our investigations in this 
thesis. Thus, the power of the study was adequate to detect significant 
differences between groups.
The use of diet diaries to assess the food intake may have some limitations. This
method relies on an accurate recording of dietary intake during a 24 hour
period. Thus, under/misreporting may occur. Also, recording consumption for a 
single day may not be representative of the usual dietary intake. Despite those
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food diaries having been checked with the participants, insufficient details may 
affect the analysis. In addition, database limitations in food composition in 
choices and variations in recipes. Therefore, as always, data obtained from diet 
diaries need to be interpreted with caution.
All the studies reported in this thesis investigated the effect of either dietary 
fibre or calcium on the GLP-1 response only. This may not have provided a 
complete view of the findings. Therefore, it is important to measure other 
combinations of gut peptides that may affect food intake and satiety, such as 
leptin, ghrelin CCK, PYY and adiponectin, which may provide explanations 
and confirmations of our findings. In addition, all the clinical studies carried out 
within this thesis measured the total human GLP-1, rather than the active form. 
Despite this, total GLP-1 is an indicator of the secretion from intestinal L-cells; 
the active form of GLP-1 could be measured in low concentrations before 
degradation by DPP-IV. However, total GLP-1 has been suggested to be 
positively related to active GLP-1 (7-36amide) concentrations (Heijboer et al., 
2011). In the future, measurements of plasma SCFA and gastric emptying may 
be required to fully understand the impact of dietary fibre and calcium on 
appetite. We did not account for this in the current investigations due to the time 
and the cost. However, the more measurements that are taken during a study.
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the more artificial and invasive the studies become and the less likely 
participants are to behave and eat normally.
Further long-term investigations are required to understand the response of 
appetite and satiety in obesity. Moreover, long-term studies on the effect of 
calcium supplementation on satiation and food intake are needed in order to 
make better recommendations. Finally, developing products with a combination 
of fibre and calcium may be more effective in the long term. They could be 
incorporated into a wide range of food products that could facilitate appetite 
control during weight loss programmes.
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Future Work
Carry out further acute studies on larger sample size to determine the 
mechanisms by which RS decreases food intake in different population 
group such as females.
Conducting larger future chronic investigations to examine the effect of 
fermentation on appetite regulation and food intake, which may confirm 
the beneficial effect of RS for weight management. Measuring SCFA as 
well as GE may be considered to confirm the impact of RS on appetite in 
overweight individuals.
Carry out investigations to examine the role of BMI in appetite regulation 
and satiety response in the long-term with a more divers study 
population. This would clarify the mechanisms for the differences in the 
glycaemic and the hormonal responses in individuals with different BMI, 
which still require more research that may help in developing new 
treatment for obesity.
Examination of the role of other gut hormones on appetite and satiety 
such as leptin, ghrelin, CCK, PYY and adiponectin as well as other
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parameters such as triglycerides which would be interesting to measure in 
upcoming research.
The effect of the calcium on appetite is still not clear and may have 
promising results. Therefore, would be interesting to investigate the 
effect of the lower energy contents of the meal after consumption the 
calcium to see the GLP-1 response with larger sample size.
Carry out larger ftirther studies to investigate the potential impact of 
calcium on postprandial lipid metabolism, which would be interesting to 
measure chylomicron and VLDL-TG levels after a high-fat meal.
Investigating acute and chronic effect of different fibre/calcium 
combination on satiety and appetite, which may help in weight 
management. This also may include investigating the effect of different 
doses of the calcium throughout the day on the absorption hence more 
effect on appetite and satiety
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Presentations
• PGR Research Conference at University of Surrey September 2010
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• Nutrition Society summer meeting at Belfast July 2012
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Appendix: B Self-Certificate Medical Questionnaire
Study: The Acute Effects of Resistant Starch on Appetite and Satiety
This study has received a favourable ethical opinion from the University of Surrey Ethics Committee
Please tick all/any of the following that apply:
□  I have no prior/present history of Coronary Heart Disease, Angina or Stroke
□  I have no prior/present history of Type 1 or Type 2 diabetes
□  I have no prior/present history of anaemia
□  I have no prior/current history of gastrointestinal diseases (for example Crohn’s disease,
Coeliac disease. Irritable Bowel Syndrome)
□  I have no prior/present history of liver disease
□  I have no prior/present history of endocrine disorders
□  I have no prior/present history of, nor am I currently being treated for, clinical 
depression and/or other psychological disorders
□  I have no prior/present history of eating disorders, including anorexia or bulimia nervosa
□  I have no prior/present history of drug or alcohol abuse within the last 2 years
□  I am not currently taking or have taken any regular medication prescribed by my GP in 
the last 6 months
□  I am not currently taking or have taken any supplements in the last 6 months 
Signed________________________________ Date / /
N am e:..........................................................  D O B :................................................................
Address:
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Appendix: C Dutch Eating Behaviour Questionnaire (DEBQ)
Participant code Date / /
Please answer the following questions as carefully and honestly as possible. 
Read each question and simply fill in the column which best applies to you.
a 1 111
O J c / 3 U >
1. If you have put on weight, do you eat less than you usually do?
2. Do you have a desire to eat when you are irritated?
3. If food tastes good to you, do you eat more than you usually do? 14. Do you try to eat less at meal times than you would like to eat?
5. Do you have a desire to eat when you have nothing to do?
6. Do you have a desire to eat when you are depressed or discouraged?
7. If food smells and looks good, do you eat more than you usually eat? 18. How often do you refuse food or drink offered because you are coneemed about your weight?
9. Do you have a desire to eat when you are feeling lonely?
10. If you see or smell something delicious, do you have a desire to eat it? 1II. Do you watch exactly what you eat?
12. Do you have a desire to eat when somebody lets you down?
13. If you have something delicious to eat, do you eat it straight away? i14. Do you deliberately eat foods that are slimming?
15. Do you have a desire to eat when you are cross?
16. Do you have a desire to eat when you are approaching something unpleasant to happen? 117. If you walk past the baker do you have a desire to buy something delicious?
IS. When you have eaten too much, do you eat less than usual the following days?
19. Do you get a desire to eat when you are anxious, worried or tense?
20. If you walk past a snack bar or cafe, do you have a desire to buy something delicious?
21. Do you deliberately eat less in order not to become heavier?
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22. Do you have a desire to eat when things are going against you, or things have gone wrong?
123. If you see others eating, do you have also the desire to eat?24. How often do you try not to eat between meals because you are watching your weight?
25. Do you have a desire to eat when you are ftdghtened?
26. Can you resist eating delicious food? 127. How often in the evening do you try not to eat because you are watching your weight?
28. Do you have a desire to eat when you are disappointed?
29. Do you eat more than usual when you see other eating? 130. Do you take your weight into account when you eat?
31. Do you have a desire to eat when you are emotionally upset?
32. When preparing a meal are you inclined to eat something? ■
33. Do you have a desire to eat when you are bored or restless?
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Appendix D: Visual Analogue Scales to assess appetite
Participant code Date / /
Answer the following questions by placing a vertical mark through the line for each 
question. Mark the line according to how you feel at this moment. Regard both the ends of 
the lines as indicating the most extreme sensations you have ever felt.
I am not 
hungry at all
How hungry do you feel?
I have never been more 
hungry
How full do you feel?
Not at all full Extremely full
How much do you think you can eat?
A lot
Nothing at all
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How thirsty do you feel?
at all thirsty
Extremely thirsty
Would you like to eat something sweet?
at all Yes, very much
t all
t all
Would you like to eat something salty?
Yes, very much
Would you like to eat something savoury?
Yes, very much
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Would you like to eat something fatty?
Yes, very much
Not at all
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Appendix E: Visual Analogue Scales to assess palatability
Participant No: Date:
Answer the following questions by placing a vertical mark through the line for each question. 
Mark the line according to how you feel at this moment. Regard both the ends of the lines as 
indicating the most extreme sensations you have ever felt.
How pleasant is the taste of this meal right now?
Not at all pleasant Extremely pleasant
How palatable is this meal right now?
Extremely palatable
mely unpalatable
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Appendix: F Food Preferences Questionnaire
Study: The Acute Effects of Resistant Starch on Appetite and Satiety
This study has received a favourable ethical opinion from the University of Surrey Ethics 
Committee
1. a) Are you a vegetarian?
□  YES □  NO
b) If you answered yes to question La), do you eat 
Cheese □  YES □  NO
Eggs □  YES □  NO
Milk □  YES □  NO
2. Do you usually have breakfast?
□  YES □  NO
362
Najlaa Al-Mana Thesis
3. a) Are you allergie to any foods?
□  YES □  NO
b) If you answered yes to question 3.a), please state what foods you are 
allergic to -
4. a) Do you have any religious dietary
requirements?
□  YES □  NO
b) If you answered yes to question 4.a), please state -
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Appendix: G Extended Health & Lifestyle Questionnaire
Study: The Acute Effects of Fenugreek fibre and calcium on Appetite and Satiety
Date:..... / ..... / ......
Screening ID Code:
Please note you are not obliged to complete all sections, and non-completion will he without 
prejudice. All information will he kept strictly confidential.
5. Do you take the contraceptive pill?
□  YES □  NO
If you answered YES to question 1 what is the name of the contraceptive pill you take?
If you answered NO to question 2 please could you proceed to question 6?
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6. Do you use the coil (intra-uterine device), Mirena coil (intra-uterine system), 
contraceptive implant, or contraceptive injections?
□  YES □  NO
If you answered YES to question 2 which of these do you use?
If you answered NO to question 2 please could you proceed to questions 3& 4?
7. Would you describe your periods as regular or irregular?
□  REGULAR □  IRREGULAR
If you answered REGULAR to question 3, what is the approximate length of time of 
your menstrual cycle (i.e. the number of days between the start of each period)
8. a) What was the date of your last period?
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h) Approximately when do you expect your next period to start?
Thank you fo r  your time in completing this questionnaire. All information will be kept strictly
confidential at all times.
366
Najlaa Al-Mana Thesis
Appendix: H The Dinner List
> Tesco Value Sweet And Sour Chicken And Rice 300G
> Tesco Free From Lasagne 250G(vegetarian)
> Tesco Value Spaghetti Bolognese 300G
> Tesco Finest Rosemary Roasted Potatoes 45OG(vegetarian)
For the desert:
1 .iTesco Free From Bramley Apple Pies (2 portions)
>  Tesco Free From Syrup Sponge Puddings (vegetarian)
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